WO2017102068A1 - Liquid crystal mixture and liquid crystal display - Google Patents

Liquid crystal mixture and liquid crystal display Download PDF

Info

Publication number
WO2017102068A1
WO2017102068A1 PCT/EP2016/002035 EP2016002035W WO2017102068A1 WO 2017102068 A1 WO2017102068 A1 WO 2017102068A1 EP 2016002035 W EP2016002035 W EP 2016002035W WO 2017102068 A1 WO2017102068 A1 WO 2017102068A1
Authority
WO
WIPO (PCT)
Prior art keywords
atoms
compounds
liquid crystal
denotes
denote
Prior art date
Application number
PCT/EP2016/002035
Other languages
French (fr)
Inventor
Kevin Adlem
Alex HOLT
Joseph SARGENT
Ian Charles Sage
Edward Plummer
Izumi Saito
Rocco Fortte
Helga Haas
Lars Lietzau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to US16/062,824 priority Critical patent/US11053442B2/en
Priority to CN201680073732.0A priority patent/CN108368425B/en
Priority to CN202210269446.9A priority patent/CN114702965A/en
Priority to KR1020187020317A priority patent/KR20180096688A/en
Priority to JP2018531413A priority patent/JP2019508511A/en
Priority to EP16805293.4A priority patent/EP3390570B1/en
Publication of WO2017102068A1 publication Critical patent/WO2017102068A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • C09K19/2014Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups containing additionally a linking group other than -COO- or -OCO-, e.g. -CH2-CH2-, -CH=CH-, -C=C-; containing at least one additional carbon atom in the chain containing -COO- or -OCO- groups, e.g. -(CH2)m-COO-(CH2)n-
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3066Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers
    • C09K19/3068Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers chain containing -COO- or -OCO- groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3098Unsaturated non-aromatic rings, e.g. cyclohexene rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/133305Flexible substrates, e.g. plastics, organic film
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/13378Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
    • G02F1/133784Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by rubbing
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/13378Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
    • G02F1/133788Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by light irradiation, e.g. linearly polarised light photo-polymerisation
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1341Filling or closing of cells
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1343Electrodes
    • G02F1/134309Electrodes characterised by their geometrical arrangement
    • G02F1/134363Electrodes characterised by their geometrical arrangement for applying an electric field parallel to the substrate, i.e. in-plane switching [IPS]
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0466Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the linking chain being a -CF2O- chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3004Cy-Cy
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3009Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/301Cy-Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3016Cy-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring

Definitions

  • the invention relates to a liquid crystal mixture comprising a photoreactive mesogen, its use for the fabrication of liquid crystal displays (LCD) with homogeneous alignment, to a process for the fabrication of LCD by photoaligning the liquid crystal mixture after assembly of the display and to the display fabricated by said process.
  • LCD liquid crystal displays
  • Liquid-crystalline media have been used for decades in electro-optical displays for the purpose of information display.
  • the liquid crystal displays used at present are usually those of the TN ("twisted nematic") type.
  • VA vertical aligned
  • the LC cell of a VA display contains a layer of an LC medium between two transparent electrodes, where the LC medium usually has a negative value of the dielectric (DC) anisotropy.
  • DC dielectric
  • FFS farnesoid-field switching
  • FFS displays usually contain an LC medium with positive dielectric anisotropy, and an alignment layer, usually of polyimide, which provides planar alignment to the molecules of the LC medium. Furthermore, FFS displays have been disclosed (see S.H. Lee et al., AppI. Phys. Lett. 73(20), 1998, 2882-2883 and S.H. Lee et al., Liquid Crystals 39(9), 2012, 1 141-1 148), which have similar electrode design and layer thickness as FFS displays, but comprise a layer of an LC medium with negative dielectric anisotropy instead of an LC medium with positive dielectric anisotropy.
  • the LC medium with negative dielectric ansiotropy shows a more favourable director orientation that has less tilt and more twist orientation compared to the LC medium with positive dielectric anisotropy, as a result of which these displays have a higher transmission.
  • PS polymer sustained
  • PSA p_olymer sustained alignment
  • a small amount for example 0.3% by weight, typically ⁇ 1 % by weight
  • one or more polymerisable compound(s) is added to the LC medium and, after introduction into the LC cell, is polymerised or crosslinked in situ, usually by UV photopolymerisation, between the electrodes with or without an applied electrical voltage.
  • the addition of polymerisable mesogenic or liquid-crystalline compounds, also known as reactive mesogens or "RMs", to the LC mixture has proven particularly suitable.
  • PSA technology has hitherto been employed principally for LC media having negative dielectric anisotropy. Unless indicated otherwise, the term "PSA" is used below as representative of PS displays and PSA displays.
  • PSA-VA, PSA-OCB, PSA-IPS, PSA-FFS and PSA-TN displays are known.
  • the polymerisation of the polymerisable compound(s) preferably takes place with an applied electrical voltage in the case of PSA-VA and PSA-OCB displays, and with or without an applied electrical voltage in the case of PSA-IPS displays.
  • the PS(A) method results in a 'pretilf in the cell.
  • the bend structure In the case of PSA-OCB displays, for example, it is possible for the bend structure to be stabilised so that an offset voltage is unnecessary or can be reduced.
  • the pretilt has a positive effect on the response times.
  • a standard MVA or PVA pixel and electrode layout can be used for PSA-VA displays.
  • PSA-VA displays are described, for example, in JP 10-036847 A,
  • PSA-OCB displays are described, for example, in T.-J- Chen et al., Jpn. J. Appl. Phys. 45, 2006, 2702-2704 and S. H. Kim, L.-C- Chien, Jpn. J. Appl. Phys. 43, 2004, 7643-7647.
  • PSA-IPS displays are described, for example, in
  • PSA-TN displays are described, for example, in Optics Express 2004, 12(7), 1221.
  • PSA- VA-IPS displays are disclosed, for example, in WO 2010/089092 A1.
  • PSA displays can be operated as active-matrix or passive-matrix displays.
  • active- matrix displays individual pixels are usually addressed by integrated, non-linear active elements, such as, for example, transistors (for example thin-film transistors or "TFTs"), while in the case of passive-matrix displays, individual pixels are usually addressed by the multiplex method, both methods being known from the prior art.
  • transistors for example thin-film transistors or "TFTs
  • P denotes a polymerisable group, usually an acrylate or methacrylate group, as described, for example, in US 7, 169,449.
  • an orientation layer - usually a polyimide - provides the initial alignment of the liquid crystal regardless of the polymer stabilisation step of the production process.
  • Photoalignment is a technology for achieving liquid crystal (LC) alignment that avoids rubbing by replacing it with a light-induced orientational ordering of the alignment surface.
  • This can be achieved through the mechanisms of photodecomposition, photodimerization, and photoisomerization (N.A. Clark et al. Langmuir 2010, 26(22), 17482- 17488, and literature cited therein) by means of polarised light.
  • a suitably derivatised polyimide layer is required that comprises the photoreactive group.
  • a further improvement would be to avoid the use of polyimide at all.
  • VA displays this was achieved by adding a self alignment agent to the LC that induces homeotropic alignment in situ by a self assembling mechanism as disclosed in WO 2012/104008 and
  • Photocrosslinkable cinnamates are known from the prior art, e.g. of the following structure as disclosed in EP0763552. From such compounds, polymers can be obtained, for example the following
  • This material was used in a photoalignment process, as disclosed in WO 99/49360, to give an orientation layer for liquid crystals.
  • orientation layers obtained by this prosess are that they give lower voltage holding ratios (VHR) than polyimides.
  • polymerisable direactive mesogenic cinnamates are disclosed for the use in polymerisable LC mixtures for e.g. optical retarders.
  • Object of the present invention is to provide a process for the fabrication of liquid crystal displays with planar alignment, whilist avoiding the rubbing process.
  • the process may be useable without polyimide on the bottom and top substrates, with poiymide on one substrate only, or with polyimide on both substrates, thus avoiding the problems involved with the rubbing process and offering to facilitate the simplification of the production process significantly.
  • liquid crystal mixtures comprising a photoalignment component A) comprising one or more photoreactive mesogens of formula I below, and a liquid-crystalline component B), hereinafter also referred to as "LC host mixture", comprising one or more mesogenic or liquid-crystalline compounds, wherein formula I is as follows: denotes an aryl or heteroaryl group, which may be substituted by one or more radicals L, are each, independently of one another, defined like A 11 or denote a cycloalkyl group having 3 to 10 C atoms, in which 1 to 4 non-adjacent CH2 groups may be replaced by O and in which one or more H atoms may be replaced by a group L, on each occurrence, identically or differently, denotes OH, F, CI, Br, I, -CN, -NO2, SF 5 , -NCO, -NCS, -OCN, - SCN, -N(R Z ) 2 , optionally substituted si
  • R 11 and R 2 identically or differently, denote a group P-Sp-, or halogen, CN, optionally fluorinated alkyl or alkenyl with up to 15 C atoms in which one or more non adjacent Ch -groups may be replaced by -0-, -S-, -CO-, -C(O)O-, -O-C(O)-, O-C(O)-O-, with the proviso that at least one of R 1 and R 12 denotes a group P-Sp-, preferably both of R 11 and R 12 denote P-Sp-,
  • R z each, independently of one another, denote H or alkyl having 1-12 C atoms,
  • Sp a spacer group or a single bond
  • a 0 or 1.
  • the present invention further relates to a process for the fabrication of liquid crystal displays comprising at least the steps of:
  • a first substrate which includes a pixel electrode and a common electrode for generating an electric field substantially parallel to a surface of the first substrate in the pixel region;
  • the second substrate being disposed opposite to the first substrate
  • liquid crystal mixture interposing a liquid crystal mixture between the first substrate and the second substrate, the liquid crystal mixture comprising component A), component B) and optionally component C);
  • the present invention further relates to the use of the liquid crystal mixtures according to the invention for the fabrication of a liquid crystal display.
  • the present invention further relates to liquid crystal displays fabricated by the process described above.
  • the invention further relates to a compound of formula I above, wherein one or both of the groups Sp denote a single bond.
  • a photoreactive group according to the present invention is a functional group of a molecule that causes a change of the geometry of the molecule either by bond rotation, skeletal rearrangement or atom- or group- transfer, or by dimerisation, upon irradiation with light of a suitable wavelength that can be absorbed by the molecule.
  • mesogenic group as used herein is known to the person skilled in the art and described in the literature, and means a group which, due to the anisotropy of its attracting and repelling interactions, essentially contributes to causing a liquid-crystal (LC) phase in low-molecular-weight or polymeric substances.
  • LC liquid-crystal
  • Compounds containing mesogenic groups do not necessarily have to have an LC phase themselves. It is also possible for mesogenic compounds to exhibit LC phase behaviour only after mixing with other compounds and/or after polymerisation. Typical mesogenic groups are, for example, rigid rod- or disc-shaped units.
  • a photoreactive mesogen according to the present invention is a mesogenic compound comprising one or more photoreactive groups.
  • Examples of molecular structures and sub-structures comprising such photoreactive groups are stilbene, (1 ,2-difluoro-2-phenyl-vinyl)-benzene, cinnamate, 4-phenylbut-3-en-2-one, chalcone, coumarin, chromone, pentalenone and azobenzene.
  • the term "linearly polarised light” means light, which is at least partially linearly polarized.
  • the aligning light is linearly polarized with a degree of polarization of more than 5:1.
  • Wavelengths, intensity and energy of the linearly polarised light are chosen depending on the photosensitivity of the photoalignable material.
  • the wavelengths are in the UV-A, UV-B and/or UV-C range or in the visible range.
  • the linearly polarised light comprises light of wavelengths less than 450 nm, more preferably less than 420 nm.
  • organic group denotes a carbon or hydrocarbon group.
  • carbon group denotes a mono- or polyvalent organic group containing at least one carbon atom, where this either contains no further atoms (such as, for example, -C ⁇ C-) or optionally contains one or more further atoms, such as, for example, N, O, S, P, Si, Se, As, Te or Ge (for example carbonyl, etc.).
  • hydrocarbon group denotes a carbon group which additionally contains one or more H atoms and optionally one or more heteroatoms, such as, for example, N, O, S, P, Si, Se, As, Te or Ge.
  • Healogen denotes F, CI, Br or I.
  • a carbon or hydrocarbon group can be a saturated or unsaturated group. Unsaturated groups are, for example, aryl, alkenyl or alkynyl groups.
  • a carbon or hydrocarbon radical having 3 or more atoms can be straight- chain, branched and/or cyclic and may also contain spiro links or condensed rings.
  • alkyl also encompass polyvalent groups, for example alkylene, arylene, heteroarylene, etc.
  • aryl denotes an aromatic carbon group or a group derived therefrom.
  • heteroaryl denotes “aryl” as defined above, containing one or more heteroatoms.
  • Preferred carbon and hydrocarbon groups are optionally substituted alkyl, alkenyl, alkynyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy and alkoxycarbonyloxy having 1 to 40, preferably 1 to 25, particularly preferably 1 to 18, C atoms, optionally substituted aryl or aryloxy having 6 to 40, preferably 6 to 25, C atoms, or optionally substituted alkylaryl, aryl- alkyl, alkylaryloxy, arylalkyloxy, arylcarbonyl, aryloxycarbonyl, aryl- carbonyloxy and aryloxycarbonyloxy having 6 to 40, preferably 6 to 25, C atoms.
  • carbon and hydrocarbon groups are C1-C40 alkyl, C2-C40 alkenyl, C2-C40 alkynyl, C3-C40 allyl, C4-C40 alkyldienyl, C4-C40 polyenyl, C6-C40 aryl, C6-C40 alkylaryl, C6-C40 arylalkyl, C6-C40 alkylaryloxy, C6-C40 arylalkyloxy, C2-C40 heteroaryl, C4-C40 cycloalkyl, C4-C40 cycloalkenyl, etc.
  • C1-C22 alkyl Particular preference is given to C1-C22 alkyl, C2-C22 alkenyl, C2-C22 alkynyl, C3-C22 allyl, C4-C22 alkyldienyl, C6-C12 aryl, C6-C20 arylalkyl and C2-C20 heteroaryl.
  • R z preferably denotes H, halogen, a straight-chain, branched or cyclic alkyl chain having 1 to 25 C atoms, in which, in addition, one or more non- adjacent C atoms may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO- or -O-CO-O- and in which one or more H atoms may be replaced by fluorine, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.
  • Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 2-methylbutyl, n-pentyl, s-pentyl, cyclo- pentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl and perfluorohexyl.
  • Preferred alkenyl groups are, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl and cyclooctenyl.
  • Preferred alkynyl groups are, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl and octynyl.
  • Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy- ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy and n-dodecoxy.
  • Preferred amino groups are, for example, dimethylamino, methylamino, methylphenylamino and phenylamino.
  • Aryl and heteroaryl groups can be monocyclic or polycyclic, i.e. they can contain one ring (such as, for example, phenyl) or two or more rings, which may also be fused (such as, for example, naphthyl) or covalently bonded (such as, for example, biphenyl), or contain a combination of fused and linked rings.
  • Heteroaryl groups contain one or more
  • heteroatoms preferably selected from O, N, S and Se.
  • a ring system of this type may also contain individual non-conjugated units, as is the case, for example, in the fluorene basic structure.
  • aryl groups having 6 to 25 C atoms and mono-, bi- or tricyclic heteroaryl groups having 2 to 25 C atoms, which optionally contain fused rings and are optionally substituted.
  • Preferred aryl groups are derived, for example, from the parent structures benzene, biphenyl, terphenyl, [1 , 1 ':3',1 "]terphenyl, naphthalene, anthracene, binaphthyl, phenanthrene, pyrene, dihydropyrene, chrysene, peryl- ene, tetracene, pentacene, benzopyrene, fluorene, indene,
  • heteroaryl groups are, for example, 5-membered rings, such as pyrrole, pyrazole, imidazole, 1 ,2,3-triazole, 1 ,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxazole, isoxazole, 1 ,2-thiazole, 1 ,3-thiazole, 1 ,2,3-oxadiazole, 1 ,2,4-oxadiazole, 1 ,2,5-oxadiazole, 1 ,3,4-oxadiazole, 1 ,2,3-thiadiazole, ,2,4-thiadiazole, 1 ,2,5-thiadiazole, 1 ,3,4-thiadiazole, 6-membered rings, such as pyridine, pyridazine, pyrimidine, pyrazine, 1 ,3,5-tria
  • phenothiazine phenoxazine
  • benzopyridazine benzopyrimidine
  • quinoxaline phenazine, naphthyridine, azacarbazole
  • benzocarboline phenanthridine, phenanthroline, thieno[2,3b]thiophene
  • heteroaryl groups may also be substituted by alkyl, alkoxy, thioalkyi, fluorine, fluoroalkyi or further aryl or heteroaryl groups.
  • the (non-aromatic) alicyclic and heterocyclic groups encompass both saturated rings, i.e. those containing exclusively single bonds, and also partially unsaturated rings, i.e. those which may also contain multiple bonds.
  • Heterocyclic rings contain one or more heteroatoms, preferably selected from Si, O, N, S and Se.
  • the (non-aromatic) alicyclic and heterocyclic groups can be monocyclic, i.e. contain only one ring (such as, for example, cyclohexane), or poly- cyclic, i.e. contain a plurality of rings (such as, for example, decahydro- naphthalene or bicyclooctane). Particular preference is given to saturated groups. Preference is furthermore given to mono-, bi- or tricyclic groups having 3 to 25 C atoms, which optionally contain fused rings and are optionally substituted.
  • Preferred alicyclic and heterocyclic groups are, for example, 5-membered groups, such as cyclopentane, tetrahydrofuran, tetrahydrothiofuran, pyrrolidine, 6-membered groups, such as cyclohexane, silinane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1 ,3-dioxane, 1,3- dithiane, piperidine, 7-membered groups, such as cycloheptane, and fused groups, such as tetrahydronaphthalene, decahydronaphthalene, indane, bicyclo[1.1.1 ]pentane-1 ,3-diyl, bicyclo[2.2.2]octane-1 ,4-diyl, spiro[3.3]heptane-2,6-diyl, octahydro-4,7-methan
  • the aryl, heteroaryl, carbon and hydrocarbon radicals optionally have one or more substituents, which are preferably selected from the group comprising silyl, sulfo, sulfonyl, formyl, amine, imine, nitrile, mercapto, nitro, halogen, C1-12 alkyl, C6-12 aryl, C1-12 alkoxy, hydroxyl, or combinations of these groups.
  • Preferred substituents are, for example, solubility-promoting groups, such as alkyl or alkoxy, and electron-withdrawing groups, such as fluorine, nitro or nitrile.
  • Substituted silyl or aryl preferably means substituted by halogen, -CN, -CO-RV 1 , -CO-O-Rv 1 , -O-CO-Ry or -O-CO-O-Rv 1 , in which R has the meaning indicated above.
  • substituents L are, for example, F, CI, CN, CFb, C2H5, -CH(CH 3 )2, OCH3, OC2H5, CF 3 , OCFs, OCHF2, OC2F5, furthermore phenyl.
  • the liquid crystal mixture according to the present invention further comprises a polymerisable component C) comprising one or more polymerisable compounds of formula P
  • Sp a , Sp b on each occurrence denote a spacer group, s1 , s2 each, independently of one another, denote 0 or 1 ,
  • a 1 , A 2 each, independently of one another, denote a radical selected from the following groups: a) the group consisting of trans-1 ,4-cyclohexylene, ,4- cyclohexenylene and 4,4 ' -bicyclohexylene, wherein, in addition, one or more non-adjacent CH2 groups may be replaced by -O- and/or -S- and wherein, in addition, one or more H atoms may be replaced by F, the group consisting of 1 ,4-phenylene and 1 ,3-phenylene, wherein, in addition, one or two CH groups may be replaced by N and wherein, in addition, one or more H atoms may be replaced by L, the group consisting of tetrahydropyran-2,5-diyl, 1 ,3-diox- ane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobutane-1 ,3
  • selenophene-2,5-diyl each of which may also be mono- or polysubstituted by L, the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may, in addition, be replaced by heteroatoms, preferably selected from the group consisting of
  • one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, denotes 0, 1 , 2 or 3, in each case, independently of one another, denotes -CO-0-, -0-CO-, -CH2O-, -OCH2-, -CF2O-, -OCF2-, or -(CH 2 )n-, where n is 2, 3 or 4, -0-, -CO-, -C(RyR z )-, -CH2CF2-, -CF2CF2- or a single bond, on each occurrence, identically or differently, denotes F, CI, CN, SCN, SF5 or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having
  • R y , R z each, independently of one another, denote H, F or straight-chain or branched alkyl having 1 to 12 C atoms, wherein, in addition, one or more H atoms may be replaced by F,
  • M denotes -O-, -S-, -CH 2 -, -CHY 1 - or -CY 1 Y 2 -, and
  • Y and Y 2 each, independently of one another, have one of the meanings indicated above for R y or denote CI or CN.
  • the polymerisable groups P and P a b are groups that are suitable for a polymerisation reaction, such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer- analogous reaction, for example addition or condensation onto a main polymer chain.
  • P and P a b are selected from the group consisting of
  • CW 1 CH-CO-(O)k3-
  • CW 1 CH-CO-NH-
  • CH 2 CW -CO-NH-
  • W 1 denotes H, F, CI, CN, CF 3 , phenyl or alkyl having 1 to 5 C atoms, in particular H, F, CI or CH3, W 2 and W 3 each, independently of one another, denote H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl or n-propyl, W 4 , W 5 and W 6 each, independently of one another, denote CI, oxaalkyl or oxacarbony
  • Very particularly preferred groups P and P a b are selected from the grouf consisting of acrylate, methacrylate, fluoroacrylate, furthermore vinyloxy chloroacrylate, oxetane and epoxide groups, and of these preferably an acrylate or methacrylate group.
  • Preferred spacer groups Sp and Sp a b are selected from the formula Sp" X", so that the radicals P-Sp- and p a/b -Sp a/b - conforms to the formulae P-Sp"-X"- and P a/b -Sp"-X"-, respectively, wherein Sp" denotes alkylene having 1 to 20, preferably 1 to 12, C atoms, which is optionally mono- or polysubstituted by F, CI, Br, I or CN and wherein, in addition, one or more non- adjacent CH2 groups may each be replaced,
  • X denotes -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-,
  • R 000 each, independently of one another, denote H or alkyl having 1 to 12 C atoms, and
  • Y 3 and Y 4 each, identically or differently, denote H, F, CI or CN.
  • X" is preferably -O-, -S-, -CO-, -C(O)O-, -OC(O)-, -O-C(O)O-, -CO-NR 0 -, -NR°-CO-, -NR°-CO-NR°- or a single bond.
  • Typical spacer groups Sp are, for example, -(CH2)pi-,
  • Particularly preferred groups Sp are, for example, in each case straight- chain ethylene, propylene, butylene, pentylene, hexylene, heptylene, octy- lene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyl- eneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene- N-methyliminoethylene, 1-methylalkylene, ethenylene, propenylene and butenylene.
  • the compounds of formula I are preferably selected from compounds of the sub-formulae 1-1 to I-8.
  • R 11 and R 2 and L are defined as indicated above and r, on each occurrence, identically or differently, is 0, 1 or 2.
  • the group preferably denotes
  • L has the meaning indicated above and preferably denotes alkyl or alkoxy having 1 to 8 C atoms, halogen or CN.
  • Particularly preferred compounds of formula I are selected from sub- formulae 1-1 -1 1-3-1 and I-3-2
  • L denotes alkyl or alkoxy having 1 to 6 C atoms, CI, or F,
  • P denotes, identically or differently, acrylate or methacrylate
  • Sp denotes, identically or differently, (Chbjt, -0(CH2)t, or a single bond, and t is an integer from 2 to 12, preferably from 2 to 8.
  • Preferred compounds of formulae 1-1-1 , 1-3-1 and I-3-2 are compounds of the following sub-formulae:
  • P 1 to P 3 each, independently of one another, denote a polymerisable group as defined for formula P, preferably an acrylate, meth- acrylate, fluoroacrylate, oxetane, vinyloxy or epoxide group,
  • Sp 1 to Sp 3 each, independently of one another, denote a single bond or a spacer group, preferably having one of the meanings indicated above and below for Sp a , and particularly preferably -(CH 2 )pi -, -(CH 2 )pi-0-, -(CH 2 ) P i-CO-0- or -(CH 2 ) P i-O-CO-O-, wherein p1 is an integer from 1 to 12, and where the linking to the adjacent ring in the last-mentioned groups takes place via the O atom, where, in addition, one or more of the radicals P 1 -Sp 1 - , P 2 -Sp 2 - and P 3 -Sp 3 - may denote a radical R aa , with the proviso that at least one of the radicals P 1 -Sp 1 - , P 2 -Sp 2 - and P 3 -Sp 3 - present does not denote R aa ,
  • R°, R 00 each, independently of one another, denote H or alkyl
  • R y and R z each, independently of one another, denote H, F, Chb or
  • ZP 1 denotes -O-, -CO-, -C(R y R 2 )- or -CF2CF2-,
  • Z p2 and ZP 3 each, independently of one another, denote -CO-O-,
  • CN SCN, SF5 or straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or
  • alkoxycarbonyloxy having 1 to 12 C atoms, preferably F,
  • L' and l_" each, independently of one another, denote H, F or CI, r denotes 0, 1 , 2, 3 or 4,
  • s denotes 0, 1 , 2 or 3,
  • t denotes 0, 1 or 2
  • x denotes 0 or .
  • the LC mixture, or component C comprises one or more compounds of formula P10-1.
  • P 1 and P 2 preferably denote acrylate or methacrylate.
  • Particularly preferred compounds of formula P10-1 are selected from the group of the following subformulae
  • n4 denote independently of each other an integer between 2 and 10, preferably 3,4,5 or 6.
  • the polymerisable compounds of formulae I and P are also suitable for polymerisation without an initiator, which is associated with considerable advantages, such as, for example, lower material costs and, in particular, reduced contamination of the LC medium by possible residual amounts of the initiator or degradation products thereof.
  • the polymerisation can thus also be carried out without addition of an initiator.
  • the LC medium thus, in a preferred embodiment, comprises no polymerisation initiator.
  • the polymerisable component C) or the LC medium as a whole may also comprise one or more stabilisers in order to prevent undesired
  • stabilisers are known to the person skilled in the art and are described in the literature. Particularly suitable are, for example, the commercially available stabilisers from the Irganox® series (BASF SE), such as, for example, Irganox® 1076. If stabilisers are employed, their proportion, based on the total amount of the RMs or the polymerisable component, is preferably 10 - 10,000 ppm, particularly preferably 50 - 1000 ppm.
  • the LC-host mixture (component B) comprises one or more, preferably two or more, low-molecular-weight (i.e. monomeric or unpolymerised) compounds.
  • the latter are stable or unreactive with respect to a polymerisation reaction or photoalignment under the conditions used for the polymerisation of the polymerisable compounds or photoalignment of the photoreactive mesogen of formula I.
  • a suitable host mixture is any dielectrically negative or positive LC mixture which is suitable for use in conventional VA, IPS or FFS displays.
  • Suitable LC mixtures are known to the person skilled in the art and are described in the literature.
  • LC media for VA displays having negative dielectric anisotropy are described in for example EP 1 378 557 A1.
  • Suitable LC mixtures having positive dielectric anisotropy which are suitable for LCDs and especially for IPS displays are known, for example, from JP 07-181 439 (A), EP 0 667 555, EP 0 673 986, DE 195 09 410, DE 195 28 106, DE 195 28 107, WO 96/23 851 , WO 96/28 521 and WO2012/079676.
  • Preferred embodiments of the liquid-crystalline medium having negative or positive dielectric anisotropy according to the invention are indicated below and explained in more detail by means of the working examples.
  • the LC host mixture is preferably a nematic LC mixture, and preferably does not have a chiral LC phase.
  • the LC medium contains an LC host mixture with negative dielectric anisotropy.
  • Preferred embodiments of such an LC medium, and the corresponding LC host mixture, are those of sections a)-z) below: a) LC medium which comprises one or more compounds of the formu- lae CY and/or PY:
  • -CH CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CO-O-,
  • L '4 each, independently of one another, denote F, CI, OCF3,
  • both L 1 and L 2 denote F or one of L 1 and L 2 denotes F and the other denotes CI
  • both L 3 and L 4 denote F or one of L 3 and L 4 denotes F and the other denotes CI.
  • the compounds of the formula CY are preferably selected from the group consisting of the following sub-formulae:
  • alkyl and alkyl * each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
  • alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms
  • (O) denotes an oxygen atom or a single bond.
  • the compounds of the formula PY are preferably selected from the group consisting of the following sub-formulae:
  • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
  • alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms
  • (O) denotes an oxygen atom or a single bond.
  • the compounds of the formula ZK are preferably selected from the group consisting of the following sub-formulae:
  • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
  • alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms.
  • Particularly preferred compounds of formula ZK1 and ZK3 are selected from the following sub-formulae:
  • propyl, butyl and pentyl groups are straight-chain groups.
  • LC medium which additionally comprises one or more compounds of the following formula:
  • R 5 and R 6 each, independently of one another, denote alkyl
  • the compounds of the formula DK are preferably selected from the group consisting of the following sub-formulae: DK9 alkyl— ⁇ H V— O O O >— alkyl * K10 alkyl— H O O V— ( D
  • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
  • alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms.
  • L and L 2 each, independently of one another, denote F, CI, OCF3,
  • both radicals L 1 and L 2 denote F or one of the radicals L 1 and L 2 denotes F and the other denotes CI.
  • the compounds of the formula LY are preferably selected from the group consisting of the following sub-formulae:
  • R 1 has the meaning indicated above, alkyl denotes a straight-chain alkyl radical having 1-6 C atoms, (O) denotes an oxygen atom or a single bond, and v denotes an integer from 1 to 6.
  • LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
  • alkyl denotes Ci-6-alkyl
  • L x denotes H or F
  • Particular preference is given to compounds of the formula G1 in which X denotes F.
  • LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
  • R 5 has one of the meanings indicated above for R 1 , alkyl denotes C-i-6-alkyl, d denotes 0 or 1 , and z and m each, independently of one another, denote an integer from 1 to 6.
  • R 5 in these compounds is particularly preferably d-6-alkyl or -alkoxy or C2-6-alkenyl, d is preferably 1.
  • the LC medium according to the invention preferably comprises one or more compounds of the above-mentioned formulae in amounts of > 5% by weight.
  • LC medium which additionally comprises one or more biphenyl compounds selected from the group consisting of the following formulae:
  • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
  • alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms.
  • the proportion of the biphenyls of the formulae B1 to B3 in the LC mixture is preferably at least 3% by weight, in particular > 5% by weight.
  • the compounds of the formula B2 are particularly preferred.
  • the compounds of the formulae B1 to B3 are preferably selected from the group consisting of the following sub-formulae:
  • alkyl* denotes an alkyl radical having 1-6 C atoms.
  • the medium according to the invention particularly preferably comprises one or more compounds of the formulae B1a and/or B2c.
  • LC medium which additionally comprises one or more terphenyl compounds of the following formula: in which R 5 and R 6 each, independently of one another, have one of the meanings indicated above, and
  • L 5 denotes F or CI, preferably F
  • L 6 denotes F, CI, OCF 3 , CF 3 , Chb, CH2F or CHF 2 , preferably F.
  • the compounds of the formula T are preferably selected from the group consisting of the following sub-formulae:
  • R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms
  • R* denotes a straight-chain alkenyl radical having 2-7 CQ atoms
  • (O) denotes an oxygen atom or a single bond
  • R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, meth- oxy, ethoxy, propoxy, butoxy or pentoxy.
  • the LC medium according to the invention preferably comprises the terphenyls of the formula T and the preferred sub-formulae thereof ino an amount of 0.5-30% by weight, in particular 1-20% by weight.
  • R preferably denotes alkyl, furthermore alkoxy, each having 1-5 C atoms.
  • the terphenyls are preferably employed in mixtures according to the invention if the ⁇ value of the mixture is to be > 0.1.
  • Preferred mixtures comprise 2-20% by weight of one or more terphenyl compounds of the formula T, preferably selected from the group of com-0 pounds T1 to T22.
  • LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
  • R 1 and R 2 have the meanings indicated above and preferably each, independently of one another, denote straight-chain alkyl having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms.
  • Preferred media comprise one or more compounds selected from the formulae O1 , O3 and 04.
  • R 9 denotes H, Chh, C2H5 or n-C3H7
  • (F) denotes an optional fluorine substituent
  • q denotes 1 , 2 or 3
  • R 7 has one of the meanings indicated for R 1 , preferably in amounts of > 3% by weight, in particular > 5% by weight and very particularly preferably 5-30% by weight.
  • Particularly preferred compounds of the formula Fl are selected from the group consisting of the following sub-formulae:
  • LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae: in which R 8 has the meaning indicated for R 1 , and alkyl denotes a straight-chain alkyl radical having 1-6 C atoms.
  • LC medium which additionally comprises one or more compounds which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds selected from the group consisting of the following formulae:
  • R 10 and R 1 each, independently of one another, denote alkyl
  • Z 1 and Z 2 each, independently of one another, denote -C2H4-,
  • LC medium which additionally comprises one or more difluoro- dibenzochromans and/or chromans of the following formulae:
  • R 11 and R 2 each, independently of one another, have one of the meanings indicated above for R 1 ,
  • ring M is trans-1 ,4-cyclohexylene or ,4-phenylene
  • c 0, 1 or 2
  • Particularly preferred compounds of the formulae BC, CR and RC are selected from the group consisting of the following sub-formulae:
  • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms
  • (O) denotes an oxygen atom or a single bond
  • c is 1 or 2
  • alkenyl and alkenyl * each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms.
  • Alkenyl and alkenyl* preferably denote
  • LC medium which additionally comprises one or more fluorinated phenanthrenes and/or dibenzofurans of the following formulae:
  • R 11 and R 12 each, independently of one another, have one of the meanings indicated above for R 11 , b denotes 0 or 1 , L denotes F, and r denotes 1 , 2 or 3.
  • Particularly preferred compounds of the formulae PH and BF are selected from the group consisting of the following sub-formulae:
  • R and R' each, independently of one another, denote a straight-chain alkyl or alkoxy radical having 1-7 C atoms.
  • L and L 2 each, independently of one another, denote F, CI, OCF3,
  • both L 1 and L 2 denote F or one of L 1 and L 2 denotes F and the other denotes CI,
  • the compounds of the formula Y are preferably selected from the group consisting of the following sub-formulae:
  • Alkoxy denotes a straight-chain alkoxy radical having 1 -6 C atoms
  • O denotes an oxygen
  • Particularly preferred compounds of the formula Y are selected from the group consisting of the following sub-formulae:
  • Alkoxy preferably denotes straight-chain alkoxy with 3, 4, or 5 C atoms.
  • LC medium which comprises 1 to 5, preferably 1 , 2 or 3, stabilisers, preferably selected from stabilisers according to the invention, in particular of the formula I or sub-formulae thereof.
  • LC medium in which the proportion of stabilisers, in particular of the formula I or sub-formulae thereof, in the mixture as a whole is 1 to 1500ppm, preferably 100 to l OOOppm.
  • LC medium which comprises 1 to 8, preferably 1 to 5, compounds of the formulae CY1 , CY2, PY1 and/or PY2.
  • the proportion of these compounds in the mixture as a whole is preferably 5 to 60%, particularly preferably 10 to 35%.
  • the content of these individual com- pounds is preferably in each case 2 to 20%.
  • LC medium which comprises 1 to 8, preferably 1 to 5, compounds of the formulae CY9, CY10, PY9 and/or PY10.
  • the proportion of these compounds in the mixture as a whole is preferably 5 to 60%, particu- larly preferably 10 to 35%.
  • the content of these individual compounds is preferably in each case 2 to 20%.
  • v) LC medium which comprises 1 to 10, preferably 1 to 8, compounds of the formula ZK, in particular compounds of the formulae ZK1 , ZK2 and/or ZK6.
  • the proportion of these compounds in the mixture as a whole is preferably 3 to 25%, particularly preferably 5 to 45%.
  • the content of these individual compounds is preferably in each case 2 to 20%.
  • w) LC medium in which the proportion of compounds of the formulae CY, PY and ZK in the mixture as a whole is greater than 70%, preferably greater than 80%.
  • alkenyl group preferably selected from the group consisting of formula CY, PY and LY, wherein one or both of R 1 and R 2 denote straight-chain alkenyl having 2-6 C atoms, formula ZK and DK, wherein one or both of R 3 and R 4 or one or both of R 5 and R 6 denote straight-chain alkenyl having 2-6 C atoms, and formula B2 and B3, very preferably selected from formulae CY15,
  • the concentration of these compounds in the LC host mixture is preferably from 2 to 70%, very preferably from 3 to 55%.
  • LC medium which contains one or more, preferably 1 to 5, compounds selected of formula PY1-PY8, very preferably of formula PY2.
  • the proportion of these compounds in the mixture as a whole is preferably 1 to 30%, particularly preferably 2 to 20%.
  • the content of these individual compounds is preferably in each case 1 to 20%.
  • LC medium which contains one or more, preferably 1, 2 or 3, compounds of formula T2.
  • the content of these compounds in the mixture as a whole is preferably 1 to 20%.
  • the LC medium contains an LC host mixture with positive dielectric anisotropy.
  • Preferred embodiments of such an LC medium, and the corresponding LC host mixture, are those of sections aa) - mmm) below:
  • LC-medium characterised in that it comprises one or more compounds selected from the group of compounds of the formul and III
  • R 20 each, identically or differently, denote a halogenated or un- substituted alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by
  • X 20 each, identically or differently, denote F, CI, CN, SF5, SCN,
  • NCS a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical, each having up to 6 C atoms, and ⁇ 20 24 each, identically or differently, denote H or F; ther, denote
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • X 20 preferably denotes F.
  • Particular preference is given to compounds of the formulae lla and lib, in particular compounds of the formulae lla and Mb wherein X denotes F.
  • the compounds of the formula III are preferably selected from the following formulae:
  • R 20 and X 20 have the meanings indicated above.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • X 20 preferably denotes F.
  • Particular preference is given to compounds of the formulae Ilia and I lie, in particular compounds of the formula Ilia;
  • LC-medium additionally comprising one or more compounds selected from the following formulae:
  • the compounds of the formula IV are preferably selected from the following formulae:
  • R 20 and X 20 have the meanings indicated above.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • the compounds of the formula V are preferably selected from the following formulae:
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • the compounds of the formula VI are preferably selected from the following formulae:
  • R 20 and X 20 have the meanings indicated above.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • the compounds of the formula VII are preferably selected from the following formulae:
  • R 20 and X 20 have the meanings indicated above.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • the medium additionally comprises one or more compounds selected from the formulae ZK1 to ZK10 given above. Especially preferred are compounds of formula ZK1 and ZK3. Particularly preferred compounds of formula ZK are selected from the sub- formulae ZK1a, ZK1 b, ZK1c, ZK3a, ZK3b, ZK3c and ZK3d.
  • the medium additionally comprises one or more compounds selected from the formulae DK1 to DK12 given above. Especially preferred compounds are DK3.
  • the medium additionally comprises one or more compounds selected from the following formulae:
  • L denotes H or F
  • alkenyl denotes C2-6-alkenyl.
  • the compounds of the formulae DK-3a and IX are preferably selected from the following formulae:
  • alkyl denotes Ci-6-alkyl, preferably n-C3H7, n-C H9 or n- C5H11 , in particular n-C3H7.
  • the medium additionally comprises one or more compounds selected from the formulae B1 , B2 and B3 given above, preferably from the formula B2.
  • the compounds of the formulae B1 to B3 are particularly preferably selected from the formulae B1 a, B2a, B2b and B2c.
  • the medium additionally comprises one or more compounds selected from the following formula: wherein L 20 denotes H or F, and R 21 and R 22 each, identically or differently, denote n-alkyl, alkoxy, oxaalkyi, fluoroalkyi or alkenyl, each having up to 6 C atoms, and preferably each, identically or differently, denote alkyl having 1 to 6 C atoms.
  • the medium comprises one or more compounds of the following formulae:
  • R 20 , X 20 and Y 20"23 have the meanings indicated
  • R 20 and X 20 have the meaning indicated above and preferably R 20 denotes alkyl having 1 to 6 C atoms and X 20 denotes F.
  • the mixture according to the invention particularly preferably comprises at least one compound of the formula Xlla and/or Xlle.
  • the medium comprises one or more compounds of formula T given above, preferably selected from the group of compounds of the formulae T21 toT23 and T25 to T27. Particular preference is given to the compounds of the formulae T21 to T23. Very particular preference is given to the compounds of the formulae
  • the medium comprises one or more compounds selected from the group of formulae DK9, DK10 and DK1 1 given above.
  • the medium additionally comprises one or more compounds selected from the following formulae:
  • R 20 and X 20 each, independently of one another, have one of the meanings indicated above, and Y 20"23 each, independently of one another, denote H or F.
  • X 20 is preferably F, CI, CF3, OCF3 or OCHF2.
  • R 20 preferably denotes alkyl, alkoxy, oxaalkyi, fluoroalkyi or alkenyl, each having up to 6 C atoms.
  • the mixture according to the invention particularly preferably comprises one or more compounds of the formula XVIII-a,
  • R 20 has the meanings indicated above.
  • R 20 preferably denotes straight-chain alkyl, in particular ethyl, n-propyl, n-butyl and n-pentyl and very particularly preferably n-propyl.
  • the compound(s) of the formula XVIII, in particular of the formula XVIII-a, is (are) preferably employed in the mixtures according to the invention in amounts of 0.5- 20% by weight, particularly preferably 1-15% by weight.
  • the medium additionally comprises one or more compounds of the formula XIX,
  • R 20 , X 20 and Y 20"25 have the meanings indicated in formula I, s denotes 0 or 1 , and
  • X 20 may also denote an alkyl radical having 1-6 C atoms or an alkoxy radical having 1-6 C atoms.
  • the alkyl or alkoxy radical is preferably straight-chain.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • X 20 preferably denotes F;
  • the compounds of the formula XIX are preferably selected from the following formulae:
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • X 20 preferably denotes F, and Y 20 is preferably F;
  • R 20 is straight-chain alkyl or alkenyl having 2 to 6 C atoms
  • the medium comprises one or more compounds of the formulae G1 to G4 given above, preferably selected from G1 and G2 wherein alkyl denotes C-i -6-alkyl, L x denotes H and X denotes F or CI. In G2, X particularly preferably denotes CI.
  • the medium comprises one or more compounds of the following formulae:
  • R 20 and X 20 have the meanings indicated above.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • X 20 preferably denotes F.
  • the medium according to the invention particularly preferably comprises one or more compounds of the formula XXII wherein X 20 preferably denotes F.
  • XX - XXII is (are) preferably employed in the mixtures according to the invention in amounts of 1-20% by weight, particularly preferably 1-15% by weight.
  • Particularly preferred mixtures comprise at least one compound of the formula XXII.
  • the medium comprises one or more compounds of the following pyrimidine or pyridine compounds of the formulae
  • R 20 and X 20 have the meanings indicated above.
  • R 20 preferably denotes alkyl having 1 to 6 C atoms.
  • X 20 preferably denotes F.
  • the medium according to the invention particularly preferably comprises one or more compounds of the formula M-1 , wherein X 20 preferably denotes F.
  • the compound(s) of the formulae M-1 - M-3 is (are) preferably employed in the mixtures according to the invention in amounts of 1-20% by weight, particularly preferably 1-15% by weight.
  • the medium comprises two or more compounds of the formula XII in particular of the formula XI le; rr)
  • the medium comprises 2-30% by weight, preferably 3-20% by weight, particularly preferably 3-15% by weight, of compounds of the formula XII; ss)
  • the medium comprises further compounds selected from the group of the compounds of the formulae II, III, IX-XIII, XVII and XVIII; tt)
  • the proportion of compounds of the formulae II, III, IX-XI, XIII, XVII and XVIII in the mixture as a whole is 40 to 95% by weight; uu)
  • the medium comprises 10-50% by weight, particularly preferably 12- 40% by weight, of compounds of the formulae II and/or III; vv)
  • the medium comprises 20-70% by weight, particularly preferably 25- 65% by weight, of compounds of the formulae IX-XIII; ww)
  • the medium comprises 4-30% by weight, particularly preferably
  • the medium comprises 1-20% by weight, particularly preferably
  • the medium comprises at least two compounds of the formulae
  • the medium comprises at least two compounds of the formulae
  • the medium comprises at least two compounds of the formula Xlla and at least two compounds of the formula XI le. bbb) The medium comprises at least one compound of the formula Xlla and at least one compound of the formula Xlle and at least one compound of the formula Ilia. ccc) The medium comprises at least two compounds of the formula Xlla and at least two compounds of the formula XI le and at least one compound of the formula Ilia. ddd) The medium comprises in total > 25% by weight, preferably ⁇ 30% by weight, of one or more compounds of the formula XII. eee) The medium comprises > 20% by weight, preferably > 24% by weight, preferably 25-60% by weight, of compounds of the formula ZK3, in particular the compound of the formula ZK3a,
  • the medium comprises at least one compound selected from the group of compounds ZK3a, ZK3b and ZK3c, preferably ZK3a, in combination with compound ZK3d
  • the medium comprises at least one compound of the formula DPGU-n-F. hhh) The medium comprises at least one compound of the formula CDUQU-n-F. iii) The medium comprises at least one compound of the formula
  • the medium comprises at least one compound of the formula CPGU-3-OT. kkk) The medium comprises at least one compound of the formula
  • the medium comprises at least one compound of the formula
  • the medium comprises at least one compound of the formula
  • the media according to the invention preferably comprise from 0.01 to 10%, particularly preferably from 0.05 to 5% and most preferably from 0.1 to 3% of component A) comprising compounds of formula I according to the invention.
  • the media preferably comprise one, two or three, more preferably one or two and most preferably one compound of the formula I according to the invention.
  • component A) consists of compounds of formula I.
  • the media according to the invention preferably comprise from 0.01 to 10%, particularly preferably from 0.05 to 7.5% and most preferably from 2 to 5% of the compounds of component C) comprising compounds of formula P according to the invention.
  • the media preferably comprise one, two or three, more preferably one or two and most preferably one compound of the formula P according to the invention.
  • the compounds used in the present invention are prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie
  • the compounds of formula I are preferably synthesised according to or in analogy to the procedure described in GB 2 306 470 A.
  • the compounds of formula I are more preferably synthesised according to the process depicted in schemes 1 and 2.
  • scheme 2 a preferred synthesis of compounds of formula I without spacer groups is shown.
  • scheme 1 "Spacer 1 " or "Spacer 2 "denotes a group "Sp” as indicated above.
  • Pg denotes a protecting group. Suitable protecting groups are known to the skilled person from the literature, as for example from P.G.M. Wuts, Th.W. Greene, Greene's Protective Groups in Organic Synthesis, Fourth Edition, 2007 John Wiley & Sons, Inc. Examples are 2- tetrahydropyranyl, benzyl, trimethylsilyl, tertbuty Id imethylsilyl ,
  • R 2 CH 3 CH 2 CH 3
  • R 1 H, CH,
  • R 2 CH 3 CH 2 CH 3
  • the first substrate includes a pixel electrode and a common electrode for generating an electric field substantially parallel to a surface of the first substrate in the pixel region.
  • Different kinds of diplays having at least two electrodes on one substrate are known to the skilled person wherein the most important difference is that either both the pixel electrode and the common electrode are structured, as it is typical for IPS displays, or only the pixel electrode is structured and the common electrode is
  • the present invention refers to any kind of electrode configurations mentioned above, i.e. IPS as well as FFS displays.
  • the process according to the present invention is independent of the kind of substrate or material of the surface which is in contact with the liquid crystal mixture according to the invention, during and after this process.
  • materials used for the substrates or surfaces are organic polymers including polyimide, indium tin oxide (ITO), indium zinc oxide (IZO), silicon nitride (SiNx) and silicon dioxide(SiO2).
  • the process is especially suitable for the use in displays containing substrates that do not have a polyimide layer on one or more of the surfaces that are in contact with the liquid crystal.
  • the polyimide can be rubbed or not rubbed, preferably not rubbed.
  • the invention relates to a display produced by the process according to the invention in which the substrates contain a rubbed or unrubbed polyimide layer, preferably an unrubbed polyimide layer.
  • the invention further relates to a display produced by the process according to the invention in which none or only one of the top and bottom substrates contains a polyimide layer.
  • the liquid crystal composition is injected between the first and second substrates or is filled into the cell by capillary force after combining the first and second substrates.
  • the liquid crystal composition may be interposed between the first and second substrates by combining the second substrate to the first substrate after loading the liquid crystal composition on the first substrate.
  • the liquid crystal is dispensed dropwise onto a first substrate in a process known as "one drop filling" (ODF) process, as disclosed in for example JPS63-179323 and JPH10-239694, or using the Ink Jet Printing (UP) method.
  • ODF one drop filling
  • UP Ink Jet Printing
  • the process according to the invention contains a process step where the liquid crystal inside the display panel is allowed to rest for a period of time in order to evenly redistribute the liquid crystal medium inside the panel (herein referred to as "annealing").
  • the photoreactive mesogen of formula I is prefably allowed to redistribute in the panel.
  • the display panel is annealed for a time between 1min and 3h, preferably between 10min and 1 h and most preferably between 20min and 30min. The annealing is preferably performed at room temperature.
  • the annealing is performed at elevated temperature, preferably at above 20°C and below 140°C, more preferably above 40°C and below 100°C and most preferably above 50°C and below 80°C.
  • one or more of the process steps of filling the display, annealing, photoalignment and curing of the polymerisable compound is performed at a temperature above the clearing point of the liquid crystal host mixture.
  • anisotropy is induced by exposing the display or the liquid crystal layer to linearly polarised light.
  • the photoreactive component A) is photoaligned in a first step using linearly polarised light and in a second step further cured using linearly polarized or unpolarised UV light.
  • the optional component C) is also further cured.
  • the linearly polarised light applied according to the inventive process is ultraviolet light which enables simultaneous photoalignment and photocuring of the photoreactive component A) and, if present, photocuring of the polymerisable
  • Photoalignment of the photoreactive compounds of formula I and curing of the polymerisable groups of compounds of formula I and the curing of the optional polymerisable compounds of formula P can be performed simultaneously or stepwise. In case the process is split into different steps, the individual steps can be performed at the same temperature or at different temperatures.
  • a so-called "post-curing" step can optionally be performed by irradiation with UV-light and/or visible light (both either linearly or unpolarised) at reduced temperature in order to remove unreacted polymerisable compounds.
  • the post-curing is preferably performed at above 20°C and below 70°C°C, more preferably below 60°C and most preferably above 20°C and below 40°C.
  • the polymerisable compounds are optionally polymerised or crosslinked (if a polymerisable compound contains two or more polymerisable groups)with the application of an electrical field. The polymerisation can be carried out in one or more steps.
  • Suitable and preferred polymerisation methods for component C) are, for example, thermal or photopolymerisation, preferably photopolymerisation, in particular UV photopolymerisation.
  • One or more initiators can optionally also be added here.
  • Suitable conditions for the polymerisation and suitable types and amounts of initiators are known to the person skilled in the art and are described in the literature.
  • Suitable for free-radical polymerisation are, for example, the commercially available photoinitiators Irgacure651®, Irgacure184®, Irgacure907®, Irgacure369® or
  • Darocurel 173® (BASF SE). If an initiator is employed, its proportion is preferably 0.001 to 5% by weight, particularly preferably 0.001 to 1% by weight. According to the present invention, an alkyl radical and/or an alkoxy radical may be straight-chain or branched.
  • It is preferably straight-chain, has 2, 3, 4, 5, 6 or 7 C atoms and accordingly preferably denotes ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexyloxy or -heptyloxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, methoxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tridecyloxy or tetradecyloxy.
  • alkyl or alkenyl radical which is at least monosubstituted by halogen is preferably straight-chain, and halogen is preferably F or CI. In the case of polysubstitution, halogen is preferably F.
  • the resultant radicals also include perfluorinated radicals. In the case of monosubstitution, the fluorine or chlorine substituent may be in any desired position, but is preferably in the co-position.
  • polar end groups are preferably F, CI or a mono- or polyfluorinated alkyl or alkoxy radical having 1 , 2 or 3 C atoms or a mono- or polyfluorinated alkenyl radical having 2 or 3 C atoms. They are particularly preferably F, CI, CF3, CHF2, OCF3, OCHF2, OCFHCF3, OCFHCHF2, OCFHCHF2, OCF2CH3,
  • the media according to the invention are prepared in a manner conventional per se.
  • the components are dissolved in one another, preferably at elevated temperature.
  • the liquid-crystalline phases of the present invention can be modified in such a way that they can be used in all types of liquid-crystal display element that have been disclosed hitherto. Additives of this type are known to the person skilled in the art and are described in detail in the literature (H. Kelker/ R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980).
  • pleochroic dyes can be added for the production of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases.
  • the present invention also relates to electro-optical liquid-crystal display elements containing a liquid-crystalline medium according to the invention.
  • the liquid crystal display is of the IPS or FFS mode.
  • denotes the optical anisotropy (589 nm, 20°C) and ⁇ denotes the dielectric anisotropy (1 kHz, 20°C).
  • the dielectric anisotropy ⁇ is determined at 20°C and 1 kHz.
  • the optical anisotropy ⁇ is de- termined at 20°C and a wavelength of 589.3 nm.
  • ⁇ and ⁇ values and the rotational viscosity ( ⁇ ) of the compounds according to the invention are obtained by linear extrapolation from liquid- crystalline mixtures consisting of 5 to 10% of the respective compound according to the invention and 90-95% of the commercially available liquid-crystal mixture ZLI-2857 (for ⁇ ) or ZLI-4792 (for ⁇ , ⁇ ) (mixtures, Merck KGaA, Darmstadt).
  • Table C gives the meanings of the codes for the left-hand or right-hand end groups.
  • the acronyms are composed of the codes for the ring elements with optional linking groups, followed by a first hyphen and the codes for the left-hand end group, and a second hyphen and the codes for the right-hand end group.
  • Table D shows illustrative structures of compounds together with their respective abbreviations.
  • V -CH CH- Zl -O-CO-
  • n and m each denote integers, and the three dots are placeholders for other abbreviations from this table.
  • DFDBC-n(0)-(0)m C-DFDBF-n-(0)m wherein n, m and I preferably, independently of one another, denote 1 to 7.
  • Table E shows illustrative compounds which can be used as additional stabilisers in the mesogenic media according to the present invention.
  • Table E shows possible stabilisers which can be added to the LC media according to the invention.
  • n here denotes an integer from 1 to 12, preferably 1 , 2, 3, 4, 5, 6, 7 or 8, terminal methyl groups are not shown).
  • the LC media preferably comprise 0 to 10% by weight, in particular 1 ppm to 5% by weight, particularly preferably 1 ppm to 1 % by weight, of stabilisers.
  • Table F shows illustrative compounds which can preferably be used as chiral dopants in the mesogenic media according to the present invention.
  • the mesogenic media comprise one or more compounds selected from the group of the compounds from Table F.
  • the mesogenic media according to the present application preferably comprise two or more, preferably four or more, compounds selected from the group consisting of the compounds from the above tables.
  • the liquid-crystal media according to the present invention preferably comprise
  • the layers are separated and the organic layer is dried over sodium sulphate, filtered and evaporated under vacuum to give the product as an oil which is further purified by column chromatography with silica gel and 1-chlorobutane.
  • the product is a slightly yellow oil.
  • reaction mixture turned to a clear solution.
  • the reaction solution is evaporated under vacuum and purified via column chromatography with 1-chlorobutane and ethyl acetate (9:1). The obtained product is then crystallized from acetonitrile to give a white crystalline solid.
  • reaction mixture turned to a clear solution.
  • the reaction solution is evaporated under vacuum and purified via column chromatography with 1-chlorobutane and ethyl acetate.
  • the obtained product is then crystallized from acetonitrile to give a white crystalline solid, m.p. 175 °C (decomp.).
  • the display cells are made with raw untreated alkali free glass using 5pm spacer beads in Norland 65 adhesive.
  • the cells are assembled by hand and then cured using a high pressure mercury lamp with 50 mW/cm 2 and 3000 mJ/cm 2 .
  • the LC mixtures are capillary filled using capillary action at room temp., annealed for 1 h at 100°C and then irradiated at the same temperature with linearly polarised UV light (50 mW/cm 2 ) for 60s. The cells are then cooled to room temperature.
  • the nematic LC host mixture N-1 to N- 6 are prepared as indicated in the following tables.

Abstract

The invention relates to a liquid crystal mixture characterised in that it comprises one or more photoreactive mesogens of formula (I), wherein the parameters and groups ocurring are defined as indicated in claim 1, to a process for the fabrication of liquid crystal displays using these liquid crystal mixtures and to a liquid crystal display obtainable by this process. The invention furhter relates to new compounds of formula (I).

Description

Liquid Crystal Mixture and Liquid Crystal Display
The invention relates to a liquid crystal mixture comprising a photoreactive mesogen, its use for the fabrication of liquid crystal displays (LCD) with homogeneous alignment, to a process for the fabrication of LCD by photoaligning the liquid crystal mixture after assembly of the display and to the display fabricated by said process.
Liquid-crystalline media have been used for decades in electro-optical displays for the purpose of information display. The liquid crystal displays used at present are usually those of the TN ("twisted nematic") type.
However, these have the disadvantage of a strong viewing-angle dependence of the contrast. In addition, so-called VA ("vertically aligned") displays are known which have a broader viewing angle. The LC cell of a VA display contains a layer of an LC medium between two transparent electrodes, where the LC medium usually has a negative value of the dielectric (DC) anisotropy. In the switched-off state, the molecules of the LC layer are aligned perpen- dicular to the electrode surfaces (homeotropically) or have a tilted homeotropic alignment. On application of an electrical voltage to the two electrodes, a realignment of the LC molecules parallel to the electrode surfaces takes place. Furthermore, so-called IPS ("in plane switching") displays and later, FFS ("fringe-field switching") displays have been reported (see, inter alia, S.H. Jung et al., Jpn. J. Appl. Phys., Volume 43, No. 3, 2004, 1028), which contain two electrodes on the same substrate, one of which is structured in a comb-shaped manner and the other is unstructured. A strong, so-called "fringe field" is thereby generated, i.e. a strong, electric field close to the edge of the electrodes, and, throughout the cell, an electric field which has both a strong vertical component and also a strong horizontal component. FFS displays have a low viewing- angle dependence of the contrast. FFS displays usually contain an LC medium with positive dielectric anisotropy, and an alignment layer, usually of polyimide, which provides planar alignment to the molecules of the LC medium. Furthermore, FFS displays have been disclosed (see S.H. Lee et al., AppI. Phys. Lett. 73(20), 1998, 2882-2883 and S.H. Lee et al., Liquid Crystals 39(9), 2012, 1 141-1 148), which have similar electrode design and layer thickness as FFS displays, but comprise a layer of an LC medium with negative dielectric anisotropy instead of an LC medium with positive dielectric anisotropy. The LC medium with negative dielectric ansiotropy shows a more favourable director orientation that has less tilt and more twist orientation compared to the LC medium with positive dielectric anisotropy, as a result of which these displays have a higher transmission. A further development are the so-called PS (polymer sustained) or PSA (p_olymer sustained alignment) displays, for which the term "p_olymer stabilised" is also occasionally used. The PSA displays are distinguished by the shortening of the response times without significant adverse effects on other parameters, such as, in particular, the favourable viewing-angle dependence of the contrast.
In these displays, a small amount (for example 0.3% by weight, typically < 1 % by weight) of one or more polymerisable compound(s) is added to the LC medium and, after introduction into the LC cell, is polymerised or crosslinked in situ, usually by UV photopolymerisation, between the electrodes with or without an applied electrical voltage. The addition of polymerisable mesogenic or liquid-crystalline compounds, also known as reactive mesogens or "RMs", to the LC mixture has proven particularly suitable. PSA technology has hitherto been employed principally for LC media having negative dielectric anisotropy. Unless indicated otherwise, the term "PSA" is used below as representative of PS displays and PSA displays.
In the meantime, the PSA principle is being used in diverse classical LC displays. Thus, for example, PSA-VA, PSA-OCB, PSA-IPS, PSA-FFS and PSA-TN displays are known. The polymerisation of the polymerisable compound(s) preferably takes place with an applied electrical voltage in the case of PSA-VA and PSA-OCB displays, and with or without an applied electrical voltage in the case of PSA-IPS displays. As can be demonstrated in test cells, the PS(A) method results in a 'pretilf in the cell. In the case of PSA-OCB displays, for example, it is possible for the bend structure to be stabilised so that an offset voltage is unnecessary or can be reduced. In the case of PSA-VA displays, the pretilt has a positive effect on the response times. A standard MVA or PVA pixel and electrode layout can be used for PSA-VA displays. In addition, however, it is also possible, for example, to manage with only one structured electrode side and no protrusions, which significantly simplifies production and at the same time results in very good contrast at the same time as very good light transmission.
PSA-VA displays are described, for example, in JP 10-036847 A,
EP 1 170 626 A2, US 6,861 ,107, US 7,169,449, US 2004/0191428 A1 , US 2006/0066793 A1 and US 2006/0103804 A1. PSA-OCB displays are described, for example, in T.-J- Chen et al., Jpn. J. Appl. Phys. 45, 2006, 2702-2704 and S. H. Kim, L.-C- Chien, Jpn. J. Appl. Phys. 43, 2004, 7643-7647. PSA-IPS displays are described, for example, in
US 6,177,972 and Appl. Phys. Lett. 1999, 75(21 ), 3264. PSA-TN displays are described, for example, in Optics Express 2004, 12(7), 1221. PSA- VA-IPS displays are disclosed, for example, in WO 2010/089092 A1.
Like the conventional LC displays described above, PSA displays can be operated as active-matrix or passive-matrix displays. In the case of active- matrix displays, individual pixels are usually addressed by integrated, non-linear active elements, such as, for example, transistors (for example thin-film transistors or "TFTs"), while in the case of passive-matrix displays, individual pixels are usually addressed by the multiplex method, both methods being known from the prior art.
In the prior art, polymerisable compounds of the following formula, for example, are used for PSA-VA:
Figure imgf000005_0001
in which P denotes a polymerisable group, usually an acrylate or methacrylate group, as described, for example, in US 7, 169,449.
Below the polymer layer which induces the above mentioned pretilt, an orientation layer - usually a polyimide - provides the initial alignment of the liquid crystal regardless of the polymer stabilisation step of the production process.
The effort for the production of a polyimide layer, treatment of the layer and improvement with bumps or polymer layers is relatively great. A simplifying technology which on the one hand reduces production costs and on the other hand helps to optimise the image quality (viewing-angle dependence, contrast, response times) would therefore be desirable. Rubbed polyimide has been used for a long time to align liquid crystals. The rubbing process causes a number of problems: mura, contamination, problems with static discharge, debris, etc.
Photoalignment is a technology for achieving liquid crystal (LC) alignment that avoids rubbing by replacing it with a light-induced orientational ordering of the alignment surface. This can be achieved through the mechanisms of photodecomposition, photodimerization, and photoisomerization (N.A. Clark et al. Langmuir 2010, 26(22), 17482- 17488, and literature cited therein) by means of polarised light. However, still a suitably derivatised polyimide layer is required that comprises the photoreactive group. A further improvement would be to avoid the use of polyimide at all. For VA displays this was achieved by adding a self alignment agent to the LC that induces homeotropic alignment in situ by a self assembling mechanism as disclosed in WO 2012/104008 and
WO 2012/038026.
N.A. Clark et al. Langmuir 2010, 26(22), 17482-17488 have shown that it is possible to self assemble a com ound of the following structure
Figure imgf000006_0001
onto a substrate to give a monolayer that is able to be photoaligned to induce homogeneous alignment of a liquid crystal. However, a separate step of self assembly before manufacture of the LC cell is required and the nature of the azo-group causes reversibility of the alignment when exposed to light. N
Another functional group known to enable photoalignment is the phenylethenylcarbonyloxy group (cinnamate). Photocrosslinkable cinnamates are known from the prior art, e.g. of the following structure
Figure imgf000006_0002
as disclosed in EP0763552. From such compounds, polymers can be obtained, for example the following
Figure imgf000007_0001
This material was used in a photoalignment process, as disclosed in WO 99/49360, to give an orientation layer for liquid crystals. A
disadavantage of orientation layers obtaind by this prosess is that they give lower voltage holding ratios (VHR) than polyimides.
In WO 00/05189 polymerisable direactive mesogenic cinnamates are disclosed for the use in polymerisable LC mixtures for e.g. optical retarders.
Figure imgf000007_0002
A structurally related compound of the following fo
Figure imgf000007_0003
comprising two cinnamic acid moieties is disclosed in GB 2 306 470 A for the use as component in liquid crstalline polymer films. This type of compound has not been used or proposed for the use as photoalignment agent.
A very similar compound is published in B.M.I, van der Zande et al., Liquid Crystals, Vol. 33, No. 6, June 2006, 723-737, in the field of liquid crystalline polymers for patternd retarders, and has the following structure:
Figure imgf000008_0001
Object of the present invention is to provide a process for the fabrication of liquid crystal displays with planar alignment, whilist avoiding the rubbing process. The process may be useable without polyimide on the bottom and top substrates, with poiymide on one substrate only, or with polyimide on both substrates, thus avoiding the problems involved with the rubbing process and offering to facilitate the simplification of the production process significantly.
Surprisingly it was found that it is possible to manufacture a liquid crystal display without a polyimide alignment layer by using a liquid crystal mixture comprising a photoreactive mesogen that enables photoalignment of the liquid crystal in situ, i.e. after assembly of the display, by means of linearly polarised light.
Therefore, the present invention relates to liquid crystal mixtures comprising a photoalignment component A) comprising one or more photoreactive mesogens of formula I below, and a liquid-crystalline component B), hereinafter also referred to as "LC host mixture", comprising one or more mesogenic or liquid-crystalline compounds, wherein formula I is as follows:
Figure imgf000009_0001
denotes an aryl or heteroaryl group, which may be substituted by one or more radicals L, are each, independently of one another, defined like A11 or denote a cycloalkyl group having 3 to 10 C atoms, in which 1 to 4 non-adjacent CH2 groups may be replaced by O and in which one or more H atoms may be replaced by a group L, on each occurrence, identically or differently, denotes OH, F, CI, Br, I, -CN, -NO2, SF5, -NCO, -NCS, -OCN, - SCN,
Figure imgf000009_0002
-N(RZ)2, optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F or CI, on each occurrence, identically or differently, denotes -CH2CH2-, -CF2CF2-, -CF2CH2-, -CH2CF2-, -C(O)O-, -OC(O)-, -CH=CH-COO-, -OCO-CH=CH-,or a single bond,
preferably -C(O)O-, -OC(O)-, -CH=CH-C(O)O-,
-O(O)C-CH=CH-, -CH2CH2- or a single bond, R11 and R 2 identically or differently, denote a group P-Sp-, or halogen, CN, optionally fluorinated alkyl or alkenyl with up to 15 C atoms in which one or more non adjacent Ch -groups may be replaced by -0-, -S-, -CO-, -C(O)O-, -O-C(O)-, O-C(O)-O-, with the proviso that at least one of R 1 and R12 denotes a group P-Sp-, preferably both of R11 and R12 denote P-Sp-,
Rz each, independently of one another, denote H or alkyl having 1-12 C atoms,
P a polymerisable group,
Sp a spacer group or a single bond, a is 0 or 1.
The present invention further relates to a process for the fabrication of liquid crystal displays comprising at least the steps of:
providing a first substrate which includes a pixel electrode and a common electrode for generating an electric field substantially parallel to a surface of the first substrate in the pixel region;
providing a second substrate, the second substrate being disposed opposite to the first substrate;
interposing a liquid crystal mixture between the first substrate and the second substrate, the liquid crystal mixture comprising component A), component B) and optionally component C);
irradiating the liquid crystal mixture with linearly polarised light causing photoalignment of the liquid crystal;
curing the polymerisable compounds of the liquid crystal mixture by irradiation with ultraviolet light or visible light having a wavelength of 450nm or below. The present invention further relates to the use of the liquid crystal mixtures according to the invention for the fabrication of a liquid crystal display.
The present invention further relates to liquid crystal displays fabricated by the process described above.
The invention further relates to a compound of formula I above, wherein one or both of the groups Sp denote a single bond.
A photoreactive group according to the present invention is a functional group of a molecule that causes a change of the geometry of the molecule either by bond rotation, skeletal rearrangement or atom- or group- transfer, or by dimerisation, upon irradiation with light of a suitable wavelength that can be absorbed by the molecule.
The term "mesogenic group" as used herein is known to the person skilled in the art and described in the literature, and means a group which, due to the anisotropy of its attracting and repelling interactions, essentially contributes to causing a liquid-crystal (LC) phase in low-molecular-weight or polymeric substances. Compounds containing mesogenic groups (mesogenic compounds) do not necessarily have to have an LC phase themselves. It is also possible for mesogenic compounds to exhibit LC phase behaviour only after mixing with other compounds and/or after polymerisation. Typical mesogenic groups are, for example, rigid rod- or disc-shaped units. An overview of the terms and definitions used in connection with mesogenic or LC compounds is given in Pure Appl.
Chem. 2001 , 73(5), 888 and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 1 16, 6340-6368. A photoreactive mesogen according to the present invention is a mesogenic compound comprising one or more photoreactive groups.
Examples of photoreactive groups are -C=C- double bonds and azo groups (-N=N-).
Examples of molecular structures and sub-structures comprising such photoreactive groups are stilbene, (1 ,2-difluoro-2-phenyl-vinyl)-benzene, cinnamate, 4-phenylbut-3-en-2-one, chalcone, coumarin, chromone, pentalenone and azobenzene.
According to the present application, the term "linearly polarised light" means light, which is at least partially linearly polarized. Preferably, the aligning light is linearly polarized with a degree of polarization of more than 5:1. Wavelengths, intensity and energy of the linearly polarised light are chosen depending on the photosensitivity of the photoalignable material. Typically, the wavelengths are in the UV-A, UV-B and/or UV-C range or in the visible range. Preferably, the linearly polarised light comprises light of wavelengths less than 450 nm, more preferably less than 420 nm.
The term "organic group" denotes a carbon or hydrocarbon group.
The term "carbon group" denotes a mono- or polyvalent organic group containing at least one carbon atom, where this either contains no further atoms (such as, for example, -C≡C-) or optionally contains one or more further atoms, such as, for example, N, O, S, P, Si, Se, As, Te or Ge (for example carbonyl, etc.). The term "hydrocarbon group" denotes a carbon group which additionally contains one or more H atoms and optionally one or more heteroatoms, such as, for example, N, O, S, P, Si, Se, As, Te or Ge. "Halogen" denotes F, CI, Br or I.
A carbon or hydrocarbon group can be a saturated or unsaturated group. Unsaturated groups are, for example, aryl, alkenyl or alkynyl groups. A carbon or hydrocarbon radical having 3 or more atoms can be straight- chain, branched and/or cyclic and may also contain spiro links or condensed rings.
The terms "alkyl", "aryl", "heteroaryl", etc., also encompass polyvalent groups, for example alkylene, arylene, heteroarylene, etc.
The term "aryl" denotes an aromatic carbon group or a group derived therefrom. The term "heteroaryl" denotes "aryl" as defined above, containing one or more heteroatoms.
Preferred carbon and hydrocarbon groups are optionally substituted alkyl, alkenyl, alkynyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy and alkoxycarbonyloxy having 1 to 40, preferably 1 to 25, particularly preferably 1 to 18, C atoms, optionally substituted aryl or aryloxy having 6 to 40, preferably 6 to 25, C atoms, or optionally substituted alkylaryl, aryl- alkyl, alkylaryloxy, arylalkyloxy, arylcarbonyl, aryloxycarbonyl, aryl- carbonyloxy and aryloxycarbonyloxy having 6 to 40, preferably 6 to 25, C atoms. Further preferred carbon and hydrocarbon groups are C1-C40 alkyl, C2-C40 alkenyl, C2-C40 alkynyl, C3-C40 allyl, C4-C40 alkyldienyl, C4-C40 polyenyl, C6-C40 aryl, C6-C40 alkylaryl, C6-C40 arylalkyl, C6-C40 alkylaryloxy, C6-C40 arylalkyloxy, C2-C40 heteroaryl, C4-C40 cycloalkyl, C4-C40 cycloalkenyl, etc. Particular preference is given to C1-C22 alkyl, C2-C22 alkenyl, C2-C22 alkynyl, C3-C22 allyl, C4-C22 alkyldienyl, C6-C12 aryl, C6-C20 arylalkyl and C2-C20 heteroaryl. Further preferred carbon and hydrocarbon groups are straight-chain, branched or cyclic alkyl radicals having 1 to 40, preferably 1 to 25, C atoms, which are unsubstituted or mono- or polysubstituted by F, CI, Br, I or CN and in which one more non-adjacent CH2 groups may each be replaced, independently of one another, by -C(RZ)=C(R2)-, -C≡C-, -N(RZ)-, -0-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another.
Rz preferably denotes H, halogen, a straight-chain, branched or cyclic alkyl chain having 1 to 25 C atoms, in which, in addition, one or more non- adjacent C atoms may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO- or -O-CO-O- and in which one or more H atoms may be replaced by fluorine, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.
Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 2-methylbutyl, n-pentyl, s-pentyl, cyclo- pentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl and perfluorohexyl.
Preferred alkenyl groups are, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl and cyclooctenyl.
Preferred alkynyl groups are, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl and octynyl.
Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy- ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy and n-dodecoxy.
Preferred amino groups are, for example, dimethylamino, methylamino, methylphenylamino and phenylamino.
Aryl and heteroaryl groups can be monocyclic or polycyclic, i.e. they can contain one ring (such as, for example, phenyl) or two or more rings, which may also be fused (such as, for example, naphthyl) or covalently bonded (such as, for example, biphenyl), or contain a combination of fused and linked rings. Heteroaryl groups contain one or more
heteroatoms, preferably selected from O, N, S and Se. A ring system of this type may also contain individual non-conjugated units, as is the case, for example, in the fluorene basic structure.
Particular preference is given to mono-, bi- or tricyclic aryl groups having 6 to 25 C atoms and mono-, bi- or tricyclic heteroaryl groups having 2 to 25 C atoms, which optionally contain fused rings and are optionally substituted. Preference is furthermore given to 5-, 6- or 7-membered aryl and heteroaryl groups, in which, in addition, one or more CH groups may be replaced by N, S or O in such a way that O atoms and/or S atoms are not linked directly to one another.
Preferred aryl groups are derived, for example, from the parent structures benzene, biphenyl, terphenyl, [1 , 1 ':3',1 "]terphenyl, naphthalene, anthracene, binaphthyl, phenanthrene, pyrene, dihydropyrene, chrysene, peryl- ene, tetracene, pentacene, benzopyrene, fluorene, indene,
indenofluorene, spirobifluorene, etc. Preferred heteroaryl groups are, for example, 5-membered rings, such as pyrrole, pyrazole, imidazole, 1 ,2,3-triazole, 1 ,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxazole, isoxazole, 1 ,2-thiazole, 1 ,3-thiazole, 1 ,2,3-oxadiazole, 1 ,2,4-oxadiazole, 1 ,2,5-oxadiazole, 1 ,3,4-oxadiazole, 1 ,2,3-thiadiazole, ,2,4-thiadiazole, 1 ,2,5-thiadiazole, 1 ,3,4-thiadiazole, 6-membered rings, such as pyridine, pyridazine, pyrimidine, pyrazine, 1 ,3,5-triazine, 1 ,2,4-triazine, 1,2,3-triazine, 1 ,2,4,5-tetrazine, 1 ,2,3,4-tetra- zine, 1 ,2,3,5-tetrazine, or condensed groups, such as indole, isoindole, indolizine, indazole, benzimidazole, benzotriazole, purine, naphthimid- azole, phenanthrimidazole, pyridimidazole, pyrazinimidazole, quinoxalin- imidazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, isoxazole, benzothiazole, benzofuran, isobenzofuran, dibenzofuran, quinoline, isoquinoline, pteridine, benzo-5,6-quinoline, benzo-6,7- quinoline, benzo-7,8-quinoline, benzoisoquinoline, acridine,
phenothiazine, phenoxazine, benzopyridazine, benzopyrimidine, quinoxaline, phenazine, naphthyridine, azacarbazole, benzocarboline, phenanthridine, phenanthroline, thieno[2,3b]thiophene,
thieno[3,2b]thiophene, dithienothiophene, dihydrothieno [3,4-b]-1 ,4-dioxin, isobenzothiophene, dibenzothiophene, benzothiadiazothiophene, or combinations of these groups. The heteroaryl groups may also be substituted by alkyl, alkoxy, thioalkyi, fluorine, fluoroalkyi or further aryl or heteroaryl groups.
The (non-aromatic) alicyclic and heterocyclic groups encompass both saturated rings, i.e. those containing exclusively single bonds, and also partially unsaturated rings, i.e. those which may also contain multiple bonds. Heterocyclic rings contain one or more heteroatoms, preferably selected from Si, O, N, S and Se.
The (non-aromatic) alicyclic and heterocyclic groups can be monocyclic, i.e. contain only one ring (such as, for example, cyclohexane), or poly- cyclic, i.e. contain a plurality of rings (such as, for example, decahydro- naphthalene or bicyclooctane). Particular preference is given to saturated groups. Preference is furthermore given to mono-, bi- or tricyclic groups having 3 to 25 C atoms, which optionally contain fused rings and are optionally substituted. Preference is furthermore given to 5-, 6-, 7- or 8-membered carbocyclic groups, in which, in addition, one or more C atoms may be replaced by Si and/or one or more CH groups may be replaced by N and/or one or more non-adjacent CH2 groups may be replaced by -O- and/or -S-.
Preferred alicyclic and heterocyclic groups are, for example, 5-membered groups, such as cyclopentane, tetrahydrofuran, tetrahydrothiofuran, pyrrolidine, 6-membered groups, such as cyclohexane, silinane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1 ,3-dioxane, 1,3- dithiane, piperidine, 7-membered groups, such as cycloheptane, and fused groups, such as tetrahydronaphthalene, decahydronaphthalene, indane, bicyclo[1.1.1 ]pentane-1 ,3-diyl, bicyclo[2.2.2]octane-1 ,4-diyl, spiro[3.3]heptane-2,6-diyl, octahydro-4,7-methanoindane-2,5-diyl.
The aryl, heteroaryl, carbon and hydrocarbon radicals optionally have one or more substituents, which are preferably selected from the group comprising silyl, sulfo, sulfonyl, formyl, amine, imine, nitrile, mercapto, nitro, halogen, C1-12 alkyl, C6-12 aryl, C1-12 alkoxy, hydroxyl, or combinations of these groups.
Preferred substituents are, for example, solubility-promoting groups, such as alkyl or alkoxy, and electron-withdrawing groups, such as fluorine, nitro or nitrile.
Preferred substituents, also referred to as "L" above and below, are F, CI, Br, I, -CN, -NO2 , -NCO, -NCS, -OCN, -SCN, -C(=0)N(Rz)2, -C(=0)Y\ - C(=0)Rz, -N(RZ)2, in which Rz has the meaning indicated above, and Y denotes halogen, optionally substituted silyl or aryl having 6 to 40, preferably 6 to 20, C atoms, and straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, preferably 2 to 12, in which one or more H atoms may optionally be replaced by F or CI.
"Substituted silyl or aryl" preferably means substituted by halogen, -CN,
Figure imgf000018_0001
-CO-RV1 , -CO-O-Rv1 , -O-CO-Ry or -O-CO-O-Rv1 , in which R has the meaning indicated above.
Particularly preferred substituents L are, for example, F, CI, CN, CFb, C2H5, -CH(CH3)2, OCH3, OC2H5, CF3, OCFs, OCHF2, OC2F5, furthermore phenyl.
In a preferred embodiment, the liquid crystal mixture according to the present invention further comprises a polymerisable component C) comprising one or more polymerisable compounds of formula P
Pa-(Spa)s1-A2-(Za-A1)n2-(Spb)s2-Pb P wherein the individual radicals have the following meanings: Pa, Pb each, independently of one another, denote a
polymerisable group,
Spa, Spb on each occurrence, identically or differently, denote a spacer group, s1 , s2 each, independently of one another, denote 0 or 1 ,
A1 , A2 each, independently of one another, denote a radical selected from the following groups: a) the group consisting of trans-1 ,4-cyclohexylene, ,4- cyclohexenylene and 4,4'-bicyclohexylene, wherein, in addition, one or more non-adjacent CH2 groups may be replaced by -O- and/or -S- and wherein, in addition, one or more H atoms may be replaced by F, the group consisting of 1 ,4-phenylene and 1 ,3-phenylene, wherein, in addition, one or two CH groups may be replaced by N and wherein, in addition, one or more H atoms may be replaced by L, the group consisting of tetrahydropyran-2,5-diyl, 1 ,3-diox- ane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobutane-1 ,3- diyl, piperidine-1 ,4-diyl, thiophene-2,5-diyl and
selenophene-2,5-diyl, each of which may also be mono- or polysubstituted by L, the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may, in addition, be replaced by heteroatoms, preferably selected from the group consisting of
Figure imgf000019_0001
Figure imgf000020_0001
where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, denotes 0, 1 , 2 or 3, in each case, independently of one another, denotes -CO-0-, -0-CO-, -CH2O-, -OCH2-, -CF2O-, -OCF2-, or -(CH2)n-, where n is 2, 3 or 4, -0-, -CO-, -C(RyRz)-, -CH2CF2-, -CF2CF2- or a single bond, on each occurrence, identically or differently, denotes F, CI, CN, SCN, SF5 or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms,
Ry, Rz each, independently of one another, denote H, F or straight-chain or branched alkyl having 1 to 12 C atoms, wherein, in addition, one or more H atoms may be replaced by F,
M denotes -O-, -S-, -CH2-, -CHY1- or -CY1 Y2-, and
Y and Y2 each, independently of one another, have one of the meanings indicated above for Ry or denote CI or CN.
The polymerisable groups P and Pa b are groups that are suitable for a polymerisation reaction, such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer- analogous reaction, for example addition or condensation onto a main polymer chain. Particular preference is given to groups for chain polymerisation, in particular those containing a C=C double bond or -C≡C triple bond, and groups which are suitable for polymerisation with ring opening, such as, for example, oxetane or epoxide groups.
Preferred groups P and Pa b are selected from the group consisting of
CW1-CO-0-, CH2=CW1-CO-, ^HC CH - , W2
Figure imgf000021_0001
Figure imgf000021_0002
CW1=CH-CO-(O)k3-, CW1=CH-CO-NH-, CH2=CW -CO-NH-,
CH3-CH=CH-0-, (CH2=CH)2CH-OCO-, (CH2=CH-CH2)2CH-OCO-, (CH2=CH)2CH-O-, (CH2=CH-CH2)2N-, (CH2=CH-CH2)2N-CO-,
HO-CW2W3-, HS-CW2W3-, HW2N-, HO-CW2W3-NH-, CH2=CW1-CO-NH-, CH2=CH-(COO)ki-Phe-(0)k2-, CH2=CH-(CO)ki-Phe-(O)k2-, Phe-CH=CH-, HOOC-, OCN- and W4W5W6Si-, wherein W1 denotes H, F, CI, CN, CF3, phenyl or alkyl having 1 to 5 C atoms, in particular H, F, CI or CH3, W2 and W3 each, independently of one another, denote H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl or n-propyl, W4, W5 and W6 each, independently of one another, denote CI, oxaalkyl or oxacarbonylalkyl having 1 to 5 C atoms, W7 and W8 each, independently of one another, denote H, CI or alkyl having 1 to 5 C atoms, Phe denotes ,4-phenylene, which is optionally substituted by one or more radicals L as defined above which are other than P-Sp-, ki, k2 and k3 each, independently of one another, denote 0 or 1 , k3 preferably denotes 1 , and k4 denotes an integer from 1 to 10.
Particularly preferred groups P and Pa b are selected from the group consisting of CH2=CW1-CO-0-, in particular CH2=CH-CO-0-,
CH2=C(CH3)-CO-0- and CH2=CF-CO-O-, furthermore CH2=CH-O-,
O
=CH)2CH-0-CO-, (CH2=CH)2CH-O-, Vv^HC CH ~ and
Figure imgf000022_0001
Very particularly preferred groups P and Pa b are selected from the grouf consisting of acrylate, methacrylate, fluoroacrylate, furthermore vinyloxy chloroacrylate, oxetane and epoxide groups, and of these preferably an acrylate or methacrylate group.
Preferred spacer groups Sp and Spa b are selected from the formula Sp" X", so that the radicals P-Sp- and pa/b-Spa/b- conforms to the formulae P-Sp"-X"- and Pa/b-Sp"-X"-, respectively, wherein Sp" denotes alkylene having 1 to 20, preferably 1 to 12, C atoms, which is optionally mono- or polysubstituted by F, CI, Br, I or CN and wherein, in addition, one or more non- adjacent CH2 groups may each be replaced,
independently of one another, by -0-, -S-, -NH-, -N(R0)-, -Si(R00R000)-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, -S-CO-, -CO-S-, -N(R00)-CO-O-, -O-CO-N(R00)-,
-N(R00)-CO-N(R00)-, -CH=CH- or -C≡C- in such a way that O and/or S atoms are not linked directly to one another,
X" denotes -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-,
-CO-N(R00)-, -N(R00)-CO-, -N(R00)-CO-N(R00)-, -OCH2-, -CH2O-, -SCH2-, -CH2S-, -CF2O-, -OCF2-, -CF2S-, -SCF2-, -CF2CH2-, -CH2CF2-, -CF2CF2-, -CH=N-, -N=CH-, -N=N-, -CH=CR0-, -CY3=CY4-, -C≡C-, -CH=CH-CO-O-,
-O-CO-CH=CH- or a single bond,
R°, R00
and R000 each, independently of one another, denote H or alkyl having 1 to 12 C atoms, and
Y3 and Y4 each, identically or differently, denote H, F, CI or CN.
X" is preferably -O-, -S-, -CO-, -C(O)O-, -OC(O)-, -O-C(O)O-, -CO-NR0-, -NR°-CO-, -NR°-CO-NR°- or a single bond.
Typical spacer groups Sp" are, for example, -(CH2)pi-,
-(CH2CH2O)qi-CH2CH2-, -CH2CH2-S-CH2CH2-, -CH2CH2-NH-CH2CH2- or -(SiR00R000-O)pi-, wherein p1 is an integer from 1 to 12, q1 is an integer from 1 to 3, and R00 and R000 have the meanings indicated above. Particularly preferred groups -Sp"-X"- are -(CH2)Pi-, -(CH2)pi-O-,
-(CH2)Pi-O-CO-, -(CH2)Pi-0-CO-O-, wherein p1 and q1 have the meanings indicated above.
Particularly preferred groups Sp" are, for example, in each case straight- chain ethylene, propylene, butylene, pentylene, hexylene, heptylene, octy- lene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyl- eneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene- N-methyliminoethylene, 1-methylalkylene, ethenylene, propenylene and butenylene.
The compounds of formula I are preferably selected from compounds of the sub-formulae 1-1 to I-8.
Figure imgf000024_0001
Figure imgf000024_0002
Figure imgf000024_0003
Figure imgf000025_0001
Figure imgf000025_0002
Figure imgf000025_0003
Figure imgf000025_0004
wherein R11 and R 2 and L are defined as indicated above and r, on each occurrence, identically or differently, is 0, 1 or 2.
The group
Figure imgf000025_0005
preferably denotes
Figure imgf000026_0001
wherein L has the meaning indicated above and preferably denotes alkyl or alkoxy having 1 to 8 C atoms, halogen or CN.
Particularly preferred compounds of formula I are selected from sub- formulae 1-1 -1 1-3-1 and I-3-2
Figure imgf000026_0002
Figure imgf000026_0003
I-3-2
Figure imgf000026_0004
wherein the groups occuring have the meanings indicated above and preferably
L denotes alkyl or alkoxy having 1 to 6 C atoms, CI, or F,
particularly preferably CH3 or C2H5,
P denotes, identically or differently, acrylate or methacrylate,
Sp denotes, identically or differently, (Chbjt, -0(CH2)t, or a single bond, and t is an integer from 2 to 12, preferably from 2 to 8.
Preferred compounds of formulae 1-1-1 , 1-3-1 and I-3-2 are compounds of the following sub-formulae:
Figure imgf000027_0001
1-1-1 b
Figure imgf000027_0002
Figure imgf000028_0001
Figure imgf000029_0001
Figure imgf000029_0002
Figure imgf000029_0003
Figure imgf000029_0004
Figure imgf000029_0005
Figure imgf000030_0001
Figure imgf000031_0001
Figure imgf000032_0001
Figure imgf000032_0002
wherein W denotes H or Chb and t is an integer from 2 to 8. Particularly preferred monomers of formula P are the following
Figure imgf000032_0003
Figure imgf000032_0004
Figure imgf000033_0001
Figure imgf000034_0001
Figure imgf000035_0001
Figure imgf000036_0001
30
Figure imgf000037_0001
wherein the individual radicals have the following meanings:
P1 to P3 each, independently of one another, denote a polymerisable group as defined for formula P, preferably an acrylate, meth- acrylate, fluoroacrylate, oxetane, vinyloxy or epoxide group,
Sp1 to Sp3 each, independently of one another, denote a single bond or a spacer group, preferably having one of the meanings indicated above and below for Spa, and particularly preferably -(CH2)pi -, -(CH2)pi-0-, -(CH2)Pi-CO-0- or -(CH2)Pi-O-CO-O-, wherein p1 is an integer from 1 to 12, and where the linking to the adjacent ring in the last-mentioned groups takes place via the O atom, where, in addition, one or more of the radicals P1-Sp1- , P2-Sp2- and P3-Sp3- may denote a radical Raa, with the proviso that at least one of the radicals P1-Sp1- , P2-Sp2- and P3-Sp3- present does not denote Raa,
Raa denotes H, F, CI, CN or straight-chain or branched alkyl having 1 to 25 C atoms, wherein, in addition, one or more non- adjacent CH2 groups may each be replaced, independently of one another, by C(R°)=C(R00)-, -C≡C-, -N(R0)-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and wherein, in addition, one or more H atoms may be replaced by F, CI, CN or P1-Sp1-, particularly preferably straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy having 1 to 12 C atoms (where the alkenyl and alkynyl radicals have at least two C atoms and the branched radicals have at least three C atoms),
R°, R00 each, independently of one another, denote H or alkyl
having 1 to 12 C atoms,
Ry and Rz each, independently of one another, denote H, F, Chb or
CF3,
ZP1 denotes -O-, -CO-, -C(RyR2)- or -CF2CF2-,
Zp2 and ZP3 each, independently of one another, denote -CO-O-,
-O-CO-, -CH2O-, -OCH2-, -CF2O-, -OCF2- or -(CH2)n3-, where n3 is 2, 3 or 4,
L on each occurrence, identically or differently, denotes F, CI,
CN, SCN, SF5 or straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or
alkoxycarbonyloxy having 1 to 12 C atoms, preferably F,
L' and l_" each, independently of one another, denote H, F or CI, r denotes 0, 1 , 2, 3 or 4,
s denotes 0, 1 , 2 or 3,
t denotes 0, 1 or 2, and
x denotes 0 or .
In a particularly preferred embodiment of the present invention the LC mixture, or component C), comprises one or more compounds of formula P10-1.
Figure imgf000039_0001
wherein the parameters are defined as described above and P1 and P2 preferably denote acrylate or methacrylate.
Particularly preferred compounds of formula P10-1 are selected from the group of the following subformulae
Figure imgf000039_0002
wherein each n4 denote independently of each other an integer between 2 and 10, preferably 3,4,5 or 6.
The polymerisable compounds of formulae I and P are also suitable for polymerisation without an initiator, which is associated with considerable advantages, such as, for example, lower material costs and, in particular, reduced contamination of the LC medium by possible residual amounts of the initiator or degradation products thereof. The polymerisation can thus also be carried out without addition of an initiator. The LC medium thus, in a preferred embodiment, comprises no polymerisation initiator. The polymerisable component C) or the LC medium as a whole may also comprise one or more stabilisers in order to prevent undesired
spontaneous polymerisation of the RMs, for example during storage or transport. Suitable types and amounts of stabilisers are known to the person skilled in the art and are described in the literature. Particularly suitable are, for example, the commercially available stabilisers from the Irganox® series (BASF SE), such as, for example, Irganox® 1076. If stabilisers are employed, their proportion, based on the total amount of the RMs or the polymerisable component, is preferably 10 - 10,000 ppm, particularly preferably 50 - 1000 ppm.
In a preferred embodiment, the LC-host mixture (component B) according to the present invention comprises one or more, preferably two or more, low-molecular-weight (i.e. monomeric or unpolymerised) compounds. The latter are stable or unreactive with respect to a polymerisation reaction or photoalignment under the conditions used for the polymerisation of the polymerisable compounds or photoalignment of the photoreactive mesogen of formula I. In principle, a suitable host mixture is any dielectrically negative or positive LC mixture which is suitable for use in conventional VA, IPS or FFS displays.
Suitable LC mixtures are known to the person skilled in the art and are described in the literature. LC media for VA displays having negative dielectric anisotropy are described in for example EP 1 378 557 A1.
Suitable LC mixtures having positive dielectric anisotropy which are suitable for LCDs and especially for IPS displays are known, for example, from JP 07-181 439 (A), EP 0 667 555, EP 0 673 986, DE 195 09 410, DE 195 28 106, DE 195 28 107, WO 96/23 851 , WO 96/28 521 and WO2012/079676. Preferred embodiments of the liquid-crystalline medium having negative or positive dielectric anisotropy according to the invention are indicated below and explained in more detail by means of the working examples.
The LC host mixture is preferably a nematic LC mixture, and preferably does not have a chiral LC phase.
In a preferred embodiment of the present invention the LC medium contains an LC host mixture with negative dielectric anisotropy. Preferred embodiments of such an LC medium, and the corresponding LC host mixture, are those of sections a)-z) below: a) LC medium which comprises one or more compounds of the formu- lae CY and/or PY:
Figure imgf000041_0001
Figure imgf000041_0002
wherein a denotes 1 or 2 b denotes 0 or 1
Figure imgf000041_0003
R and R2 each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -0-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
Zx and∑y each, independently of one another, denote -CH2CH2-,
-CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CO-O-,
-O-CO-, -C2F4-, -CF=CF-, -CH=CH-CH2O- or a single bond, preferably a single bond,
L '4 each, independently of one another, denote F, CI, OCF3,
CF3, CH3, CH2F, CHF2.
Preferably, both L1 and L2 denote F or one of L1 and L2 denotes F and the other denotes CI, or both L3 and L4 denote F or one of L3 and L4 denotes F and the other denotes CI.
The compounds of the formula CY are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000042_0001
CY2
Figure imgf000042_0002
Figure imgf000043_0001
Figure imgf000044_0001
Figure imgf000044_0002
Figure imgf000044_0003
Figure imgf000044_0004
Figure imgf000044_0005
Figure imgf000044_0006
Figure imgf000044_0007
30
Figure imgf000045_0001
Figure imgf000046_0001
alkyl— H — { H -CH20— < O >— (O)alkyl*
CY32
Figure imgf000047_0001
wherein a denotes 1 or 2, alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms, and (O) denotes an oxygen atom or a single bond. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
The compounds of the formula PY are preferably selected from the group consisting of the following sub-formulae:
PY1 alkyl- O >— ( O )— alkyl*
F F
PY2 alkyl— O ) O V— O-alkyl*
Figure imgf000047_0002
Figure imgf000048_0001
Figure imgf000049_0001
30
Figure imgf000050_0001
Figure imgf000050_0002
wherein alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms, and (O) denotes an oxygen atom or a single bond. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2- CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3- CH=CH-(CH2)2-.
LC medium which additionally comprises one or more compounds of the following formula:
Figure imgf000050_0003
which the individual radicals have the following meanings
Figure imgf000050_0004
-^Ό ^- denotes— H — or — < 0
R3 and R4 each, independently of one another, denote alkyl having 1 to 12 C atoms, in which, in addition, one or two non-adjacent CH2 groups may be replaced by -0-, -CH=CH-, -CO-, -O-CO- or -CO-O- in such a way that O atoms are not linked directly to one another, > denotes -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-,
-OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH- CH2O- or a single bond, preferably a single bond.
The compounds of the formula ZK are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000051_0001
alkyl ZK1
Figure imgf000051_0002
alkenyl— ( H — ( H —alkyl ZK3
alkenyl— < H V—{ ZK4
H V- alkenyl*
Figure imgf000052_0001
Figure imgf000052_0002
Figure imgf000052_0003
Figure imgf000052_0004
Figure imgf000052_0005
Figure imgf000052_0006
in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3- CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3- CH=CH-(CH2)2-.
Especially preferred are compounds of formula ZK1 and ZK3. Particularly preferred compounds of formula ZK are selected from the following sub-formulae:
Figure imgf000053_0001
wherein the propyl, butyl and pentyl groups are straight-chain groups.
Most preferred are compounds of formula ZK1 a and ZK3a. LC medium which additionally comprises one or more compounds of the following formula:
Figure imgf000054_0001
in which the individual radicals on each occurrence, identically or differently, have the following meanings:
R5 and R6 each, independently of one another, denote alkyl
having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -0-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
denotes ( H >— or — ( o
Figure imgf000054_0002
Figure imgf000054_0003
denotes 1 or 2.
The compounds of the formula DK are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000055_0001
DK9 alkyl— < H V— O O O >— alkyl* K10 alkyl— H O O V— ( D
H alkyl*
Figure imgf000056_0001
Figure imgf000056_0002
in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, Chh- CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3- CH=CH-(CH2)2-.
LC medium which additionally comprises one or more compounds the following formula:
Figure imgf000056_0003
in which the individual radicals have the following meanings:
Figure imgf000057_0001
with at least one ring F being different from cyclohexylene, f denotes 1 or 2,
R1 and R2 each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non- adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another,
Zx denotes -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-,
-OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH- CH2O- or a single bond, preferably a single bond,
L and L2 each, independently of one another, denote F, CI, OCF3,
CF3, CH3, CH2F, CHF2.
Preferably, both radicals L1 and L2 denote F or one of the radicals L1 and L2 denotes F and the other denotes CI.
The compounds of the formula LY are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000058_0001
Figure imgf000059_0001
Figure imgf000059_0002
Figure imgf000059_0003
Figure imgf000059_0004
Figure imgf000059_0005
Figure imgf000059_0006
Figure imgf000059_0007
30
Figure imgf000060_0001
Figure imgf000061_0001
Figure imgf000061_0002
in which R1 has the meaning indicated above, alkyl denotes a straight-chain alkyl radical having 1-6 C atoms, (O) denotes an oxygen atom or a single bond, and v denotes an integer from 1 to 6. R preferably denotes straight-chain alkyl having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms, in particular CH3, C2H5, n-C3H7, n-C4H9, n-CsHu , CH2=CH-, CH2-CHCH2CH2-, CH3- CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-
CH=CH- or CH3-CH=CH-(CH2)2-. e) LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
Figure imgf000061_0003
G2
Figure imgf000061_0004
G3 alkyl— o ) < O > ( O >-X
G4 alkyl— o ) O > ( O >-X
in which alkyl denotes Ci-6-alkyl, Lx denotes H or F, and X denotes F, CI, OCF3, OCHF2 or OCH=CF2. Particular preference is given to compounds of the formula G1 in which X denotes F.
LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
Figure imgf000062_0001
Figure imgf000062_0002
Figure imgf000062_0003
Figure imgf000062_0004
Figure imgf000063_0001
Figure imgf000064_0001
Figure imgf000064_0002
Figure imgf000064_0003
Figure imgf000064_0004
in which R5 has one of the meanings indicated above for R1, alkyl denotes C-i-6-alkyl, d denotes 0 or 1 , and z and m each, independently of one another, denote an integer from 1 to 6. R5 in these compounds is particularly preferably d-6-alkyl or -alkoxy or C2-6-alkenyl, d is preferably 1. The LC medium according to the invention preferably comprises one or more compounds of the above-mentioned formulae in amounts of > 5% by weight.
LC medium which additionally comprises one or more biphenyl compounds selected from the group consisting of the following formulae:
alkyl— < O > < o >— alkyl* B
Figure imgf000065_0001
in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl and alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2- CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3- CH=CH-(CH2)2-.
The proportion of the biphenyls of the formulae B1 to B3 in the LC mixture is preferably at least 3% by weight, in particular > 5% by weight.
The compounds of the formula B2 are particularly preferred.
The compounds of the formulae B1 to B3 are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000065_0002
Figure imgf000066_0001
in which alkyl* denotes an alkyl radical having 1-6 C atoms. The medium according to the invention particularly preferably comprises one or more compounds of the formulae B1a and/or B2c.
LC medium which additionally comprises one or more terphenyl compounds of the following formula:
Figure imgf000066_0002
in which R5 and R6 each, independently of one another, have one of the meanings indicated above, and
Figure imgf000066_0003
Figure imgf000066_0004
in which L5 denotes F or CI, preferably F, and L6 denotes F, CI, OCF3, CF3, Chb, CH2F or CHF2, preferably F.
The compounds of the formula T are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000067_0001
F F F F
T7
Figure imgf000068_0001
Figure imgf000069_0001
Figure imgf000070_0001
in which R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms, R* denotes a straight-chain alkenyl radical having 2-7 CQ atoms, (O) denotes an oxygen atom or a single bond, and m
denotes an integer from 1 to 6. R* preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2- CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-. 5 R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, meth- oxy, ethoxy, propoxy, butoxy or pentoxy.
The LC medium according to the invention preferably comprises the terphenyls of the formula T and the preferred sub-formulae thereof ino an amount of 0.5-30% by weight, in particular 1-20% by weight.
Particular preference is given to compounds of the formulae T1 , T2, T3 and T21. In these compounds, R preferably denotes alkyl, furthermore alkoxy, each having 1-5 C atoms.
5
The terphenyls are preferably employed in mixtures according to the invention if the Δη value of the mixture is to be > 0.1. Preferred mixtures comprise 2-20% by weight of one or more terphenyl compounds of the formula T, preferably selected from the group of com-0 pounds T1 to T22. LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
Figure imgf000071_0001
Figure imgf000072_0001
in which R1 and R2 have the meanings indicated above and preferably each, independently of one another, denote straight-chain alkyl having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms.
Preferred media comprise one or more compounds selected from the formulae O1 , O3 and 04.
LC medium which additionally comprises one or more compounds of the following formula:
Figure imgf000072_0002
in which denotes
H
Figure imgf000072_0003
Figure imgf000073_0001
R9 denotes H, Chh, C2H5 or n-C3H7, (F) denotes an optional fluorine substituent, and q denotes 1 , 2 or 3, and R7 has one of the meanings indicated for R1, preferably in amounts of > 3% by weight, in particular > 5% by weight and very particularly preferably 5-30% by weight.
Particularly preferred compounds of the formula Fl are selected from the group consisting of the following sub-formulae:
Figure imgf000073_0002
Figure imgf000073_0003
FI3
Figure imgf000073_0004
Figure imgf000074_0001
Figure imgf000074_0002
Figure imgf000074_0003
Figure imgf000074_0004
Figure imgf000074_0005
in which R7 preferably denotes straight-chain alkyl, and R9 denotes Chta, C2H5 or n-C3H7. Particular preference is given to the compounds of the formulae FI1 , FI2 and FI3. LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
Figure imgf000075_0001
Figure imgf000075_0002
Figure imgf000075_0003
Figure imgf000075_0004
in which R8 has the meaning indicated for R1, and alkyl denotes a straight-chain alkyl radical having 1-6 C atoms.
LC medium which additionally comprises one or more compounds which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds selected from the group consisting of the following formulae:
N1
Figure imgf000075_0005
Figure imgf000076_0001
Figure imgf000077_0001
Figure imgf000077_0002
Figure imgf000077_0003
in which
R10 and R 1 each, independently of one another, denote alkyl
having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -0-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms, and R10 and R11 preferably denote straight-chain alkyl or alkoxy having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms, and
Z1 and Z2 each, independently of one another, denote -C2H4-,
-CH=CH-, -(CH2)4-, -(CH2)3O-, -O(CH2)3-, -CH=CH- CH2CH2-, -CH2CH2CH=CH-, -CH2O-, -OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CF=CH-, -CH=CF-, -CH2- or a single bond. LC medium which additionally comprises one or more difluoro- dibenzochromans and/or chromans of the following formulae:
Figure imgf000078_0001
Figure imgf000078_0002
Figure imgf000078_0003
in which
R11 and R 2 each, independently of one another, have one of the meanings indicated above for R1 ,
ring M is trans-1 ,4-cyclohexylene or ,4-phenylene,
Zm -C2H4-, -CH2O-, -OCH2-, -CO-O- or -O-CO-,
c is 0, 1 or 2,
preferably in amounts of 3 to 20% by weight, in particular in amounts of 3 to 15% by weight.
Particularly preferred compounds of the formulae BC, CR and RC are selected from the group consisting of the following sub-formulae:
Figure imgf000079_0001
5
Figure imgf000079_0002
Figure imgf000079_0003
Figure imgf000079_0004
Figure imgf000079_0005
Figure imgf000079_0006
30
Figure imgf000080_0001
Figure imgf000081_0001
in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, (O) denotes an oxygen atom or a single bond, c is 1 or 2, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl and alkenyl* preferably denote
CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3- (CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
Very particular preference is given to mixtures comprising one, two or three compounds of the formula BC-2. LC medium which additionally comprises one or more fluorinated phenanthrenes and/or dibenzofurans of the following formulae:
Figure imgf000082_0001
in which R11 and R12 each, independently of one another, have one of the meanings indicated above for R11 , b denotes 0 or 1 , L denotes F, and r denotes 1 , 2 or 3.
Particularly preferred compounds of the formulae PH and BF are selected from the group consisting of the following sub-formulae:
Figure imgf000083_0001
Figure imgf000083_0002
Figure imgf000083_0003
Figure imgf000083_0004
in which R and R' each, independently of one another, denote a straight-chain alkyl or alkoxy radical having 1-7 C atoms.
LC medium which additionally comprises one or more monocycl compounds of the following formula
Figure imgf000083_0005
wherein
R1 and R2 each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adja- cerit CH2 groups may be replaced by -0-, -CH=CH-, -CO- -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
L and L2 each, independently of one another, denote F, CI, OCF3,
Figure imgf000084_0001
Preferably, both L1 and L2 denote F or one of L1 and L2 denotes F and the other denotes CI,
The compounds of the formula Y are preferably selected from the group consisting of the following sub-formulae:
Figure imgf000084_0002
Figure imgf000084_0003
Y3
Figure imgf000084_0004
Figure imgf000084_0005
Figure imgf000085_0001
Figure imgf000085_0002
Figure imgf000085_0003
Figure imgf000085_0004
Figure imgf000085_0005
20
Figure imgf000085_0006
25
in which, Alkyl and Alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, Alkoxy denotes a straight-chain alkoxy radical having 1 -6 C atoms, Alkenyl and Alkenyl* each, independently of one another, denote a straight- chain alkenyl radical having 2-6 C atoms, and O denotes an oxygen
30
atom or a single bond. Alkenyl and Alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CHs- (CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
Particularly preferred compounds of the formula Y are selected from the group consisting of the following sub-formulae:
Figure imgf000086_0001
Figure imgf000086_0002
wherein Alkoxy preferably denotes straight-chain alkoxy with 3, 4, or 5 C atoms.
LC medium which, apart from the stabilisers according to the invention, in particular of the formula I or sub-formulae thereof and the comonomers, comprises no compounds which contain a terminal vinyloxy group (-0-CH=CH2).
LC medium which comprises 1 to 5, preferably 1 , 2 or 3, stabilisers, preferably selected from stabilisers according to the invention, in particular of the formula I or sub-formulae thereof.
LC medium in which the proportion of stabilisers, in particular of the formula I or sub-formulae thereof, in the mixture as a whole is 1 to 1500ppm, preferably 100 to l OOOppm. t) LC medium which comprises 1 to 8, preferably 1 to 5, compounds of the formulae CY1 , CY2, PY1 and/or PY2. The proportion of these compounds in the mixture as a whole is preferably 5 to 60%, particularly preferably 10 to 35%. The content of these individual com- pounds is preferably in each case 2 to 20%. u) LC medium which comprises 1 to 8, preferably 1 to 5, compounds of the formulae CY9, CY10, PY9 and/or PY10. The proportion of these compounds in the mixture as a whole is preferably 5 to 60%, particu- larly preferably 10 to 35%. The content of these individual compounds is preferably in each case 2 to 20%. v) LC medium which comprises 1 to 10, preferably 1 to 8, compounds of the formula ZK, in particular compounds of the formulae ZK1 , ZK2 and/or ZK6. The proportion of these compounds in the mixture as a whole is preferably 3 to 25%, particularly preferably 5 to 45%. The content of these individual compounds is preferably in each case 2 to 20%. w) LC medium in which the proportion of compounds of the formulae CY, PY and ZK in the mixture as a whole is greater than 70%, preferably greater than 80%. x) LC medium in which the LC host mixture contains one or more
compounds containing an alkenyl group, preferably selected from the group consisting of formula CY, PY and LY, wherein one or both of R1 and R2 denote straight-chain alkenyl having 2-6 C atoms, formula ZK and DK, wherein one or both of R3 and R4 or one or both of R5 and R6 denote straight-chain alkenyl having 2-6 C atoms, and formula B2 and B3, very preferably selected from formulae CY15,
CY16, CY24, CY32, PY15, PY16, ZK3, ZK4, DK3, DK6, B2 and B3, most preferably selected from formulae ZK3, ZK4, B2 and B3. The concentration of these compounds in the LC host mixture is preferably from 2 to 70%, very preferably from 3 to 55%.
LC medium which contains one or more, preferably 1 to 5, compounds selected of formula PY1-PY8, very preferably of formula PY2. The proportion of these compounds in the mixture as a whole is preferably 1 to 30%, particularly preferably 2 to 20%. The content of these individual compounds is preferably in each case 1 to 20%.
LC medium which contains one or more, preferably 1, 2 or 3, compounds of formula T2. The content of these compounds in the mixture as a whole is preferably 1 to 20%.
In another preferred embodiment of the present invention the LC medium contains an LC host mixture with positive dielectric anisotropy. Preferred embodiments of such an LC medium, and the corresponding LC host mixture, are those of sections aa) - mmm) below:
LC-medium, characterised in that it comprises one or more compounds selected from the group of compounds of the formul and III
Figure imgf000088_0001
III
Figure imgf000088_0002
wherein
R20 each, identically or differently, denote a halogenated or un- substituted alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by
-C≡C-, -CF2O-, -CH=CH-, -O- , -OO^ - -0-. -CO-O- or -O-CO- in such a way that O atoms are not linked directly to one another,
X20 each, identically or differently, denote F, CI, CN, SF5, SCN,
NCS, a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical, each having up to 6 C atoms, and γ20 24 each, identically or differently, denote H or F; ther, denote
Figure imgf000089_0001
The compounds of the formula II are preferably selected from the following formulae:
Figure imgf000090_0001
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F. Particular preference is given to compounds of the formulae lla and lib, in particular compounds of the formulae lla and Mb wherein X denotes F.
The compounds of the formula III are preferably selected from the following formulae:
Figure imgf000091_0001
Figure imgf000091_0002
Figure imgf000091_0003
Figure imgf000091_0004
Figure imgf000092_0001
wherein R20 and X20 have the meanings indicated above.
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F. Particular preference is given to compounds of the formulae Ilia and I lie, in particular compounds of the formula Ilia;
LC-medium additionally comprising one or more compounds selected from the following formulae:
Figure imgf000092_0002
Figure imgf000093_0001
wherein
R20, X20 and Y20"23 have the meanings indicated above, and Z20 denotes -C2H4-, -(CH2)4-, -CH=CH-, -CF=CF-, -C2F4-,
-CH2CF2-, -CF2CH2-, -CH2O-, -OCH2-, -COO- or -OCF2-, in formulae V and VI also a single bond, in formulae V and VIII
Figure imgf000093_0002
r denotes 0 or 1 , and s denotes 0 or 1 ;
The compounds of the formula IV are preferably selected from the following formulae:
F
IVa
2 H H o x20
Figure imgf000094_0001
Figure imgf000094_0002
Figure imgf000094_0003
wherein R20 and X20 have the meanings indicated above.
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F or OCF3, furthermore OCF=CF2 or CI;
The compounds of the formula V are preferably selected from the following formulae:
Figure imgf000094_0004
Figure imgf000094_0005
Figure imgf000095_0001
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F and OCF3, furthermore OCHF2, CF3, OCF=CF2 and OCH=CF2; The compounds of the formula VI are preferably selected from the following formulae:
Figure imgf000096_0001
Figure imgf000096_0002
Figure imgf000096_0003
Figure imgf000096_0004
wherein R20 and X20 have the meanings indicated above.
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F, furthermore OCF3, CF3, CF=CF2, OCHF2 and OCH=CF2;
The compounds of the formula VII are preferably selected from the following formulae:
Figure imgf000097_0001
F
Vllb
R20— ( H >— ( H — COO— ( O X:
wherein R20 and X20 have the meanings indicated above.
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F, furthermore OCF3, OCHF2 and OCH=CF2. cc) The medium additionally comprises one or more compounds selected from the formulae ZK1 to ZK10 given above. Especially preferred are compounds of formula ZK1 and ZK3. Particularly preferred compounds of formula ZK are selected from the sub- formulae ZK1a, ZK1 b, ZK1c, ZK3a, ZK3b, ZK3c and ZK3d. dd) The medium additionally comprises one or more compounds selected from the formulae DK1 to DK12 given above. Especially preferred compounds are DK3. ee) The medium additionally comprises one or more compounds selected from the following formulae:
IX
alkenyl— ( H >— H >— < O >— X20 wherein X20 has the meanings indicated above, and
L denotes H or F,
"alkenyl" denotes C2-6-alkenyl.
The compounds of the formulae DK-3a and IX are preferably selected from the following formulae:
Figure imgf000098_0001
Figure imgf000098_0002
wherein "alkyl" denotes Ci-6-alkyl, preferably n-C3H7, n-C H9 or n- C5H11 , in particular n-C3H7.
The medium additionally comprises one or more compounds selected from the formulae B1 , B2 and B3 given above, preferably from the formula B2. The compounds of the formulae B1 to B3 are particularly preferably selected from the formulae B1 a, B2a, B2b and B2c.
The medium additionally comprises one or more compounds selected from the following formula:
Figure imgf000099_0001
wherein L20 denotes H or F, and R21 and R22 each, identically or differently, denote n-alkyl, alkoxy, oxaalkyi, fluoroalkyi or alkenyl, each having up to 6 C atoms, and preferably each, identically or differently, denote alkyl having 1 to 6 C atoms. The medium comprises one or more compounds of the following formulae:
Figure imgf000099_0002
wherein R20, X20 and Y20"23 have the meanings indicated
formula III, and each, independently of one another, denote
Figure imgf000100_0001
Figure imgf000101_0001
30
Figure imgf000102_0001
Figure imgf000102_0002
Figure imgf000102_0003
Figure imgf000102_0004
wherein R20 and X20 have the meaning indicated above and preferably R20 denotes alkyl having 1 to 6 C atoms and X20 denotes F.
The mixture according to the invention particularly preferably comprises at least one compound of the formula Xlla and/or Xlle.
The medium comprises one or more compounds of formula T given above, preferably selected from the group of compounds of the formulae T21 toT23 and T25 to T27. Particular preference is given to the compounds of the formulae T21 to T23. Very particular preference is given to the compounds of the formulae
Figure imgf000103_0001
Figure imgf000103_0002
Figure imgf000103_0003
Figure imgf000103_0004
Figure imgf000103_0005
Figure imgf000103_0006
The medium comprises one or more compounds selected from the group of formulae DK9, DK10 and DK1 1 given above.
The medium additionally comprises one or more compounds selected from the following formulae:
Figure imgf000104_0001
Figure imgf000104_0002
Figure imgf000104_0003
Figure imgf000104_0004
Figure imgf000105_0001
Figure imgf000105_0002
wherein R20 and X20 each, independently of one another, have one of the meanings indicated above, and Y20"23 each, independently of one another, denote H or F. X20 is preferably F, CI, CF3, OCF3 or OCHF2. R20 preferably denotes alkyl, alkoxy, oxaalkyi, fluoroalkyi or alkenyl, each having up to 6 C atoms.
The mixture according to the invention particularly preferably comprises one or more compounds of the formula XVIII-a,
XVIII-a
Figure imgf000105_0003
wherein R20 has the meanings indicated above. R20 preferably denotes straight-chain alkyl, in particular ethyl, n-propyl, n-butyl and n-pentyl and very particularly preferably n-propyl. The compound(s) of the formula XVIII, in particular of the formula XVIII-a, is (are) preferably employed in the mixtures according to the invention in amounts of 0.5- 20% by weight, particularly preferably 1-15% by weight. mm) The medium additionally comprises one or more compounds of the formula XIX,
Figure imgf000106_0001
wherein R20, X20 and Y20"25 have the meanings indicated in formula I, s denotes 0 or 1 , and
Figure imgf000106_0002
In the formula XIX, X20 may also denote an alkyl radical having 1-6 C atoms or an alkoxy radical having 1-6 C atoms. The alkyl or alkoxy radical is preferably straight-chain.
R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F;
The compounds of the formula XIX are preferably selected from the following formulae:
XlXa
Figure imgf000106_0003
Figure imgf000107_0001
Figure imgf000108_0001
wherein R20, X20 and Y20 have the meanings indicated above. R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F, and Y20 is preferably F;
Figure imgf000108_0002
R20 is straight-chain alkyl or alkenyl having 2 to 6 C atoms;
The medium comprises one or more compounds of the formulae G1 to G4 given above, preferably selected from G1 and G2 wherein alkyl denotes C-i -6-alkyl, Lx denotes H and X denotes F or CI. In G2, X particularly preferably denotes CI. The medium comprises one or more compounds of the following formulae:
Figure imgf000109_0001
wherein R20 and X20 have the meanings indicated above. R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F. The medium according to the invention particularly preferably comprises one or more compounds of the formula XXII wherein X20 preferably denotes F. The compound(s) of the formulae
XX - XXII is (are) preferably employed in the mixtures according to the invention in amounts of 1-20% by weight, particularly preferably 1-15% by weight. Particularly preferred mixtures comprise at least one compound of the formula XXII. The medium comprises one or more compounds of the following pyrimidine or pyridine compounds of the formulae
Figure imgf000110_0001
wherein R20 and X20 have the meanings indicated above. R20 preferably denotes alkyl having 1 to 6 C atoms. X20 preferably denotes F. The medium according to the invention particularly preferably comprises one or more compounds of the formula M-1 , wherein X20 preferably denotes F. The compound(s) of the formulae M-1 - M-3 is (are) preferably employed in the mixtures according to the invention in amounts of 1-20% by weight, particularly preferably 1-15% by weight.
Further preferred embodiments are indicated below:
The medium comprises two or more compounds of the formula XII in particular of the formula XI le; rr) The medium comprises 2-30% by weight, preferably 3-20% by weight, particularly preferably 3-15% by weight, of compounds of the formula XII; ss) Besides the compounds of the formulae XII, the medium comprises further compounds selected from the group of the compounds of the formulae II, III, IX-XIII, XVII and XVIII; tt) The proportion of compounds of the formulae II, III, IX-XI, XIII, XVII and XVIII in the mixture as a whole is 40 to 95% by weight; uu) The medium comprises 10-50% by weight, particularly preferably 12- 40% by weight, of compounds of the formulae II and/or III; vv) The medium comprises 20-70% by weight, particularly preferably 25- 65% by weight, of compounds of the formulae IX-XIII; ww) The medium comprises 4-30% by weight, particularly preferably
5-20% by weight, of compounds of the formula XVII; xx) The medium comprises 1-20% by weight, particularly preferably
2-15% by weight, of compounds of the formula XVIII; . yy) The medium comprises at least two compounds of the formulae
Xlle-1
Figure imgf000111_0001
Figure imgf000112_0001
Figure imgf000112_0002
zz) The medium comprises at least two compounds of the formulae
Figure imgf000112_0003
Figure imgf000112_0004
Figure imgf000112_0005
aaa) The medium comprises at least two compounds of the formula Xlla and at least two compounds of the formula XI le. bbb) The medium comprises at least one compound of the formula Xlla and at least one compound of the formula Xlle and at least one compound of the formula Ilia. ccc) The medium comprises at least two compounds of the formula Xlla and at least two compounds of the formula XI le and at least one compound of the formula Ilia. ddd) The medium comprises in total > 25% by weight, preferably≥ 30% by weight, of one or more compounds of the formula XII. eee) The medium comprises > 20% by weight, preferably > 24% by weight, preferably 25-60% by weight, of compounds of the formula ZK3, in particular the compound of the formula ZK3a,
Figure imgf000113_0001
fff) The medium comprises at least one compound selected from the group of compounds ZK3a, ZK3b and ZK3c, preferably ZK3a, in combination with compound ZK3d
Figure imgf000113_0002
999) The medium comprises at least one compound of the formula DPGU-n-F. hhh) The medium comprises at least one compound of the formula CDUQU-n-F. iii) The medium comprises at least one compound of the formula
CPU-n-OXF. jjj) The medium comprises at least one compound of the formula CPGU-3-OT. kkk) The medium comprises at least one compound of the formula
PPGU-n-F.
Ill) The medium comprises at least one compound of the formula
PGP-n-m, preferably two or three compounds. mmm) The medium comprises at least one compound of the formula
PGP-2-2V having the structure
Figure imgf000114_0001
The media according to the invention preferably comprise from 0.01 to 10%, particularly preferably from 0.05 to 5% and most preferably from 0.1 to 3% of component A) comprising compounds of formula I according to the invention. The media preferably comprise one, two or three, more preferably one or two and most preferably one compound of the formula I according to the invention.
In a preferred embodiment component A) consists of compounds of formula I.
The media according to the invention preferably comprise from 0.01 to 10%, particularly preferably from 0.05 to 7.5% and most preferably from 2 to 5% of the compounds of component C) comprising compounds of formula P according to the invention. The media preferably comprise one, two or three, more preferably one or two and most preferably one compound of the formula P according to the invention. The compounds used in the present invention are prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie
[Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), to be precise under reaction conditions which are known and suitable for the said reactions. Use can also be made here of variants known per se, which are not mentioned here in greater detail.
The compounds of formula I are preferably synthesised according to or in analogy to the procedure described in GB 2 306 470 A.
The compounds of formula I are more preferably synthesised according to the process depicted in schemes 1 and 2. In scheme 2, a preferred synthesis of compounds of formula I without spacer groups is shown. In scheme 1 , "Spacer1" or "Spacer2"denotes a group "Sp" as indicated above. Pg denotes a protecting group. Suitable protecting groups are known to the skilled person from the literature, as for example from P.G.M. Wuts, Th.W. Greene, Greene's Protective Groups in Organic Synthesis, Fourth Edition, 2007 John Wiley & Sons, Inc. Examples are 2- tetrahydropyranyl, benzyl, trimethylsilyl, tertbuty Id imethylsilyl ,
triisopropylsilyl, methoxymethyl, and the like.
Figure imgf000116_0001
Q ester cleavage .O
PgO— Spacer— Q—^ ^)— 1( PgO— Spacer— o—^ )
OH O
1) protection
2) Baeyer-Villiger Oxidation
3) ester cleavage
Figure imgf000116_0002
1) esterification
2) debenzylation
Figure imgf000116_0003
O— <\ — ¾ o Br— Spacer2— OH
HO— Spacer— O
etherifi cation ester cleavage
with A
with e.g. acrylic acid derivative
Figure imgf000116_0004
Figure imgf000116_0005
R2 = CH3 CH2CH3
Scheme 1.
Figure imgf000117_0001
R1 = H, CH,
R2 = CH3 CH2CH3
Pg = e.g. THP
Scheme 2.
In the following, the production process according to the present invention is described in greater detail.
The first substrate includes a pixel electrode and a common electrode for generating an electric field substantially parallel to a surface of the first substrate in the pixel region. Different kinds of diplays having at least two electrodes on one substrate are known to the skilled person wherein the most important difference is that either both the pixel electrode and the common electrode are structured, as it is typical for IPS displays, or only the pixel electrode is structured and the common electrode is
unstructured, which is the case for FFS displays. It has to be understood that the present invention refers to any kind of electrode configurations mentioned above, i.e. IPS as well as FFS displays. The process according to the present invention is independent of the kind of substrate or material of the surface which is in contact with the liquid crystal mixture according to the invention, during and after this process. Examples of materials used for the substrates or surfaces are organic polymers including polyimide, indium tin oxide (ITO), indium zinc oxide (IZO), silicon nitride (SiNx) and silicon dioxide(SiO2). The process is especially suitable for the use in displays containing substrates that do not have a polyimide layer on one or more of the surfaces that are in contact with the liquid crystal. In case one or more substrates contain a polyimide layer, the polyimide can be rubbed or not rubbed, preferably not rubbed.
Hence, the invention relates to a display produced by the process according to the invention in which the substrates contain a rubbed or unrubbed polyimide layer, preferably an unrubbed polyimide layer.
The invention further relates to a display produced by the process according to the invention in which none or only one of the top and bottom substrates contains a polyimide layer.
In one embodiment of the present invention the liquid crystal composition is injected between the first and second substrates or is filled into the cell by capillary force after combining the first and second substrates. In an alternative embodiment, the liquid crystal composition may be interposed between the first and second substrates by combining the second substrate to the first substrate after loading the liquid crystal composition on the first substrate. Preferably, the liquid crystal is dispensed dropwise onto a first substrate in a process known as "one drop filling" (ODF) process, as disclosed in for example JPS63-179323 and JPH10-239694, or using the Ink Jet Printing (UP) method. In a preferred embodiment, the process according to the invention contains a process step where the liquid crystal inside the display panel is allowed to rest for a period of time in order to evenly redistribute the liquid crystal medium inside the panel (herein referred to as "annealing"). For the production of the displays according to the present invention, the photoreactive mesogen of formula I is prefably allowed to redistribute in the panel. After filling and assembly, the display panel is annealed for a time between 1min and 3h, preferably between 10min and 1 h and most preferably between 20min and 30min. The annealing is preferably performed at room temperature.
In an alternative embodiment, the annealing is performed at elevated temperature, preferably at above 20°C and below 140°C, more preferably above 40°C and below 100°C and most preferably above 50°C and below 80°C.
In a preferred embodiment, one or more of the process steps of filling the display, annealing, photoalignment and curing of the polymerisable compound is performed at a temperature above the clearing point of the liquid crystal host mixture.
During the photoalignment of the liquid crystal inside the liquid crystal panel, anisotropy is induced by exposing the display or the liquid crystal layer to linearly polarised light.
In a preferred embodiment of the present invention the photoreactive component A) is photoaligned in a first step using linearly polarised light and in a second step further cured using linearly polarized or unpolarised UV light. In the second step the optional component C) is also further cured. In another preferred embodiment, the linearly polarised light applied according to the inventive process is ultraviolet light which enables simultaneous photoalignment and photocuring of the photoreactive component A) and, if present, photocuring of the polymerisable
component C).
Photoalignment of the photoreactive compounds of formula I and curing of the polymerisable groups of compounds of formula I and the curing of the optional polymerisable compounds of formula P can be performed simultaneously or stepwise. In case the process is split into different steps, the individual steps can be performed at the same temperature or at different temperatures.
After the photoalignment and curing step(s) a so-called "post-curing" step can optionally be performed by irradiation with UV-light and/or visible light (both either linearly or unpolarised) at reduced temperature in order to remove unreacted polymerisable compounds. The post-curing is preferably performed at above 20°C and below 70°C°C, more preferably below 60°C and most preferably above 20°C and below 40°C. The polymerisable compounds are optionally polymerised or crosslinked (if a polymerisable compound contains two or more polymerisable groups)with the application of an electrical field. The polymerisation can be carried out in one or more steps. Suitable and preferred polymerisation methods for component C) are, for example, thermal or photopolymerisation, preferably photopolymerisation, in particular UV photopolymerisation. One or more initiators can optionally also be added here. Suitable conditions for the polymerisation and suitable types and amounts of initiators are known to the person skilled in the art and are described in the literature. Suitable for free-radical polymerisation are, for example, the commercially available photoinitiators Irgacure651®, Irgacure184®, Irgacure907®, Irgacure369® or
Darocurel 173® (BASF SE). If an initiator is employed, its proportion is preferably 0.001 to 5% by weight, particularly preferably 0.001 to 1% by weight. According to the present invention, an alkyl radical and/or an alkoxy radical may be straight-chain or branched. It is preferably straight-chain, has 2, 3, 4, 5, 6 or 7 C atoms and accordingly preferably denotes ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexyloxy or -heptyloxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, methoxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tridecyloxy or tetradecyloxy.
Oxaalkyl preferably denotes straight-chain 2-oxapropyl (= methoxy- methyl), 2- (= ethoxymethyl) or 3-oxabutyl (= 2-methoxyethyl), 2-, 3- or 4-oxapentyl, 2-, 3-, 4- or 5-oxahexyl, 2-, 3-, 4-, 5- or 6-oxaheptyl, 2-, 3-, 4-, 5-, 6- or 7-oxaoctyl, 2-, 3-, 4-, 5-, 6-, 7- or 8-oxanonyl, 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-oxadecyl.
An alkyl radical in which one CH2 group has been replaced by -CH=CH-, may be straight-chain or branched. It is preferably straight-chain and has 2 to 10 C atoms. Accordingly, it denotes, in particular, vinyl, prop-1- or -2- enyl, but- -, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, hept-1-, -2-, -3-, -4-, -5- or -6-enyl, oct-1-, -2-, -3-, -4-, -5-, -6- or -7-enyl, non-1-, -2-, -3-, -4-, -5-, -6-, -7- or -8-enyl, dec-1-, -2-, -3-, -4-, -5-, -6-, -7-, -8- or -9-enyl. An alkyl or alkenyl radical which is at least monosubstituted by halogen is preferably straight-chain, and halogen is preferably F or CI. In the case of polysubstitution, halogen is preferably F. The resultant radicals also include perfluorinated radicals. In the case of monosubstitution, the fluorine or chlorine substituent may be in any desired position, but is preferably in the co-position.
In the formulae above and below, polar end groups (substituents X) are preferably F, CI or a mono- or polyfluorinated alkyl or alkoxy radical having 1 , 2 or 3 C atoms or a mono- or polyfluorinated alkenyl radical having 2 or 3 C atoms. They are particularly preferably F, CI, CF3, CHF2, OCF3, OCHF2, OCFHCF3, OCFHCHF2, OCFHCHF2, OCF2CH3,
OCF2CHF2, OCF2CHF2, OCF2CF2CHF2, OCF2CF2CHF2, OCFHCF2CF3, OCFHCF2CHF2, OCF2CF2CF3, OCF2CF2CCIF2, OCCIFCF2CF3,
OCH=CF2 or CH=CF2, very particularly preferably F or OCF3, furthermore CF3, OCF=CF2, OCHF2 or OCH=CF2.
The media according to the invention are prepared in a manner conventional per se. In general, the components are dissolved in one another, preferably at elevated temperature. By means of suitable additives, the liquid-crystalline phases of the present invention can be modified in such a way that they can be used in all types of liquid-crystal display element that have been disclosed hitherto. Additives of this type are known to the person skilled in the art and are described in detail in the literature (H. Kelker/ R. Hatz, Handbook of Liquid Crystals, Verlag Chemie, Weinheim, 1980). For example, pleochroic dyes can be added for the production of coloured guest-host systems or substances can be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. The present invention also relates to electro-optical liquid-crystal display elements containing a liquid-crystalline medium according to the invention. In a preferred embodiment the liquid crystal display is of the IPS or FFS mode.
Further combinations of the embodiments and variants of the invention in accordance with the description arise from the claims.
The invention is explained in greater detail below with reference to working examples, but without intending to be restricted thereby. The person skilled in the art will be able to glean from the examples working details that are not given in detail in the general description, generalise them in accordance with general expert knowledge and apply them to a specific problem.
Besides the usual and well-known abbreviations, the following abbrevia- tions are used:
C: crystalline phase; N: nematic phase; Sm: smectic phase; I: isotropic phase. The numbers between these symbols show the transition temperatures of the substance concerned.
Temperature data are in °C, unless indicated otherwise.
Physical, physicochemical or electro-optical parameters are determined by generally known methods, as described, inter alia, in the brochure "Merck Liquid Crystals - Licristal® - Physical Properties of Liquid Crystals - Description of the Measurement Methods", 1998, Merck KGaA,
Darmstadt.
Above and below, Δη denotes the optical anisotropy (589 nm, 20°C) and Δε denotes the dielectric anisotropy (1 kHz, 20°C). The dielectric anisotropy Δε is determined at 20°C and 1 kHz. The optical anisotropy Δη is de- termined at 20°C and a wavelength of 589.3 nm. The Δε and Δη values and the rotational viscosity (γι) of the compounds according to the invention are obtained by linear extrapolation from liquid- crystalline mixtures consisting of 5 to 10% of the respective compound according to the invention and 90-95% of the commercially available liquid-crystal mixture ZLI-2857 (for Δε) or ZLI-4792 (for Δη, γι) (mixtures, Merck KGaA, Darmstadt).
In the present invention and especially in the following examples, the structures of the mesogenic compounds are indicated by means of abbreviations, also called acronyms. In these acronyms, the chemical formulae are abbreviated as follows using Tables A to C below. All groups CnH2n+i , CmH2m+i and C1H21+1 or CnH2n-i , CmH2m-i and C1H21-1 denote straight-chain alkyl or alkenyl, preferably 1E-alkenyl, each having n, m and I C atoms respectively. Table A lists the codes used for the ring elements of the core structures of the compounds, while Table B shows the linking groups. Table C gives the meanings of the codes for the left-hand or right-hand end groups. The acronyms are composed of the codes for the ring elements with optional linking groups, followed by a first hyphen and the codes for the left-hand end group, and a second hyphen and the codes for the right-hand end group. Table D shows illustrative structures of compounds together with their respective abbreviations.
Table A: Ring elements
Figure imgf000124_0001
P
Figure imgf000124_0002
Figure imgf000125_0001
Figure imgf000126_0001
Table B: Linking groups
Figure imgf000126_0002
V -CH=CH- Zl -O-CO-
Figure imgf000126_0003
XI -CH=CF- Ol -0-CH2-
B -CF=CF- Q -CF2-0- T -C≡C- Ql -O-CF2- w -CF2CF2- T -C≡C-
Table C: End qroups
Left-hand side Right-hand side
Use alone
-n- CnH2n+1- -n --CnH2n+1
-nO- CnH2n+1-0- -nO -0-CnH2n+1
-V- CH2=CH- -V -CH=CH2
-nV- CnH2n+1-CH=CH- -nV -CnH2n-CH=CH2
-Vn- CH2=CH- CnH2n+i- -Vn -CH=CH-CnH2n+1
-nVm- CnH2n+1-CH=CH-C, mH2m- -nVm -CnH2n-CH=CH-CmH2m+1
-N- N≡C- -N -C≡N
-S- S=C=N- -S -N=C=S
-F- F- -F -F
-CL- Cl- -CL -CI
Figure imgf000127_0001
-D- CF2H- -D -CF2H
-T- CF3- -T -CF3
Figure imgf000127_0002
-DO- CF2HO - -OD -OCF2H
-TO- CF3O - -OT -OCF3
-FXO- CF2=CH-O- -OXF -O-CH=CF2
-A- H-C≡C- -A -C≡C-H
-nA- CnH2n+1-C=C- -An -C=C-CnH2n+1
-NA- N≡c-e≡c- -AN -C≡C-C≡N
Use together with one another and with others
-...A...- -C≡C- -...A... -C≡C-
-...V...- CH=CH- -...V... -CH=CH- -...Z...- -CO-O- -...Z... -CO-O-
"...Zl.„- -O-CO- -...Zl... -O-CO-
-...K...- -CO- -...K... -co-
-...W...- -CF=CF- -...W... -CF=CF- wherein n and m each denote integers, and the three dots are placeholders for other abbreviations from this table.
The following table shows illustrative structures together with their respective abbreviations. These are shown in order to illustrate the meaning of the rules for the abbreviations. They furthermore represent compounds which are preferably used.
Table D: Illustrative structures
Figure imgf000128_0001
CC-n-V
Figure imgf000128_0002
CC-n-Vm CnH2n+1-^ >-(CH2)^CH=CH2
CC-n-mV
-(CH
CnH2n+1 2)-CH=CH— C,H 21+1
CC-n-mVI
Figure imgf000129_0001
cc-v-v
Figure imgf000129_0002
CC-V-mV
Figure imgf000129_0003
CC-V-Vm
Figure imgf000129_0004
CC-Vn-mV
CnH2n+1-CH=CH - _ - (CH2)m-CH=CH2 CC-nV-mV
CnH2n+1-CH=CH -{ -(^CH=CH-CmH2m+1 CC-nV-Vm
Figure imgf000130_0001
CP-n-m
Figure imgf000130_0002
CP-nO-m
Figure imgf000130_0003
CP-n-Om
Figure imgf000130_0004
CP-V-m
Figure imgf000130_0005
CP-Vn-m
C 'η H' "2_n+1-CH- =CH-
Figure imgf000130_0006
CP-nV-m
Figure imgf000130_0007
CP-V-V CH2=CH-< (CH2)m-CH=C
CP-V-mV
Figure imgf000131_0001
CP-V-Vm
=CH-(CH2)n ~^ ^ ~ (CH2)m-CH=CH 2 CP-Vn-mV
Figure imgf000131_0002
CP-nV-mV
Figure imgf000131_0003
CP-nV-Vm
Figure imgf000131_0004
PP-n-m
Figure imgf000131_0005
PP-nO-m CnH2n+1 -f~% f - OCmH2m+1 PP-n-Om
CNH2N+1 ~f f y— CH=CH2
PP-n-V
Figure imgf000132_0001
PP-n-Vm
Figure imgf000132_0002
PP-n-mV
Figure imgf000132_0003
PP-n-mVI
Figure imgf000132_0004
CCP-n-m
Figure imgf000132_0005
CCP-nO-m
Figure imgf000132_0006
CCP-n-Om CnH2n+1 CH=CH,
CCP-n-V
Figure imgf000133_0001
CCP-n-Vm
Figure imgf000133_0002
CCP-n-mV
Figure imgf000133_0003
CCP-n-mVI
Figure imgf000133_0004
CCP-V-m
Figure imgf000133_0005
CCP-nV-m
Figure imgf000133_0006
CCP-Vn-m
Figure imgf000134_0001
Figure imgf000134_0002
Figure imgf000134_0003
Figure imgf000134_0004
Figure imgf000134_0005
Figure imgf000134_0006
CPP-n-Om
Figure imgf000134_0007
CPP-V-m
Figure imgf000135_0001
CPP-nV-m
Figure imgf000135_0002
CPP-Vn-m
Figure imgf000135_0003
CPP-nVm-l
Figure imgf000135_0004
PGP-n-m
Figure imgf000135_0005
PGP-n-V
Figure imgf000135_0006
PGP-n-Vm
Figure imgf000135_0007
PGP-n-mV
Figure imgf000136_0001
PGP-n-mVI
Figure imgf000136_0002
CCEC-n-m
Figure imgf000136_0003
CCEC-n-Om
Figure imgf000136_0004
CCEP-n-m
Figure imgf000136_0005
CCEP-n-Om
Figure imgf000136_0006
CPPC-n-m
Figure imgf000136_0007
CGPC-n-m
Figure imgf000137_0001
Figure imgf000137_0002
Figure imgf000137_0003
Figure imgf000137_0004
Figure imgf000137_0005
CPGP-n-mVI
Figure imgf000137_0006
CP-n-F
Figure imgf000138_0001
CP-n-CL
Figure imgf000138_0002
GP-n-F
Figure imgf000138_0003
GP-n-CL
Figure imgf000138_0004
CCP-n-OT
Figure imgf000138_0005
CCG-n-OT
Figure imgf000138_0006
CCP-n-T
Figure imgf000138_0007
CCG-n-F
Figure imgf000139_0001
CCG-V-F
Figure imgf000139_0002
CCG-V-F
Figure imgf000139_0003
CCU-n-F
Figure imgf000139_0004
CDU-n-F
Figure imgf000139_0005
CPG-n-F
Figure imgf000139_0006
CPU-n-F
Figure imgf000140_0001
CGU-n-F
Figure imgf000140_0002
PGU-n-F
Figure imgf000140_0003
GGP-n-F
Figure imgf000140_0004
GGP-n-CL
Figure imgf000140_0005
PGIGI-n-F
Figure imgf000140_0006
PGIGI-n-CL
Figure imgf000141_0001
CCPU-n-F
Figure imgf000141_0002
CCGU-n-F
Figure imgf000141_0003
CPGU-n-F
Figure imgf000141_0004
CPGU-n-OT
Figure imgf000141_0005
DPGU-n-F
Figure imgf000141_0006
PPGU-n-F
Figure imgf000142_0001
CCZU-n-F
Figure imgf000142_0002
CCQP-n-F
Figure imgf000142_0003
CCQG-n-F
Figure imgf000142_0004
CCQU-n-F
Figure imgf000142_0005
PPQG-n-F
Figure imgf000142_0006
PPQU-n-F
Figure imgf000143_0001
Figure imgf000143_0002
GGQU-n-F
Figure imgf000143_0003
CDUQU-n-F
Figure imgf000144_0001
CPUQU-n-F
Figure imgf000144_0002
CGUQU-n-F
Figure imgf000144_0003
PGPQP-n-F
Figure imgf000144_0004
PGPQG-n-F
Figure imgf000144_0005
PGPQU-n-F
Figure imgf000144_0006
PGUQU-n-F
Figure imgf000145_0001
APUQU-n-F
Figure imgf000145_0002
DGUQU-n-F
Figure imgf000145_0003
CY-n-Om CY-n-m
Figure imgf000145_0004
CY-V-Om CY-nV-(0)m
Figure imgf000145_0005
CVC-n-m CVY-V-m
Figure imgf000145_0006
CCY-n-m CCY-n-Om
Figure imgf000146_0001
Figure imgf000146_0002
Figure imgf000146_0003
Figure imgf000146_0004
Figure imgf000146_0005
Figure imgf000146_0006
CCQY-n-(0)m CCQIY-n-(0)m
Figure imgf000146_0007
CPQY-n-(0)m CPQIY-n-Om
Figure imgf000147_0001
CLY-n-(0)m CYLI-n-m
Figure imgf000147_0002
LYLI-n-m LY-n-(0)m
Figure imgf000147_0003
PGIGI-n-F PGP-n-m
Figure imgf000147_0004
YPY-n-m YPY-n-mV
Figure imgf000147_0005
BCH-nm BCH-nmF
Figure imgf000147_0006
CPYP-n-(0)m CPGP-n-m
Figure imgf000148_0001
CPYC-n-m CYYC-n-m
Figure imgf000148_0002
CCYY-n-m CPYG-n-(0)m
Figure imgf000148_0003
CBC-nm CBC-nmF
Figure imgf000148_0004
CNap-n-Om CCNap-n-Om
CENap-n-Om
Figure imgf000148_0005
CETNap-n-Om CK-n-F
Figure imgf000148_0006
DFDBC-n(0)-(0)m C-DFDBF-n-(0)m wherein n, m and I preferably, independently of one another, denote 1 to 7.
The following table, Table E, shows illustrative compounds which can be used as additional stabilisers in the mesogenic media according to the present invention.
Table E
Table E shows possible stabilisers which can be added to the LC media according to the invention.
(n here denotes an integer from 1 to 12, preferably 1 , 2, 3, 4, 5, 6, 7 or 8, terminal methyl groups are not shown).
Figure imgf000149_0001
Figure imgf000149_0002
Figure imgf000149_0003
Figure imgf000150_0001
Figure imgf000150_0002
Figure imgf000150_0003
Figure imgf000150_0004
25
30
Figure imgf000151_0001
Figure imgf000151_0002
Figure imgf000151_0003
30 - 151 -
Figure imgf000152_0001
Figure imgf000153_0001
Figure imgf000153_0002
Figure imgf000153_0003
30 - 153 -
Figure imgf000154_0001
Figure imgf000155_0001
Figure imgf000155_0002
Figure imgf000155_0003
The LC media preferably comprise 0 to 10% by weight, in particular 1 ppm to 5% by weight, particularly preferably 1 ppm to 1 % by weight, of stabilisers. Table F below shows illustrative compounds which can preferably be used as chiral dopants in the mesogenic media according to the present invention. Table F
Figure imgf000156_0001
Figure imgf000156_0002
Figure imgf000156_0003
CM 45
Figure imgf000157_0001
Figure imgf000157_0002
Figure imgf000157_0003
Figure imgf000157_0004
R/S-811
Figure imgf000157_0005
Figure imgf000158_0001
Figure imgf000158_0002
Figure imgf000158_0003
Figure imgf000158_0004
R/S-5011
In a preferred embodiment of the present invention, the mesogenic media comprise one or more compounds selected from the group of the compounds from Table F.
The mesogenic media according to the present application preferably comprise two or more, preferably four or more, compounds selected from the group consisting of the compounds from the above tables. The liquid-crystal media according to the present invention preferably comprise
- seven or more, preferably eight or more, individual compounds,
preferably of three or more, particularly preferably of four or more, different formulae, selected from the group of the compounds from Table D.
Hereinafter, the present invention is described in more detail and specifically with reference to the Examples, which however are not intended to limit the present invention.
Examples Synthesis Examples
Synthesis Example 1 :
3-methyl-4-{[(2E)-3-[4-({6-[(3-oxoprop-1-en-2-yl)oxy]hexyl}oxy)- phenyl]prop-2-enoyl]oxy}phenyl 4-{[6-(prop-2-enoyloxy)- hexyl]oxy}benzoate 14
1.1 Synthesis of 1 -[4- benzyloxy)-3-methylphenyl]ethan-1 -one 1
Figure imgf000159_0001
1
12.7 g (85.0 mmol) of 1-(4-hydroxy-3-methyl-phenyl)-ethanone, 12.7 mL (107 mmol) benzyl bromide and 7.62 g (55.0 mmol) potassium carbonate are dissolved / suspended in methyl(ethyl)ketone and stirred for 18 h under reflux. The reaction mixture is cooled down to room temperature (RT) and the precipitating solid is filtered and washed with methyl tertiary- butyl ether (MTB-E). The product is further crystallized out of heptane at 5°C and is directly used in the next synthesis step. .2 Synthesis of 4-(benzyloxy)-3-methylphenyl acetate 2
Figure imgf000160_0001
2
39.1 mL (0.165 mmol) m-chloroperbenzoic acid are suspended in in 102 mL methylene chloride and a solution of 19.3 g (80.0 mmol) of ketone 1 in 72 mL methylene chloride is added dropwise to the reaction mixture. The yellow reaction mixture is then stepwise heated up to reflux and stirred for 16 h. The reaction mixture is cooled to room temperature (RT) and poured onto ice water. The phases are separated and the organic layer is filtered off from precipitated 3-chlorobenzoic acid, washed with sodium hydrogen carbonate, tested for peroxide remnants (with ammonia iron(ll) sulphate solution), dried over sodium sulphate, filtered and evaporated under vacuum. The crude product is filtered through 900g silica gel with toluene and ethyl acetate (95:5) to give the product as a yellow oil.
1.3 S nthesis of 4-(benzyioxy)-3-methylphenol 3
Figure imgf000160_0002
23.4 g (91.0 mmol) acetate 2 are solved in 181.0 mL ethanol and 5.84 mL (197.0 mmol) sodium hydroxide solution (32%) are added dropwise to the solution (the reaction solution turned to red color). The reaction mixture is stirred for 2h at ambient temperature and then poured onto ice water and trated with HCI solution till a pH value of 1 is achieved. The reaction mixture is extracted with methyl tertiary-butyl ether (MTB-E), the organic layer dried over sodium sulphate, filtered and evaporated under vacuum. The black oil is filtered over silica gel with methylene chloride and the obtained solid is then crystallized out of heptane at -25°C to give slightly brown colored crystals.
1H NMR (500 MHz, DMSO-d6)
δ = 2.13 ppm (s, 3 H, CH3), 4.99 (s, 2 H, CH2-O), 6.51 (dd, J = 2.86, 8.62 Hz, 1 H), 6.58 (d, J = 2.49 Hz, 1 H), 6.81 (d, J = 8.70 Hz, 1 H), 7.32 (d, J = 7.23 Hz, 1 H), 7.39 (t, J = 7.71 Hz, 2 H), 7.44 (d, J = 8.70 Hz, 2 H).
1.4 Synthesis of methyl 4-[(6-hydroxyhexyl)oxy]benzoate 4
Figure imgf000161_0001
4
40.0 g (263 mmol) methyl 4-hydroxybenzoate and 43.6 g (315 mmol) are dissolved in 150 mL methyl(ethyl)ketone and 49.9 g (276 mmol) 6- bromohexan-1-ol are added and the reaction mixture is heated up to reflux and stirred for 16 h. The reaction mixture is then cooled to room temperature (RT) and the precipitating residue is filtered off, is washed with acetone and dried under vacuum. The crude product is crystallized at 5°C out of toluene and the product can be used in the next step without further purification.
1.5 Synthesis of methyl 4-[(6-{[tris(propan-2-yl)silyl]oxy}hexyl)- oxyjbenzoate 5
Figure imgf000161_0002
18.8 g (74.51 mmol) ester 4 and 0.45 g (3.73 mmol) 4- dimethylaminopyridine are solved in 90 mL N,N-dimethylformamide (DMF). 15.8 g (81.96 mmol) chloro-triisopropyl-silane (dissolved in 30 mL DMF) are added dropwise to the reaction mixture at room temperature (RT) and stirred for 16 h. The reaction mixture is diluted with methyl tertiary-butyl ether (MTB-E) and poured in ice water. The layers are separated and the organic layer is dried over sodium sulphate, filtered and evaporated under vacuum to give the product as an oil which is further purified by column chromatography with silica gel and 1-chlorobutane. The product is a slightly yellow oil.
1.6 Synthesis of 4-[(6-{[tris(propan-2-yl)silyl]oxy}hexyl)oxy]benzoic acid 6
Figure imgf000162_0001
27.0 g (66.0 mmol) of ester 5 are dissolved in a mixture of 160 mL methanol and 80 mL tetrahydrofuran and 90 mL NaOH (2N). The reaction mixture is stirred for 2 h at 40°C. The reaction mixture is cooled to room temperature (RT), poured cautiously onto ice water, neutralized with HCI (2N) and extracted with ethyl acetate. The organic layer is washed with brine, dried over sodium sulphate, filtered and evaporated under vacuum to give the product as a white solid which is purified by crystallization out of ethyl acetate at 3°C to give white crystalline solid. H NMR (500 MHz, DMSO-d6)
δ = 1.02 ppm (mc, 21 H, Si-(C3H7)3), 1.34 -1.47 (m, 4H, CH2), 1.51 (quint, J = 6.57 Hz, 2 H, CH2), 1.73 (quint, J = 6.01 Hz, 2 H, CH2), 3.69 (t, J = 6.33 Hz, 2 H, CH2), 4.02 (t, J = 6.45 Hz, 2 H, CH2), 6.98 (d, J = 8.91 Hz, 2 H), 7.87 (J = 8.89 Hz, 2 H). 1.7 Synthesis of 4-(benzyloxy)-3-methylphenyl 4-[(6-{[tris(propan-2- yl silyl]oxy}hexyl)oxy]benzoate 7
Figure imgf000163_0001
7
28. Og (70.7 mmol) of acid 6, 15.5 g (72.18 mmol) phenol 3 and 1 .72 g (14.15 mmol) 4-dimethylaminopyridine are solved in 280 mL methylene chloride. The reaction mixture is treated successively with 16.2 g (84.89 mmol) N-(3-dimethylaminoproyl)-N'-ethylcarbodiimide hydrochloride and stirred for 16 h at room temperature (RT). The reaction mixture is diluted with water and extracted with methylene chloride. The combined organic layers are washed with brine, dried over sodium sulphate, filtered and evaporated under vacuum to yield a yellow solid. The crude product is purified via column chromatography with silica gel and heptane / ethyl acetate (8:2) to give a colorless solid.
1.8 Synthesis of 4-hydroxy-3-methylphenyl 4-[(6-{[tris(propan-2- yl)silyl]oxy}hexyl)oxy]benzoate 8
Figure imgf000163_0002
39.0 g (65.8 mmol) of compound 7 are dissolved in 390 mL tetrahydrofuran and 15.0 g (140.9 mmol) Pd-C (5% basic) are added and the reaction mixture is treated with hydrogen atmosphere under normal pressure and room temperature for 45 min. The catalyst was filtered off and the reaction mixture was evaporated under vacuum. The crude product (oil which crystallizes) is purified via column chromatography with 1 -chlorbutane and ethyl acetate (8:2). The resulting product is crystallized with acetonitrile. 1 H NMR (500 MHz, CDC )
δ = 1 .06 (mc, 21 H, Si-(C3H7)3), 1.40 - 1.53 (m, 2 H, CH2), 1.56 (quint, J = 7.73 Hz, 2 H, CH2), 1.83 (7.82 Hz, 2 H, CH2), 2.25 (s, 3 H, CHs), 3.70 (t, J = 6.46 Hz, 2H, CH2), 4.04 (t, J = 6.53 Hz, 2H , CH2), 4.78 (s, 1 H, OH), 6.76 (d, J = 8.58 Hz, 1 H), 6.88 (dd, J = 2.76, 8.56 Hz, 1 H), 6.95 (mc, 3 H), 8.12 (d, J = 8.91 Hz).
1.9 Synthesis of methyl (2E)-3-{4-[(6-hydroxyhexyl)oxy]phenyl}-prop- 2-enoate 9
Figure imgf000164_0001
25.9 g (145 mmol) methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate, 24.2 g (175 mmol) potassium carbonate are solved in 451 mL N,N- dimethylformamide (DMF) and heated to 90°C. 28.7 g (159 mmol) 6- bromohexan-1-ol is added and the mixture is stirred at 90°C for 16 h. The reaction mixture is cooled to room temperature (RT), diluted with water and methyl tertiary-butyl ether (MTB-E) and the layers are separated. The organic layer is washed with water and brine and is filtered and evaporated under vacuum. The resulting crude product is crystallized from toluene to give white crystalline solid.
1.10 Synthesis of methyl (2E)-3-{4-[(6-{[tris(propan-2-yl)silyl]oxy}- hexyl)oxy]phenyl}prop-2-enoate 10
Figure imgf000164_0002
26.5 g (93.5 mmol) ester 9 are dissolved in Ν,Ν-dimethylformamide (DMF) and 0.57 g (4.67 mmol) 4-dimethylaminopyridine is added. 19.8 g (102.8 mmol) chloro-triisopropyl-silane (dissolved in 36 mL DMF) are added dropwise and the reaction mixture is stirred at room temperature for 16 h. The reaction mixture is diluted with methyl tertiary-butyl ether (MTB-E) and poured onto ice water. The organic layer is separated, dried over sodium sulphate, filtered and evaporated under vacuum. The crude product is purified via column chromatography (silica gel, heptane / MTB- E 9: 1 ) to yield a colorless oil.
1.1 1 Synthesis of methyl (2E)-3-{4-[(6-{[tris(propan-2-yl)silyl]oxy}- hexyl)ox henyl}prop-2-enoate 11
Figure imgf000165_0001
33.7 g (77.0 mmol) is dissolved in 187 mL methanol and 94 mL tetrahydrofuran. 97.4 mL (195 mmol) NaOH (2N) is added and the the reaction mixture is stirred at 38°C for 4 h. The mixture is cooled to room temperature (RT) and poured in ice water. 2N HCI is added to get a pH value of 5-6 followed by an extraction with ethyl acetate. The combined organic layers are washed with brine, dried over sodium sulphate, filtered and evaporated under vacuum. The crude product is crystallized with acetonitrile to give a white crystalline solid.
1H NMR (500 MHz, DMSO-d6)
δ = 1.02 ppm (s, 21 H, Si-(C3H7)3), 1.41 (mc, 4 H, CH2), 1.52 (quint, J = 6.77 Hz, 2 H, CH2), 1.72 (quint, J = 7.39 Hz, 2 H, CH2), 3.66 (t, J = 6.36 Hz, 2 H, CH2), 4.00 (t, J = 6.46 Hz, 2 H, CH2), 6.37 (d, J = 15.96 Hz, 1 H, trans -HOCH-), 6.94 (d, J = 8.78 Hz, 1 H), 7.54 (d, J = 15.94 Hz, 1 H, trans -HC=CH-), 7.62 (d, J = 8.78 Hz, 1 H).
1.12 Synthesis of 3-methyl-4-{[(2E)-3-{4-[(6-{[tris(propan-2-yl)silyl]- oxy}hexyl)oxy]phenyl}prop-2-enoyl]oxy}phenyl 4-[(6-{[tris(propan- 2-yl)silyl]oxy}hexyl)oxy]benzoate 12
Figure imgf000166_0001
15.7 g (31.4 mmol) phenole 8, 13.9 g (32.9 mmol) acid 11 , 0.76 g (6.29 mmol) 4-dimethylaminopyridine are dissolved in 100 mL methylene chloride and 7.22 g (37.71 mmol) N-(3-dimethylaminoproyl)-N - ethylcarbodiimide hydrochloride is added portionwise to the reaction mixture. The yellow reaction mixture is stirred for 16 h at room temperature (RT), diluted with water an extracted with methylene chloride. The organic layer is dried over sodium sulphate, filtered and evaporated under vacuum. The crude product is crystallized from ethyl acetate to give white crystalline solid.
1.13 Synthesis of 4-{[(2E)-3-{4-[(6-hydroxyhexyl)oxy]phenyl}prop-2- eno l]oxy}-3-methylphenyl 4-[(6-hydroxyhexyl)oxy]benzoate 13
Figure imgf000166_0002
21.5 g (23.8 mmol) cinnamate 12 are dissolved in 151 mL methylene chloride and cooled to 3°C. 19.1 mL (118.9 mmol) triethylamin tris hydrofluoride are added dropwise. The reaction mixture is then stirred for 16 h at room temperature and poured in water. The layers are separated and the organic layer is washed with brine, dried over sodium sulphate and evaporated under vacuum to give a white solid. The crude product is crystallized out of acetonitrile and the product is obtained as a white crystalline solid. 1.14 Synthesis of 3-methyl-4-{[(2E)-3-[4-({6-[(3-oxoprop-1-en-2- yl)oxy]hexyl}oxy)phenyl]prop-2-enoyl]oxy}phenyl 4-{[6-(prop-2- enoyloxy)hexyl]oxy}benzoate 14
Figure imgf000167_0001
7.50 g (12.6 mmol) of cinnamate 13 is dissolved in 243 mL methylene chloride. 2.74 g (38.0 mmol) acrylic acid, 0.93 g (7.61 mmol) 4- dimethylaminopyridine are added to the solution and the mixture is cooled to 3°C. 6.7 mL (38.0 mmol) N-(3-dimethylaminoproyl)-N'-ethylcarbo- diimide (dissolved in 5 mL methylene chloride) are added dropwise to the reaction mixture so that the temperature stays below 10°C. The mixture is stirred for further 30 min with ice cooling and is stirred for 16 h at room temperature. During this time the reaction mixture turned to a clear solution. The reaction solution is evaporated under vacuum and purified via column chromatography with 1-chlorobutane and ethyl acetate (9:1). The obtained product is then crystallized from acetonitrile to give a white crystalline solid.
Phase sequence: K 59 N 147.6 I H NMR (500 MHz, CDC )
δ = 1.38-1.63 ppm ( m, 8 H, CH2), 1.75 (mc, 4 H, CH2), 1.86 (mc, 4 H, CH2), 2.26 (s, 3 H, CH3), 4.04 (t, J = 6.4 Hz, 2 H, CH2), 4.07 (t, J = 6.4 Hz, 2 H, CH2), 4.20 (t, J = 6.62 Hz, 2 H, CH2), 4.21 (t, J = 6.62 Hz, 2 H, CH2), 5.84 (d, J = 10.44 Hz, 2 H, 0(CO)CH=CH(Cis)H), 6.15 (dd, J = 10.44, 17.35 Hz, 2 H, 0(CO)CH=CH2), 6.43 (d, J = 17.34 Hz, 2 H, 0(C=0)-
Figure imgf000167_0002
6.95 (d, J = 8.69, 2 H), 6.99 (d, J = 8.86, 2 H), 7.09 (dd, J = 2.71 , 8.59 Hz, 1 H), 7.14
^(overlapped), J = 3.0 Hz, 1 H), 7.15 (d (overlapped), J = 8.82 Hz, 1 H), 7.57 (d, J
= 8.68 Hz, 2 H), 7.87 (d, J = 15.89 Hz, 1 H, trans -HC=CH-), 8.16 (d, J = 8.82 Hz, 2 H).
Synthesis Example 2:
Synthesis of [3-ethyl-4-[(E)-3-(4-prop-2-enoyloxyphenyl)prop-2-enoyl]oxy- phenyl] (E)-3-(4-prop-2-enoyloxyphenyl)prop-2-enoate (19)
2.1 Synthesis of methyl (E)-3-(4-tetrahydropyran-2-yloxyphenyl)prop- 2-enoate (15)
Figure imgf000168_0001
15
10.00 g (56.12 mmol) methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate are suspended in 100 ml methylene chloride. After adding 2.12 g (8.44 mmol) toluene-4-sufonatepyridinium 10.15 ml (112 mmol) 3,4-dihydro-2H-pyrane dissolved in 70 ml methyle chloride are added dropwise. The mixture is stirred overnight. After adding water the organic layer is separated, washed with bicarbonate sol. and brine, dried over sodium sulfate and evaporated. The residue is purified via column chromatography with n- heptane/ethyl acetate to give a white solid.
2.2 Synthesis of (E)-3-(4-tetrahydropyran-2-yloxyphenyl)prop-2-enoic acid (16)
Figure imgf000169_0001
16
14.5g (55.28 mmol) of cinnamate 15 are dissolved in 200 ml methanol at 40°C. 70 ml of 2mol/l sodium hydroxide sol. are added. After 2h refluxing the mixture is acidified (pH 4.5) with hydrochloric acid an extracted with ethyl acetate. The organic layer is dried over sodiumsulfate and the solvent is evaporated. 16 is obtained as a yellowish solid.
2.3 Synthesis of [3-ethyl-4-[(E)-3-(4-tetrahydropyran-2-yloxyphenyl)- prop-2-enoyl]oxy-phenyl] (E)-3-(4-tetrahydropyran-2-yloxy- phenyl)prop-2-enoate (17)
Figure imgf000169_0002
10.07 g (52.55 mmol) N-(3-dimethylaminoproyl)-N'-ethylcarbo-diimide hydro chloride are added to a solution of 11 ,86 g (47.77 mmol) of the cinnamatic acid 16, 1.17g (9.55 mmol) dithylamino pyridine (DMAP) and 3.3 g (23.88 mmo) 2-ethyl benzene-1 ,4-diol are dissolved in 150 ml methylene chloride. The solution was stirred at room temperature over night. Water is added to the mixture wich is extracted with methylene chloride afterwards. The organic layer is dried over sodium sulfate and evaporated. The residue is purfified via column chromatography with 1- chlorobutane and ethyl acetate to obtain a white solid. 2.4 Synthesis of [3-ethyl-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy- phenyl] (E)-3-(4-hydroxyphenyl)prop-2-enoate (18)
Figure imgf000170_0001
18
30,0 ml hydrochloric acid (2mol/l, 60mmol) are added to a solution of 1 1.60 g (19.38 mmol) 18 in 400 ml THF at a temperature below 10°C. The mixture is stirred at roomtemperature for 4, neutralized with sodium bicarbonate sol. and extracted with ethylene acetate. The organic layer is washed with brine, dried over sodium sulfate, filtrated and evaporated tobtain a white solid.
2.5 Synthesis of methyl [3-ethyl-4-[(E)-3-(4-prop-2-enoyloxyphenyl)- prop-2-enoyl]oxy- phenyl] (E)-3-(4-prop-2-enoyloxyphenyl)prop- 2-enoate (19)
Figure imgf000170_0002
19
2.00 g (4.65 mmol) of cinnamate 18 is suspended in 60 mL methylene chloride. 0.77g (10.69 mmol) acrylic acid, 56.8 mg (0.46 mmol) 4- dimethylaminopyridine are added to the suspension and the mixture is cooled to 3°C. 1 .89 mL (10.69 mmol) N-(3-dimethylaminoproyl)-N - ethylcarbo-diimide (dissolved in 5 mL methylene chloride) are added dropwise to the reaction mixture so that the temperature stays below 10°C. The mixture is stirred for further 30 min with ice cooling and is stirred for 16 h at room temperature. During this time the reaction mixture turned to a clear solution. The reaction solution is evaporated under vacuum and purified via column chromatography with 1-chlorobutane and ethyl acetate. The obtained product is then crystallized from acetonitrile to give a white crystalline solid, m.p. 175 °C (decomp.).
1H NMR (500 MHz, DMSO)
8 = 1 .16 ppm ( t, J = 7.61 Hz, 3 H, CH3), 2.55 (q, J = 7.61 Hz, 2 H, CH2), 6.21 (dd, J = 1.1 Hz, J = 10.44 Hz, 2 H,
Figure imgf000171_0001
6.46 (dd, J = 10.38, 17.35 Hz, 2 H, 0(CO)Ctf=CH2), 6.60 (d, J = 17.35 Hz, 2 H,
Figure imgf000171_0002
(d, J = 16.17 Hz, 1 H, trans -HC=CH-), 7.16 (dd, J = 2.89, J = 8.67, 1 H), 7.25 (m, 2 H), 7.33 (dd, J = 1 .16, 8.56 Hz, 4H), 7.95 (mc, 6 H).
Syntheisis Example 3:
S nthesis of
Figure imgf000171_0003
Synthesis of methyl 4-triisopropylsilyloxybenzoate (20)
Figure imgf000171_0004
20
5.61 g (37.25 mmol) methyl 4-hydroxybenzoate and 0.22 g (1.86 mmol) 4- dimethylaminopyridine are solved in 45 mL N,N-dimethylformamide (DMF). 7.9 g (41.00 mmol) chloro-triisopropyl-silane (dissolved in 30 mL DMF) are added dropwise to the reaction mixture at room temperature (RT) and stirred for 16 h. The reaction mixture is diluted with methyl tertiary-butyl ether (MTB-E) and poured in ice water. The layers are separated and the organic layer is dried over sodium sulphate, filtered and evaporated under vacuum to give the product as an oil which is further purified by column chromatography with silica gel and chloro butane as a solvent. .2 Synthesis of 4-triiso ropylsilyloxybenzoic acid 21
Figure imgf000172_0001
9.26 g (30.0 mmol) of ester 20 are dissolved in a mixture of 130 ml_ methanol and 65 ml_ tetrahydrofuran and 75 mL NaOH (2N). The reaction mixture is stirred for 2 h at 40°C. The reaction mixture is cooled to room temperature (RT), poured cautiously onto ice water, neutralized with HCI (2N) and extracted with ethyl acetate. The organic layer is washed with brine, dried over sodium sulphate, filtered and evaporated under vacuum to give the product as a white solid which is purified by crystallization out of ethyl acetate at 3°C to give white crystalline solid.
3.3 Synthesis of (4-benzyloxy-3-methyl-phenyl) 4- triisopropylsilyloxy- benzoate 22
Figure imgf000172_0002
7.3g (25 mmol) of acid 21 , 5.2 g (26 mmol) phenol 3 and 0.62 g (5.1 mmol) 4-dimethylaminopyridine are solved in 100 mL methylene chloride. The reaction mixture is treated successively with 5.8 g (29.5 mmol) N-(3- dimethylaminoproyl)-N'-ethylcarbodiimide hydrochloride and stirred for 16 h at room temperature (RT). The reaction mixture is diluted with water and extracted with methylene chloride. The combined organic layers are washed with brine, dried over sodium sulphate, filtered and evaporated under vacuum to yield a yellow solid. The crude product is purified via column chromatography with silica gel and heptane / ethyl acetate (8:2)
Synthesis of (4-hydroxy-3-methyl-phenyl) 4-triisopropylsilyloxy- benzoate 2
Figure imgf000173_0001
9.85 g (20 mmol) of compound 22 are dissolved in 120 ml_ tetrahydrofuran and 4.56 g (42.8 mmol) Pd-C (5% basic) are added and the reaction mixture is treated with hydrogen atmosphere under normal pressure and room temperature for 45 min. The catalyst was filtered off and the reaction mixture was evaporated under vacuum. The crude product (oil which crystallizes) is purified via column chromatography with 1-chlorbutane and ethyl acetate (8:2). The resulting product is crystallized with acetonitrile.
3.5 Synthesis of [3-methyl-4-[(E)-3-[4-(6-triisopropylsilyloxyhexoxy)- phenyl]prop-2-enoyl]oxy-phenyl] 4-triisopropylsilyloxybenzoate 24
Figure imgf000173_0002
6.0 g (15.0 mmol) phenole 23, 6.7 g (16 mmol) acid 11 , 0.37 g (3.04 mmol) 4-dimethylaminopyridine are dissolved in 50 ml_ methylene chloride and 3.5 g (18.2 mmol) N-(3-dimethylaminoproyl)-N - ethylcarbodiimide hydrochloride is added portionwise to the reaction mixture. The yellow reaction mixture is stirred for 16 h at room temperature (RT), diluted with water an extracted with methylene chloride. The organic layer is dried over sodium sulphate, filtered and evaporated under vacuum. The crude product is crystallized from ethyl acetate to give white crystalline solid.
3.6 Synthesis of [4-[(E)-3-[4-(6-hydroxyhexoxy)phenyl]prop-2- -3-methyl-phenyl] 4-hydroxybenzoate 25
Figure imgf000174_0001
16.1 g (20.0 mmol) cinnamate 24 are dissolved in 125 mL methylene chloride and cooled to 3°C. 15.9 mL (157 mmol) triethylamin tris hydrofluoride are added dropwise. The reaction mixture is then stirred for 16 h at room temperature and poured in water. The layers are separated and the organic layer is washed with brine, dried over sodium sulphate and evaporated under vacuum to give a white solid. The crude product is crystallized out of acetonitrile and the product is obtained as a white crystalline solid.
3.7 Synthesis of [3-methyl-4-[(E)-3-[4-[6-(2-methylprop-2- enoyloxy)hexoxy]phenyl]prop-2-enoyl]oxy-phenyl] 4-(2-
Figure imgf000174_0002
8.34 g (17.0 mmol) of cinnamate 25 is dissolved in 330 mL methylene chloride. 4.41 g (51 .3 mmol) methacrylic acid, 1.43 g (10.16 mmol) 4- dimethylaminopyridine are added to the solution and the mixture is cooled to 3°C. 8.9 mL (51.0 mmol) N-(3-dimethylaminoproyl)-N'-ethylcarbo- diimide (dissolved in 77 mL methylene chloride) are added dropwise to the reaction mixture so that the temperature stays below 10°C. The mixture is stirred for further 30 min with ice cooling and is stirred for 16 h at room temperature. During this time the reaction mixture turned to a clear solution. The reaction solution is evaporated under vacuum and purified via column chromatography with 1-chlorobutane and ethyl acetate (9:1). The obtained product is then crystallized from acetonitrile to give a white crystalline solid. In analogy to Synthesis examples 1 to 3, the following compounds are obtained:
Figure imgf000175_0001
Figure imgf000176_0001
30 -176-
Figure imgf000177_0001
- 177-
Figure imgf000178_0001
Figure imgf000179_0001
Fabrication of display cells
The display cells are made with raw untreated alkali free glass using 5pm spacer beads in Norland 65 adhesive. The cells are assembled by hand and then cured using a high pressure mercury lamp with 50 mW/cm2 and 3000 mJ/cm2.
Cell filling and curing
The LC mixtures are capillary filled using capillary action at room temp., annealed for 1 h at 100°C and then irradiated at the same temperature with linearly polarised UV light (50 mW/cm2) for 60s. The cells are then cooled to room temperature.
Nematic host mixtures
The nematic LC host mixture N-1 to N- 6 are prepared as indicated in the following tables.
Mixture N-1 :
Composition Physical properties
Compound T(N,I) = 73.5 °C
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.583
1 CC-3-V 37.00 Δη (20°C, 589.3 nm) = 0.1005
2 CCY-3-O1 5.00 ει ι (20°C, 1 kHz) = 3.70
3 CCY-3-O2 9.50 Δε (20°C, 1 kHz) = -3.65
4 CCY-4-O2 5.00 ki(20°C) = 12.7
5 CPY-2-02 10.00 k3(20°C) = 14.7
6 CPY-3-02 10.00 γι (20°C) = 93
7 CY-3-02 11.50
8 PY-3-02 12.00
∑ 100.0
Mixture N-2:
Composition Physical properties
Compound T(N,I) = 78.0 °C
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5907
1 CC-3-V 36.00 Δη (20°C, 589.3 nm) = 0.1095
2 CC-3-V1 5.00 επ (20°C, 1 kHz) = 16.6
3 CCP-V-1 8.00 Δε (20°C, 1 kHz) = 9.6
4 PGP-2-2V 3.00 ki(20°C) = 12.1
5 CCQU-3-F 9.50 k3(20°C) = 13.4
6 PUQU-3-F 8.50 γι (20°C) = 78
7 APUQU-2-F 5.00
8 APUQU-3-F 8.00
9 PGUQU-3-F 4.00
10 PGUQU-4-F 8.00
11 PGUQU-5-F 5.00
∑ 100.0
Mixture N-3:
Composition Physical properties
Compound T(N,I) 73.5 °C
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5902
1 APUQU-2-F 6.00 Δη (20°C, 589.3 nm) = ■ 0.1086
2 APUQU-3-F 6.00 ε| | (20°C, 1 kHz) = 12.9
3 CC-3-V 44.5 Δε (20°C, 1 kHz) 9.6
4 CC-3-V1 4.00 ki(20°C) : 12.4
5 CCP-3-OT 7.00 k3(20°C) : 13.8
6 CCP-V-1 5.00 γι (20°C) : 67
7 CPGU-3-OT 3.00
8 PGP-2-2V 5.50
9 PGUQU-3-F 3.00
10 PGUQU-4-F 7.00
1 1 PGUQU-5-F 3.00
12 PUQU-3-F 6.00
∑ 100.0
Mixture N-4:
Composition Physical properties
Compound T(N,I) [°C] = 80.5
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5865
1 CC-3-V 44.00 Δη (20°C, 589.3 nm) = 0.0991
2 CC-3-V1 12.00 ει ι (20°C, 1 kHz) = 5.3
3 CCP-V-1 11.00 Δε (20°C, 1 kHz) = 2.7
4 CCP-V2-1 9.00 ki(20°C) = 14.6
5 PGP-2-3 6.00 k3(20°C) = 15.9
6 PGUQU-3-F 6.00 γι (20°C) [mPa s] = 53
7 APUQU-3-F 4.50
8 PP-1 -2V1 7.00
9 PPGU-3-F 0.50
∑ 100.00
Mixture N-5:
Composition Physical properties
Compound T(N,I) [°C] = 94.5
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5894
1 CC-3-V 37.00 Δη (20°C, 589.3 nm) = 0.1049
2 CC-3-V1 9.50 ει ι (20°C, 1 kHz) = 7.8
3 CCP-V-1 1 .50 Δε (20°C, 1 kHz) = 4.9
4 CCP-V2-1 3.00 ki(20°C) = 15.6
5 PGP-2-2V 10.50 k3(20°C) = 17.1
6 APUQU-3-F 5.00 γι (20°C) [mPa s] = 67
7 APUQU-2-F 5.00
8 PGUQU-4-F 3.50
9 PGUQU-3-F 2.00
10 CCP-3-OT 9.00
11 CCP-5-OT 2.00
12 CCQU-3-F 2.00
∑ 100.00
Mixture N-6:
Composition Physical properties
Compound T(N,I) [°C] = 100
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5782
1 CC-3-V 34.00 Δη (20°C, 589.3 nm) = 0.1003
2 CC-3-V1 . 2.50 ει ι (20°C, 1 kHz) = 12.3
3 CCP-V-1 10.00 Δε (20°C, 1 kHz) = 9.1
4 PUQU-3-F 7.00 ki(20°C) = 14.2
5 PGUQU-n-F 4.00 k3(20°C) = 17.3
6 CPGU-3-OT 6.00 γι (20°C) [mPa s] = 99
7 CCGU-3-F 4.00
8 APUQU-3-F 8.00
9 CCU-3-F 4.50
10 CCP-3-OT 4.00
11 CCP-5-OT 3.00
12 CCQU-3-F 10.00
13 CPPC-3-3 3.00
∑ 00.00
Mixture N-7:
Composition Physical properties
Compound T(N,I) [°C] = 80
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5996
1 CC-3-V 40.50 Δη (20°C, 589.3 nm) = 0.1127
2 CC-3-V1 6.00 ει ι (20°C, 1 kHz) = 10.1
3 CCP-V-1 9.50 Δε (20°C, 1 kHz) = 6.9
4 CPU-3-F 7.00 ki(20°C) = 13.2
5 CPGU-3-OT 5.00 k3(20°C) = 13.3
6 APUQU-2-F 5.00 γι (20°C) [mPa s] = 63
7 APUQU-3-F 7.50
8 PGP-2-3 6.00
9 PGP-2-4 6.00
10 PPGU-3-F 0.50
11 PUQU-3-F 7.00
∑ 100.00
Mixture N-8:
Composition Physical properties
Compound T(N.I) [°C] = 90.4
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5760
1 CGPC-3-3 3.00 Δη (20°C, 589.3 nm) = 0.0913
2 CGPC-5-3 3.00 si t (20°C, 1 kHz) = 7.0
3 CC-3-V 42.50 Δε (20°C, 1 kHz) = 4.3
4 CC-3-V1 8.00 ki(20°C) = 14.3
5 CCP-3-1 5.00 k3(20°C) = 18.1
6 CCP-3-3 5.00 γι (20°C) [mPa s] = 77
7 CCP-V-1 12.00
8 CCP-V2-1 3.50
9 DGUQU-4-F 2.00
10 PGUQU-3-F 1.50
11 PGUQU-4-F 1.00
12 PGUQU-5-F 3.00
13 PPGU-3-F 0.50
14 PUQU-3-F 10.00
∑ 100.00
Mixture N-9:
Composition Physical properties
Compound T(N,I) PC] = 79.5
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5937
1 APUQU-2-F 6.00 Δη (20°C, 589.3 nm) = 0.1095
2 APUQU-3-F 6.00 si f (20°C, 1 kHz) = 15.1
3 CC-3-V 44.50 Δε (20°C, 1 kHz) = 1 1.6
4 CCP-V-1 12.50 ki(20°C) = 1 1.9
5 CPGU-3-OT 5.00 k3(20°C) = 13.5
6 DPGU-4-F 2.00 γι (20°C) [mPa s] = 72
7 PGP-2-2V 1.50
8 PGUQU-3-F 4.50
9 PGUQU-4-F 8.00
10 PUQU-3-F 10.00
∑ 100.00
Mixture N-10:
Composition Physical properties
Compound T(N,I) [°C] = 94.6
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5767
1 APUQU-2-F 6.00 Δη (20°C, 589.3 nm) = 0.0919
2 APUQU-3-F 6.00 ει ι (20°C, 1 kHz) = 7.0
3 PGUQU-3-F 3.00 Δε (20°C, 1 kHz) = 4.3
4 CCGU-3-F 4.00 ki(20°C) = 15.0
5 CC-3-V 42.00 k3(20°C) = 18.8
6 CC-3-V1 8.00 γι (20°C) [mPa s] = 75
7 PP-1-2V1 3.00
8 CCP-V-1 15.50
9 CCP-V2-1 15.50
10 PPGU-3-F 0.50
∑ 100.00
Mixture N-11 :
Composition Physical properties
Compound T(N,I) [°C] ' = 78
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5907
1 CC-3-V 36.00 Δη (20°C, 589.3 nm) = 0.1095
2 CC-3-V1 5.00 ει ι (20°C, 1 kHz) = 16.6
3 CCP-V-1 8.00 Δε (20°C, 1 kHz) = 12.9
4 PGP-2-2V 3.00 ki(20°C) = 12.1
5 CCQU-3-F 9.50 k3(20°C) = 13.4
6 PUQU-3-F 8.50 γι (20°C) [mPa s] = 78
7 APUQU-2-F 5.00
8 APUQU-3-F 8.00
∑ PGUQU-3-F 4.00
PGUQU-4-F 8.00
PGUQU-5-F 5.00
100.00
Mixture N-12:
Composition Physical properties
Compound T(N,I) [°C] = 94
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5776
1 APUQU-2-F 6.00 Δη (20°C, 589.3 nm) = 0.1038
2 APUQU-3-F 8.00 ει ι (20°C, 1 kHz) = 21.1
3 CDUQU-3-F 10.00 Δε (20°C, 1 kHz) = 17.3
4 DGUQU-4-F 4.00 ki(20°C) = 15.9
5 DPGU-4-F 5.00 k3(20°C) = 16.1
6 PGUQU-3-F ' 3.00 γι (20°C) [mPa s] = 111
7 PGUQU-4-F 7.00
8 CCQU-3-F 9.00
9 CC-3-2V1 10.00
10 CC-3-V 24.50
11 CC-3-V1 9.50
12 CCP-3-OT 4.00
∑ 100.00
Mixture N-13:
Composition Physical properties
Compound T(N,I) [°C] = 87
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5829
1 CC-3-V 30.00 Δη (20°C, 589.3 nm) = 0.1019
2 CC-3-V1 10.00 ει ι (20°C, 1 kHz) = 3.5
3 CC-3-4 2.50 Δε (20°C, 1 kHz) = -3.7
4 CCP-V-1 1.50 ki(20°C) = 15.2
5 PGIY-2-O4 4.00 k3(20°C) = 18.0
6 CCY-3-O2 10.00 γι (20°C) [mPa s] = 112
7 CCY-5-02 2.00
8 CLY-3-02 8.00
9 CPY-2-02 6.00
10 CPY-3-02 10.00
11 CY-3-02 12.00
12 B-20-05 4.00
∑ 100.00
Mixture N-14:
Composition Physical properties
Compound T(N,I) [°C] = 86
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5962
1 CPP-3-2 4.50 Δη (20°C, 589.3 nm) = 0.1118
2 CC-3-V 23.50 ει ι (20°C, 1 kHz) = 3.7
3 CC-3-01 4.00 Δε (20°C, 1 kHz) = -4.3
4 CCY-3-02 4.00 ki(20°C) = 15.0
5 CCY-3-03 7.00 k3(20°C) = 16.7
6 CCY-4-02 8.00 γι (20°C) [mPa s] = 143
7 CLY-3-02 8.00
8 CPY-2-02 7.00
9 CPY-3-02 11.00
10 CY-3-O2 11.00
11 PY-3-02 12.00
∑ 100.00
Mixture N-15:
Composition Physical properties
Compound T(N,I) [°C] = 75.2
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5837
1 CC-3-V 37.00 Δη (20°C, 589.3 nm) = 0.1016
2 PY-3-O2 11.50 ει ι (20°C, 1 kHz) = 3.7
3 CCY-3-02 5.00 Δε (20°C, 1 kHz) = -3.7
4 CY-3-02 11.50 ki(20°C) = 13.2
5 CCY-3-01 5.00 k3(20°C) = 15.2
6 CCY-4-02 4,00 γι (20°C) [mPa s] = 99
7 CLY-3-O2 7.00
8 CPY-2-02 9.00
9 CPY-3-02 10.00
∑ 100.00
Mixture N-16:
Composition Physical properties
Compound T(N,I) [°C] = 75.5
No. Abbreviation c/% ne (20°C, 589.3 nm) = 1.5823
1 CCY-3-01 6.00 Δη (20°C, 589.3 nm) = 0.1011
2 CC-3-V 31.50 ει ι (20°C, 1 kHz) = 3.8
3 CPY-2-O2 10.00 Δε (20°C, 1 kHz) = -4.1
4 CPY-3-O2 10.00 ki(20°C) = 13.3
5 PYP-2-3 4.00 k3(20°C) = 15.1
6 CCY-3-02 6.00 γι (20°C) [mPa s] = 113
7 CCY-4-02 2.00
8 CLY-3-02 5.00
9 CY-3-02 15.00
10 CY-5-02 5.00
11 CY-3-04 5.50
∑ 100.00
Mixture examples
Nematic LC mixtures M-1 to M-16 according to the invention are prepared from the nematic host mixtures N-1 to N-16 listed above and
photoalignment additives of formula I, according to the compositions given in the following table.
Figure imgf000196_0001
Alignment Experiments
Test displays are fabricated using raw untreated glass or ITO glass, are then filled with a nematic mixture according to mixture examples M-1 and M-2, respectively, and then cured, as described above. Next, the alignment quality is studied between crossed polarisers on a light box. A good dark state is observed when the cells are placed between crossed polarisers. A good transmissive state is observed when the cells are rotated by 45°.
This shows, that excellent uniform planar alignment is achieved with mixtures from examples M1 and M-2.
In a comparative experiment, a test display is filled with a nematic host mixture N-1 without a photoalignment additive of formula I and is cured in the same way as described for Mixture Examples M-1 and M-2 according to the invention. In the comparative experiment, under all polarizer configurations an inhomogeneous transmissive state is observed.

Claims

Patent Claims
1. Liquid crystal mixture, characterised in that it comprises a
photoalignment component A) comprising one or more photoreactive compounds of formula I, and a liquid-crystalline component B), comprising one or more mesogenic or liquid-crystalline compounds, wherein formula I is as follows:
Figure imgf000198_0001
wherein denotes an aryl or heteroaryl group, which may be substituted by one or more radicals L, are each, independently of one another, defined like A 1 or denote a cycloalkyl group having 3 to 10 C atoms, in which 1 to 4 non-adjacent CH2 groups may be replaced by O and in which one or more H atoms may be replaced by a group L, on each occurrence, identically or differently, denotes OH, F, CI, Br, I, -CN, -NO2, SF5, -NCO, -NCS, -OCN, - SCN,
Figure imgf000198_0002
-C(=O)R2, -N(RZ)2, optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F or CI, Z11 on each occurence, identically or differently, denotes
-CH2CH2-, -CF2CF2-, -CF2CH2-, -CH2CF2-, -C(O)0-, -OC(O)-, -CH=CH-COO-, -OCO-CH=CH-, or a single bond,
R1 and R12 identically or differently, denote a group P-Sp-, or halogen, CN, optionally fluorinated alkyl or alkenyl with up to 15 C atoms in which one or more non adjacent Chb-groups may be replaced by -0-, -S-, -CO-, -C(O)O-, -O-C(O)-, O-C(0)-0-, with the proviso that at least one of R1 and R12 denotes a group P-Sp-,
Rz each, independently of one another, denote H or alkyl having 1-12 C atoms,
P a polymerisable group,
Sp a spacer group or a single bond, a denotes 0 or 1.
Liquid crystal mixture according to claim 1 , characterised in that component A) comprises one or more compounds of formula I s 1-1 to I-8
1-1
Figure imgf000199_0001
Figure imgf000200_0001
Figure imgf000200_0002
Figure imgf000200_0003
Figure imgf000200_0004
Figure imgf000200_0005
Ġ 30
Figure imgf000201_0001
wherein R11 and R12 and L are defined as indicated in claim 1 , and r, on each occurrence, identically or differently, is 0, 1 or 2.
3. Liquid crystal mixture according to claim 1 or 2, characterised in that the total concentration of compounds of formula I in the mixture is in the range of from 0.01 to 10% by weight.
4. Liquid crystal mixture according to one or more of claims 1 to 3
characterised in that it additonally comprises a polymerisable component C) comprising one or more compounds of formula P
Pa-(Spa)s1 -A2-(Z1 -A1 )n2-(Spb)s2-Pb P wherein
Pa, Pb each, independently of one another, denote a
polymerisable group,
Spa, Spb on each occurrence, identically or differently, denote a spacer group, s1 , s2 each, independently of one another, are 0 or 1 ,
A1 , A2 each, independently of one another, denote a radical selected from the following groups: a) the group consisting of trans-1 ,4-cyclohexylene, 1 ,4- cyclohexenylene and 4,4'-bicyclohexylene, wherein, in addition, one or more non-adjacent CH2 groups may be replaced by -O- and/or -S- and wherein, in addition, one or more H atoms may be replaced by F, the group consisting of 1 ,4-phenylene and 1 ,3-phenylene, wherein, in addition, one or two CH groups may be replaced by N and wherein, in addition, one or more H atoms may be replaced by L, c) the group consisting of tetrahydropyran-2,5-diyl, 1 ,3-diox- ane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobutane-1 ,3- diyl, piperidine-1 ,4-diyl, thiophene-2,5-diyl and
selenophene-2,5-diyl, each of which may also be mono- or polysubstituted by L, d) the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may, in addition, be replaced by heteroatoms, pref- erably selected from:
Figure imgf000202_0001
Figure imgf000203_0001
where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, is 0, 1 , 2 or 3,
Z1 in each case, independently of one another, denotes
-CO-0-, -O-CO-, -CH2O-, -OCH2-, -CF2O-, -OCF2-, or -(CH2)n-, where n is 2, 3 or 4, -0-, -CO-, -C(R°R00)-, -CH2CF2-, -CF2CF2- or a single bond,
L on each occurrence, identically or differently, denotes F,
CI, CN, SCN, SF5 or straight-chain or branched, in each case optionally fluorinated, alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having up to 12 C atoms,
R°, R00 each, independently of one another, denote H, F or
straight-chain or branched alkyl having 1 to 12 C atoms, wherein, in addition, one or more H atoms may be replaced by F,
M denotes -O-, -S-, -CH2-, -CHY1- or -CY1Y2-, and
Y and Y2 each, independently of one another, have one of the
meanings indicated above for R° or denote CI or CN.
Liquid crystal mixture according to claim 4, characterised in that the concentration of polymerisable compounds of formula P is in the range of from 0.01 to 10% by weight.
Liquid crystal mixture according to claim 4 or 5, characterised in that it comprises one or more compounds of formula P selected from the compounds of the sub-formulae P10-1-1 and P10-1-2
Figure imgf000204_0001
wherein
n4 is an integer from 1 to 10. Liquid crystal mixture according to one or more of claims 1 to 6, characterised in that the LC host mixture has negative dielectric anisotropy.
Liquid crystal mixture according to claim 7, characterised in that the LC host mixture comprises one or more compounds selected from the following formulae:
Figure imgf000205_0001
Figure imgf000205_0002
wherein
a is 1 or 2, b is O or l ,
Figure imgf000205_0003
R1 and R2 each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non- adjacent Chb groups may be replaced by -O-, -CH=CH-, -CO-, -O-CO- or -CO-O- in such a way that O atoms are not linked directly to one another, denotes -CH=CH-, -CH2O-, -OCH2-, -CF2O-, -OCF2-, -0-, -CH2-, -CH2CH2- or a single bond, preferably a single bond,
L1-4 each, independently of one another, denote F, CI, OCF3,
CF3, CH3, CH2F, CHF2.
Liquid crystal mixture according to one or more of claims 1 to 6, characterised in that the LC host mixture has positive dielectric anisotropy.
Liquid crystal mixture according to claim 9, characterised in that the LC host mixture comprises one or more compounds selected from the group consisting of the compounds of the formulae II and III,
Figure imgf000206_0001
wherein
R20 each, identically or differently, denote a halogenated or un- substituted alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by -c=c-, -CF20-, -CH=CH-, -o- , X - , -O-, -CO-0- or -0-CO- in such a way that O atoms are not linked directly to one another, each, identically or differently, denote F, CI, CN, SF5, SCN, NCS, a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical, each having up to 6 C atoms, and
each, identically or differently, denote H or F,
each, identically or differently,
Figure imgf000207_0001
denote
Figure imgf000207_0002
11. Liquid crystal mixture according to claim 9 or 10, characterised in that it comprises one or more compounds selected from the group consisting of compounds of formulae XI and XII
Figure imgf000207_0003
Figure imgf000208_0001
wherein R20, X20 and Y20"23 have the meanings indicated in formula in claim 10, and
each, independently of one another,
Figure imgf000208_0002
denote
H
Figure imgf000208_0003
and
Figure imgf000208_0004
12. Liquid crystal mixture according to one or more of claims 1 to 1 1 ,
characterised in that the LC host mixture comprises one or more compounds selected from the following formula:
R3 -< C V-Zy-< D " R4 D wherein the individual radicals have the following meanings:
Figure imgf000209_0001
°r
Figure imgf000209_0002
~i o
R3 and R4 each, independently of one another, denote alkyl having 1 to 12 C atoms, wherein, in addition, one or two non-adjacent CH2 groups may be replaced by -0-, -CH=CH-, -CO-, -O-CO- or -CO-O- in such a way that O atoms are not linked directly to one another,
∑ denotes -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-,
-OCH2-, -COO-, -OCO-, -C2F4-, -CF=CF- or a single bond
Liquid crystal mixture according to one or more of claims 1 to 12, characterised in that the LC host mixture comprises one or more compounds selected from the following formulae:
Figure imgf000209_0003
C4H9 D1 b
Figure imgf000209_0004
Figure imgf000210_0001
Figure imgf000210_0002
14. Use of the liquid crystal mixture according to one or more of claims 1 to 13 for the fabrication of a liquid crystal display.
15. Process for the fabrication of a liquid crystal display, comprising at least the steps of:
providing a first substrate which includes a pixel electrode and a common electrode for generating an electric field substantially parallel to a surface of the first substrate in the pixel region;
providing a second substrate, the second substrate being disposed opposite to the first substrate;
interposing a liquid crystal mixture according to one or more of claims 1 to 13;
irradiating the liquid crystal mixture with linearly polarised light causing photoalignment of the liquid crystal;
curing the polymerisable compounds of the liquid crystal mixture by irradiation with ultraviolet light or visible light having a wavelength of 450 nm or below.
16. Process according to claim 5, characterised in that the linearly
polarised light is ultraviolet light or visible light having a wavelength of 450nm or below.
Display, produced by a proccess according to claim 15 or 16.
18. Display according to claim 17, wherein the display is an IPS or FFS display.
19. Display according to claim 17 or 18, in which both the first and the second substrate contain a rubbed or unrubbed polyimide layer.
20. Display according to claim 17 or 18, in which none or only one of the first and second substrates contains a polyimide layer.
21. Compound of formula I as given in claim 1 , wherein one or both of the groups Sp denote a single bond.
PCT/EP2016/002035 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display WO2017102068A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US16/062,824 US11053442B2 (en) 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display
CN201680073732.0A CN108368425B (en) 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display
CN202210269446.9A CN114702965A (en) 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display
KR1020187020317A KR20180096688A (en) 2015-12-17 2016-12-02 Liquid crystal mixtures and liquid crystal displays
JP2018531413A JP2019508511A (en) 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display
EP16805293.4A EP3390570B1 (en) 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP15200931.2 2015-12-17
EP15200931 2015-12-17
EP16185694.3 2016-08-25
EP16185694 2016-08-25

Publications (1)

Publication Number Publication Date
WO2017102068A1 true WO2017102068A1 (en) 2017-06-22

Family

ID=57471790

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/002035 WO2017102068A1 (en) 2015-12-17 2016-12-02 Liquid crystal mixture and liquid crystal display

Country Status (7)

Country Link
US (1) US11053442B2 (en)
EP (1) EP3390570B1 (en)
JP (1) JP2019508511A (en)
KR (1) KR20180096688A (en)
CN (2) CN114702965A (en)
TW (1) TWI722076B (en)
WO (1) WO2017102068A1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018192896A1 (en) * 2017-04-20 2018-10-25 Merck Patent Gmbh Light modulation element
JP2019066758A (en) * 2017-10-04 2019-04-25 Jnc株式会社 Method for manufacturing liquid crystal display element and apparatus for manufacturing liquid crystal display element
WO2019206788A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2019206787A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2019206791A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2019206789A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020017622A1 (en) * 2018-07-20 2020-01-23 公立大学法人兵庫県立大学 Photoreactive composition, liquid crystal cell using photoreactive composition, and method for producing liquid crystal cell
WO2020038859A1 (en) 2018-08-22 2020-02-27 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020038861A1 (en) 2018-08-22 2020-02-27 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020043643A1 (en) 2018-08-28 2020-03-05 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020071135A1 (en) * 2018-10-02 2020-04-09 Dic株式会社 Liquid crystal composition using alignment assistant, liquid crystal display element and method for producing same
WO2020074440A1 (en) 2018-10-10 2020-04-16 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020120371A2 (en) 2018-12-12 2020-06-18 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020245084A1 (en) 2019-06-04 2020-12-10 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
JPWO2020121639A1 (en) * 2018-12-12 2021-02-15 Dic株式会社 Polymerizable compound-containing liquid crystal composition, liquid crystal display device, and polymerizable compound
EP3792334A1 (en) 2019-09-16 2021-03-17 Merck Patent GmbH Liquid crystal mixture and liquid crystal display
WO2021151846A1 (en) 2020-01-29 2021-08-05 Merck Patent Gmbh Method for adjustment of alignment of liquid crystals
WO2021160633A1 (en) 2020-02-13 2021-08-19 Merck Patent Gmbh Liquid crystal device
WO2021160705A1 (en) 2020-02-13 2021-08-19 Merck Patent Gmbh Liquid crystal devive
US11353751B2 (en) 2019-09-26 2022-06-07 Merck Patent Gmbh Double layer liquid crystal device and process of manufacture
EP4012004A1 (en) 2020-12-11 2022-06-15 Merck Patent GmbH Liquid crystal device
WO2022122780A1 (en) 2020-12-11 2022-06-16 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
DE102022001602A1 (en) 2021-05-07 2022-11-10 MERCK Patent Gesellschaft mit beschränkter Haftung Liquid crystal medium containing polymerizable compounds

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107384439A (en) * 2017-07-27 2017-11-24 默克专利股份有限公司 Liquid crystal media and the liquid crystal display for including it
JP2020093995A (en) * 2018-12-12 2020-06-18 Dic株式会社 Polymerizable cinnamate ester derivative manufacturing method
EP3914669A1 (en) 2019-01-22 2021-12-01 Merck Patent GmbH Method for the preparation of a liquid crystal polymer film
CN111763518B (en) * 2020-06-12 2021-11-12 江苏三月科技股份有限公司 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element thereof
WO2022250083A1 (en) * 2021-05-28 2022-12-01 三菱ケミカル株式会社 Compound production method, method for producing polymerizable composition, polymer production method, method for producing optically anisotropic body, and compound
TW202311275A (en) * 2021-08-05 2023-03-16 日商積水醫療股份有限公司 Method for producing alkylsilyloxy substituted benzyl compound

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770107A (en) * 1995-10-05 1998-06-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Reactive liquid crystalline compound
WO2000005189A1 (en) * 1998-07-24 2000-02-03 Rolic Ag Crosslinkable liquid crystalline compounds
EP1524308A1 (en) * 2003-10-17 2005-04-20 MERCK PATENT GmbH Polymerisable Cinnamates with lateral substitution
EP2843027A1 (en) * 2012-04-24 2015-03-04 DIC Corporation Liquid crystal composition comprising polymerizable compounds and liquid crystal display element using same
EP2933308A1 (en) * 2012-12-12 2015-10-21 DIC Corporation Nematic liquid crystal composition and liquid crystal display element using same
EP2955570A1 (en) * 2013-02-06 2015-12-16 DIC Corporation Liquid crystal display element and manufacturing method for same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW500747B (en) * 1999-01-19 2002-09-01 Hayashi Telempu Kk Alignment layer and a liquid crystal display using the same
DE602004001650T2 (en) * 2003-10-17 2007-07-19 Merck Patent Gmbh Polymerizable cinnamic acid derivatives with a lateral substitution
JP4402429B2 (en) * 2003-11-11 2010-01-20 大日本印刷株式会社 Optical element
KR101108227B1 (en) * 2007-10-10 2012-01-31 주식회사 엘지화학 Polymer for liquid crystal photoalignment, liquid crystal photoalignment film containing the same and liquid crystal display containing the same
US9157027B2 (en) * 2012-04-24 2015-10-13 Jnc Corporation Compound having four polymerizable groups, liquid crystal composition and liquid crystal display device
JP5978938B2 (en) * 2012-11-13 2016-08-24 Jnc株式会社 Polymerizable compound, polymerizable composition, and liquid crystal display device
CN104884981A (en) * 2012-12-14 2015-09-02 默克专利股份有限公司 Birefringent rm lens

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770107A (en) * 1995-10-05 1998-06-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Reactive liquid crystalline compound
WO2000005189A1 (en) * 1998-07-24 2000-02-03 Rolic Ag Crosslinkable liquid crystalline compounds
EP1524308A1 (en) * 2003-10-17 2005-04-20 MERCK PATENT GmbH Polymerisable Cinnamates with lateral substitution
EP2843027A1 (en) * 2012-04-24 2015-03-04 DIC Corporation Liquid crystal composition comprising polymerizable compounds and liquid crystal display element using same
EP2933308A1 (en) * 2012-12-12 2015-10-21 DIC Corporation Nematic liquid crystal composition and liquid crystal display element using same
EP2955570A1 (en) * 2013-02-06 2015-12-16 DIC Corporation Liquid crystal display element and manufacturing method for same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZANDE VAN DER B M I ET AL: "PATTERNED RETARDERS PREPARED BY PHOTOISOMERIZATION AND PHOTOPOLYMERIZATION OF LIQUID CRYSTALLINE FILMS", LIQUID CRYSTALS, TAYLOR & FRANCIS, vol. 33, no. 6, 1 June 2006 (2006-06-01), pages 723 - 737, XP001244939, ISSN: 0267-8292, DOI: 10.1080/02678290600647345 *

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018192896A1 (en) * 2017-04-20 2018-10-25 Merck Patent Gmbh Light modulation element
US11124705B2 (en) 2017-04-20 2021-09-21 Merck Patent Gmbh Light modulation element
JP2019066758A (en) * 2017-10-04 2019-04-25 Jnc株式会社 Method for manufacturing liquid crystal display element and apparatus for manufacturing liquid crystal display element
JP7078921B2 (en) 2017-10-04 2022-06-01 Jnc株式会社 Liquid crystal display element manufacturing method and liquid crystal display element manufacturing equipment
US11905450B2 (en) 2018-04-23 2024-02-20 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
CN111989383A (en) * 2018-04-23 2020-11-24 默克专利股份有限公司 Liquid crystal mixture and liquid crystal display
US11312907B2 (en) 2018-04-23 2022-04-26 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2019206788A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
US11352560B2 (en) 2018-04-23 2022-06-07 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2019206791A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
CN111971368B (en) * 2018-04-23 2024-01-30 默克专利股份有限公司 Liquid crystal mixture and liquid crystal display
US11939511B2 (en) 2018-04-23 2024-03-26 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2019206787A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
CN111971368A (en) * 2018-04-23 2020-11-20 默克专利股份有限公司 Liquid crystal mixture and liquid crystal display
WO2019206789A1 (en) 2018-04-23 2019-10-31 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
JP7471577B2 (en) 2018-07-20 2024-04-22 兵庫県公立大学法人 Photoreactive composition, liquid crystal cell using photoreactive composition, and method for manufacturing liquid crystal cell
WO2020017622A1 (en) * 2018-07-20 2020-01-23 公立大学法人兵庫県立大学 Photoreactive composition, liquid crystal cell using photoreactive composition, and method for producing liquid crystal cell
WO2020038861A1 (en) 2018-08-22 2020-02-27 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020038859A1 (en) 2018-08-22 2020-02-27 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
WO2020043643A1 (en) 2018-08-28 2020-03-05 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
JPWO2020071135A1 (en) * 2018-10-02 2021-02-15 Dic株式会社 Liquid crystal composition and liquid crystal display element using an orientation aid, and a method for manufacturing the same.
WO2020071135A1 (en) * 2018-10-02 2020-04-09 Dic株式会社 Liquid crystal composition using alignment assistant, liquid crystal display element and method for producing same
WO2020074440A1 (en) 2018-10-10 2020-04-16 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
CN112805353A (en) * 2018-10-10 2021-05-14 默克专利股份有限公司 Liquid crystal mixture and liquid crystal display
WO2020120371A2 (en) 2018-12-12 2020-06-18 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
JPWO2020121639A1 (en) * 2018-12-12 2021-02-15 Dic株式会社 Polymerizable compound-containing liquid crystal composition, liquid crystal display device, and polymerizable compound
WO2020245084A1 (en) 2019-06-04 2020-12-10 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
EP3792334A1 (en) 2019-09-16 2021-03-17 Merck Patent GmbH Liquid crystal mixture and liquid crystal display
US11353751B2 (en) 2019-09-26 2022-06-07 Merck Patent Gmbh Double layer liquid crystal device and process of manufacture
WO2021151846A1 (en) 2020-01-29 2021-08-05 Merck Patent Gmbh Method for adjustment of alignment of liquid crystals
DE112021001011T5 (en) 2020-02-13 2022-12-01 MERCK Patent Gesellschaft mit beschränkter Haftung liquid crystal device
WO2021160705A1 (en) 2020-02-13 2021-08-19 Merck Patent Gmbh Liquid crystal devive
WO2021160633A1 (en) 2020-02-13 2021-08-19 Merck Patent Gmbh Liquid crystal device
EP4012004A1 (en) 2020-12-11 2022-06-15 Merck Patent GmbH Liquid crystal device
WO2022122780A1 (en) 2020-12-11 2022-06-16 Merck Patent Gmbh Liquid crystal mixture and liquid crystal display
DE102022001602A1 (en) 2021-05-07 2022-11-10 MERCK Patent Gesellschaft mit beschränkter Haftung Liquid crystal medium containing polymerizable compounds

Also Published As

Publication number Publication date
EP3390570B1 (en) 2020-03-18
US20200255740A1 (en) 2020-08-13
EP3390570A1 (en) 2018-10-24
TWI722076B (en) 2021-03-21
TW201736581A (en) 2017-10-16
CN108368425B (en) 2023-01-13
KR20180096688A (en) 2018-08-29
CN108368425A (en) 2018-08-03
JP2019508511A (en) 2019-03-28
US11053442B2 (en) 2021-07-06
CN114702965A (en) 2022-07-05

Similar Documents

Publication Publication Date Title
EP3390570B1 (en) Liquid crystal mixture and liquid crystal display
EP3784750B1 (en) Liquid crystal mixture and liquid crystal display
EP3784752B1 (en) Liquid crystal mixture and liquid crystal display
US11312907B2 (en) Liquid crystal mixture and liquid crystal display
EP3784755B1 (en) Liquid crystal mixture and liquid crystal display
KR20140004180A (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3980510A1 (en) Liquid crystal mixture and liquid crystal display
WO2020074440A1 (en) Liquid crystal mixture and liquid crystal display
EP3841183A1 (en) Liquid crystal mixture and liquid crystal display
EP3841182A1 (en) Liquid crystal mixture and liquid crystal display
EP3792334B1 (en) Liquid crystal mixture and liquid crystal display
WO2020120371A2 (en) Liquid crystal mixture and liquid crystal display
EP4259748A1 (en) Liquid crystal mixture and liquid crystal display

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16805293

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2018531413

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20187020317

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020187020317

Country of ref document: KR